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S u m m a r y .
Triplet repeats are simple tandem repeats with a bas ic  
unit  of three nucleotides. The CTG/CAG class, which is o v e r ­
represented in higher eukaryote genomes, occurs in a number  o f  
regulatory  genes, often encoding poly-glutamine.  More r e c e n t ly ,  
expansion of CAG/CTG triplet repeats in certain human genes h a s  
become associated with certain diseases,  leading either to loss o f  
function (as the case may be with CTG in Myotonic Dystrophy) o r  
gain of function (CAG encoding glutamine stretches in SCAl, 
Huntington's  disease, Kennedy's Disease). Since the mouse is t h e  
best mammalian  organism in which to study the biology o f  
triplet repeats and the genes in which they occur, a set of m o u s e  
cDNAs containing triplet repeats was isolated and p a r t i a l l y  
c h a r a c t e r i s e d .
To this end, DNA sequencing was performed to i d e n t i fy  
the trinucleotide  repeats.  Sequences  flanking the t r i n u c l e o t i d e  
repeat  were used to identify genes which show similarity  o r  
identity to previously character ised genes. This was used to  
compare the lengths of the t rinucleotide  repeats found in t h e  
mouse clones described in this work with those found in  
(previously character ised)  genes which have t r i n u c l e o t i d e  
repeats at identical positions.
To identify clones which showed changes to mRNA 
abundance during deve lopm ent  and adult tissue, reverse d o t -  
blot analysis was performed on a subset of cDNA clones d e r i v e d  
from the 8.5 and 12.5 dpc whole mouse embryo cDNA libraries.
Finally, four clones (two high and two low RNA 
abundance)  were selected for further  molecular analysis.  Of 
these four clones, the two which exhibited high levels of RNA in
the reverse dot blot exper iments ,  showed a more c o m p le x  
expression pattern in northern analysis and all four c lo n es  
appear to derive from single copy (per haploid genome) genes.
In conclusion, this work has indicated that mouse g e n e s  
contained similarly sized trinucleotide repeats compared to t h o s e  
found in human genes; that these repeats are possibly c o n s e r v e d  
between distantly related species and this may be related to t h e  
proper function of the genes. A third of those genes (which w e r e  
analysed for the existence of RNA derived from the p a r e n t a l  
gene) displayed detectable  amounts  of expression and m o s t  
showed variat ions in the RNA abundance either at d i f f e r e n t  
stages during deve lopm ent  or in different  adult tissues. Most o f  
those were derived from unknown genes. This indicates t h a t  
there may be many novel genes containing CAG/CTG 
trinucleotide in the mouse which may be identified in the f u t u r e  
for further  character isa t ion  during developmenta l  and o r g a n  
specific analysis.
One clone (mCTG 63), although not novel, contains t h e  
largest perfect CAG/CTG triplet repeat found in this work. T h e  
repeat  may be transcribed  as CTG in the coding strand of th is  
gene. This situation is analogous to the CTG triplet repeat w h ic h  
has a role in myotonic dystrophy (found in the 3 ’UTR of t h e  
DM PK gene). This clone is worth further analysis for this reason.
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C hapter  1 
G e n e r a l  I n t r o d u c t io n
1.1 I n t r o d u c t io n .
One of the aims of today's research is to unders tand  how t h e  
various parts of an organism function and how they i n t e r a c t  
together.  This has been true from early modern biology w h e r e  
scientists first  described phenomena visually and later with the a id  
of the microscope. As more elaborate  and powerful  eq u ip m en t  a n d  
techniques  have been invented,  the rate of accumula t ion  o f  
information  and the resolution of the mechanisms  has i n c r e a s e d  
r a p id ly .
Molecular biology techniques have been used with great e f f e c t  
in unders tand ing  biological systems. For instance, the p o l y m e r a s e  
chain reaction (PCR) has been applied to the identificat ion of t h e  
whole gene content  of certain organisms including man and m o u s e .  
For example,  it has been used in the mapping of genes on to  
physical and genetical maps (Love ct al, 1990) and the identification 
of gene sequence using a modified version (i.e. cycle s e q u e n c i n g  
using f luorescent dye- te rm ina to rs  as described by P e r k in - E lm e r ;  
Trower et al, 1995) of the DNA dideoxy sequencing protocol ( S a n g e r  
et al, 1978). The second example here highlights another  point,  t h a t  
these methods can always be improved.
Mammalian  systems are relatively u n d e r -c h a ra c te r i s e d  as  
concerning deve lopm enta l  processes. Most work has been done in  
other organisms,  part icular ly, the fruit fly Drosophila,  in which it  
has been easier to dissect development.  As a result  of this, m a n y  
m am m al ian  deve lopm enta l  genes have been ident ified by t h e i r  
homology to Drosophila  genes. However,  this assumes that g e n e s  
that are used in development,  are common to all organisms. This
F ig u re  1.1
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F igure  1.1 A p p roach es  for analysis  o f  m a m m a l ia n  genom es .
This Figure details the different ways for the analysis  o f  
mammalian genomes, to identify genes and to locate m uta t ions  t h a t  
cause disease. Adapted from Frankel (1995).
appears  to be true for the pr imary deve lopm enta l  genes (such as  
homeobox containing genes; see Section 1.3). However  this does n o t  
preclude the action of novel genes in the d ev e lopm en t  of a n y  
structures found to be unique to an individual species.
Alternat ive approaches  have been developed that make i t  
easier to dissect d ev e lopm en t  in mammals.  A combinat ion of o ld e r  
and more recent ly developed techniques  (see Figure 1.1), make i t  
now possible to dissect m ammalian  deve lopm en t  more e f fec t ive ly .  
The mouse has an im portan t  role in this process as it is the b e s t  
understood and character ised model system for the invest igation of  
developmental biology of  mammals.  The early embryologica l  s tag e s  
post ferti l isation are common to both human (a pr imate)  and t h e  
mouse. However,  in rodents  there is a process of "turning" w h e r e  
the embryo is observed to invert with respect  to the r o s t r a l - c a u d a l  
axis, with the pr imordial cell types rearranging themselves .  A f t e r  
this process major organogenesis occurs in a way which is similar to  
human development .  A more detailed description of m u r i n e  
development can be found in Kauffman and Kauffman (1992).
1.2 M olecu lar  techn iques  for f inding  novel  genes .
1.2.1  M ass  s e q u e n c in g  e x p er im en ts .
The most basic of  strategies rely on the random sequencing of  
genetic material.  Examples of this would be the human g e n o m e  
project  (Dausset et al, 1990), its mouse coun te rpar t  and m a s s  
sequencing of cDNA clones from a particular library.
These projects initially generate  a lot of information which is 
subjected to other criteria to determine interest from a p a r t i c u l a r
view point. For example, an anonymous gene sequence w o u ld  
require  to be analysed for its spa t io- tempora l  express ion to a s se s s  
its possible involvement in developmental  processes.  This is feasible 
for a few genes but to apply this to a large number  of cloned g e n e s  
would be very time consuming.
Related to the mass sequencing projects outlined above, t h e r e  
are a group of techniques which take advantage of the d i f f e r e n c e s  
in t ranscr ibed  material between different  cell types and d i f f e r e n t  
stages during development .  Among the differentia lly  e x p r e s s e d  
genes there are genes which are unique for a part icular  cell type o r  
developmental  stage. These genes provide a way into the m o l e c u l a r  
charac ter isa t ion  of that cell type and of specific d e v e l o p m e n t a l  
p r o c e s s e s .
The basic requirement for these techniques  is the existence of  
two distinct pools of expressed  genetic informat ion which can b e  
used to describe and identify differences between them. Subtractive 
hybr id isa t ion  (Hedrick et al, 1984) uses solution hybridisa t ion to  
remove sequences which are shared between the two pools of  
informat ion.  The rem ainder  is specific to one library. A re c ip ro c a l  
exper iment  is required to determine the unique portion of the o t h e r  
library. This approach has also d isadvantages.  For example, g e n e s  
which have high steady state expression levels may be o v e r ­
represented in the final subtracted fraction because of an i m b a la n c e  
in input material.  This is counteracted by having an excess of t h e  
driver l ibrary (which constitutes the probing sequences).  U n iq u e  
sequences  can also become excluded because of s e q u e n c e s  
co rresponding  to specific protein domains which are s h a r e d  
between different proteins like DNA binding domains and motifs fo r  
st ructural  proteins.  These common sequences be tween genes can
lead to the removal of cell- type specific gene sequences  co n ta in in g  
them.
mRNA different ial  display (Liang and Pardee, 1992) a l t h o u g h  
requir ing two different reference points, does not rely o n  
hybrid isat ion.  It is PCR based. Essentially PCR is performed w i t h  
random primer sets on the two cDNA sources, the products  are size 
separa ted  e lectrophoret ica l ly  and compared to each o th e r .  
Differences  between the electrophoretic  pat terns  are taken to b e  
specific to one or the other mRNA sources.
All of the above techniques  generated much s e q u e n c e  
information,  but it was necessary to apply other test criteria to  
enhance the quality of the data for the specific question that w a s  
originally asked i.e. which gene sequences are specifically e x p r e s s e d  
in a particular cell type.
1.2 .2  C o m p a r a t iv e  seq u e n c e  ana lys is
Another  way to identify genes with interesting pat terns  {e.g. 
sequences  which correlate with functional domains  in prote ins) is 
the use of sequence comparison.  This is based on the matching o f  
residues  (amino acids or nucleic acid bases) between d i f f e r e n t  
sequences  and building up of a score of re la tedness  based on t h e  
matches  in sequence. These scoring methods are conducted by t h e  
use of a lgor ithm based program m es  which add up the scores for a 
comparison  based on a system of marking matches positively, a n d  
penalt ies  for mismatches,  insertions and deletions. T h e s e  
programmes have been developed to handle sequences in two ways. 
Global al ignments  {e.g. dot matrix) make comparisons  over t h e  
whole sequences. This is sensitive but it is long and slow w h i l e
making all the possible combinations of compar isons. More w id e ly  
used in explicit  search program m es  is the local a l ignment  m e t h o d  
which searches for short perfect matches (called words) of a defined 
m in im um  size (k-tuple value). Examples  of such program m es  a r e  
the FASTA program m e (Lipman and Pearson, 1985) and BLAST 
(Altschul et al, 1990). FASTA is more sensitive than BLAST b e c a u s e  
after an initial scoring round it then re-scores the data using a PA M  
(Point Accepted Mutation)  table. This assumes that not more t h a n  
one change has occurred at any one position and allows for m o r e  
distant re lat ionships  between sequences  to be ascertained. A m o r e  
detailed explanat ion and compar ison of available s e a r c h  
programmes can be found in Chapter 7 (page 215-248) of the Guide 
to Human Genome Computing (1994).
The identification of sequence pat terns by informatics is a 
useful technique, but one should be cautious of the results and it is 
better  to independent ly  verify similarit ies by d i r e c t  
exper im enta t ion .  For example, repet it ive sequence can a l t e r  
significantly the score of alignments  and lead to m i s - i n t e r p r e t a t i o n  
of data. However,  without computer based sequence compar isons,  i t  
would be impossible to handle the large volume of data b e in g  
generated by the genome sequencing projects.  This makes them an  
invaluable tool for modern biology.
1.3 Sem i-sp ec i f ic  m ethods  for the identi f icat ion  of  genes.
Semi-specif ic methods are also available for the id e n t i f i c a t io n  
of novel genes. Selection depends on ascerta ined qualit ies of  
individual data. This can be a pattern within the information. For  
example  a motif within DNA which represen ts  a c o n s e r v e d  
funct ional domain of a protein, such as a DNA binding motif .
Alternatively it can take the form of other types of information,  f o r  
example  expression analysis.
1.3.1  H e te r o lo g o u s  scr e en in g .
As mentioned above, pat terns within the sequence of b o th  
RNA and DNA can be used to identify interesting anonymous  genes .  
There are many examples  of the use of conserved sequence, w h ic h  
relates to conserved functional domains  in proteins. These can b e  
used to identify new members  of gene families by way of
heterologous screening where similar sequences  are picked up in 
library screens by using relaxed screening conditions.
1.3 .1 .1 U s ing  h e tero logou s  sequences  as probes .
An example of this is the homeobox containing g e n e s  
( rev iewed in Gehring, 1987) which are found in e u k a r y o t i c  
organisms (Holland and Hogan, 1986). A homeobox is a 60 a m in o  
acid domain which forms a helix-loop-hel ix  s tructure  w h ich  
mediates  sequence specific binding to DNA (Gehring, 1987). T h e  
homeobox was first identified in Drosophila  where mutations in 
genes which contained homeoboxes were found to be the cause of
deve lopm en ta l  (homeotic) mutants  (Lewis, 1978). H e te ro lo g o u s  
screening found more genes in Drosophila  which contained th is  
homeobox. Homeotic genes are organised in two clusters and t h e  
physical  order of these genes corresponds to the order in w h ic h
they are expressed along the an te r io r -pos te r io r  axis of the e m b r y o  
during development  (Harding et al, 1985). The most  3' gene h a v in g  
the most anter ior expression limit. By further  h e t e r o lo g o u s  
screening homeobox containing genes have also been found in o t h e r  
organisms which possess a segmented body pat tern, (e.g. m o u se ,  
Duboule et al, 1986; Human, Boncinelli  et al, 1988) where they a r e  
similar ly organised into clusters and exhibit the cluster po s i t io n  
effect descr ibed above both in body pattern formation (Graham e t  
al,  1989) and further elaborations in structures which develop a f t e r  
the body pattern, e.g. hind brain (Wilkinson and Krumlauf,  1990) .  
Heterologous screening does have its l imitations. For example it can  
only be used for the identification of new members  of a g e n e  
family. It cannot  be used to identify new classes of genes w h ic h
may contain un-described protein domains.
1 .3 .1 .2  D egenerate  PCR.
Another  method of heterologous screening has been u s e d  
successfully; it is PCR based and relies on the design of d e g e n e r a t e  
oligonucleot ides which are used as primers to drive amplificat ion of  
new sequences between the primer pairs. Cloning and s e q u e n c e
analysis is used to establish if the sequences  amplified are t h o s e  
from the original sequences or those which are derived from n o v e l  
m em bers  of that part icular  class of genes. For instance, a d d i t io n a l  
members  of specific subgroups of the G protein linked seven t r a n s -
m em brane  domain receptor  super-family  have been identified b y
this method (Libert et al, 1989).
1 .3 .2  I n s e r t io n a l  m u ta g e n e s i s .
1.3 .2.1  E n h a n cer  traps.
Another  technique which has been used is the introduct ion of  
reporter  genes into the genetic material of an organism. T h e  
reporter gene product is expressed under the control of e n d o g e n o u s  
regula tory  sequences and therefore acts as an assay of activity of
regulatory sequences in the organism; the reporter  gene e x p r e s s i o n  
pat tern partially or wholly reflecting the expression of t h e  
endogenous  genes which are under  the control of the r e g u l a t o r y  
sequences. This approach was first applied to the fruit fly, 
Drosophila m e l a n o g a s te r  (O'Kane and Gerhing, 1987). A m o d i f i e d  
transposon (P-element) was used as the backbone for an i n t e g ra t i o n
vector. It also contained a p-galactosidase gene under the i n f lu e n c e
of a weak Drosophila  promoter.  In the presence of an a c t iv e  
transposase ,  this construct moved to other sites in the Drosophi la  
genome,  where the p-galactosidase gene was expressed under t h e  
influence of regulatory  sequences. This construct was termed a n  
enhancer trap. A large number  of independent  t ransposit ion e v e n t s  
have been isolated in an attempt to saturate  the Drosophi la  g e n o m e  
and characterise the expression of genes.
Initial success in this organism lead other groups to extend the 
use of  the enhancer  trap vector approach to other organisms (C. 
elegans', Hope, 1991; Zebrafish, Westerf ield  et al, 1990) in c lu d in g  
mouse (Gossler et al, 1989; Korn et al, 1991). Two a l t e r n a t i v e
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approaches  to the construct ion of enhancer  trap vectors were u s e d  
in the mouse. The first construct  was based on m a m m a l i a n  
retrotransposons (Freidrich and Soriano, 1991). However  like the P -  
element vector  used in Drosophila,  these re t ro t ransposons  exhibit  a 
n on - random  integration pattern and are biased towards s e q u e n c e s  
which are t ranscr ip t iona lly  active at the time of integration. This is 
restr ic t ive because not all genes are actively expressed at any o n e  
time in the cells which are t ransformed in these exper iments  (e.g. 
oocytes or murine ES cells).
The second approach was to introduce enhancer  traps d i r e c t ly  
into the genome of embryonic  stem (ES) cells (Gossler et al, 1989:  
Allen et al, 1990). Stable integration of the constructs  was m a d e  
possible by the addition of a positive selectable marker  under  t h e  
influence of a cons titutive promoter.  For example, the c o n s t r u c t  
used by Gossler et al (1989), contains a p-galactosidase r e p o r t e r  
gene linked to a minimal promoter  from the heat shock p r o t e i n  
gene 68 (hsp68) and the Tn5 neomycin pho sp h o tran s fe ra se  gene as  
a selectable marker,  whose expression is driven by the m o u s e  
thymidine  kinase promoter .
Using this construct, Korn et al (1992) targeted 59 ES cell l ines  
and detected reporter  gene activity in 13 of them. Six of t h e s e  
showed a spat io- tempora l  restriction in expression pat tern in 
chimaeric  embryos.  For non-staining targeted cell lines, only 9 o u t  
of 46 showed changes in pattern* of expression when introduced into 
donor blastocysts and allowed to contr ibute to chimaeric e m b r y o s .  
From some of these cell lines which displayed a s p a t i o - t e m p o r a l  
pattern of reporter  gene expression in chimaeric embryos,  p u t a t i v e  
regula tory  genes have been identified. For example ETL ( e n h a n c e r  
trap locus) -1 (Soininen et al, 1992) a gene which was found in t h e
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vicinity of the enhancer  trap insertion site of ES cell line D 6 - 0 2 8  
(Korn et al, 1991), shows homology to the Drosophila  gene, B r a h m a  
(Tamkun et al, 1992), which controls homeobox expression. It a lso  
has similarity to the RAD54 gene of yeast (Emery et al, 1991).
1.3.2 .2 O ther  types  o f  insert ional  reporter  constructs .
Other types of vectors have been developed because t h e  
gene(s) which are the targets of the endogenous r e g u l a t o r y
elements  detected by an enhancer  trap vector may be at s o m e  
distance from the integration site. These constructs are known as  
gene traps (e.g. Gossler at al, 1989) or promoter  traps (6'.^. 
Vonm elchner  and Ruley, 1989) as activation of the reporte r  g e n e  
relies on the insertion (of the construct) to be within the gene or t h e  
promoter  sequences immediately upstream of the endogenous  gene.  
This makes them more efficient for the identificat ion of g e n e  
sequences. Gene traps are distinguished from promoter  traps in t h a t  
they have a 3' splice acceptor at the 5' end of the reporter  gene.  
These constructs  work by the splicing of the t ransgene t r a n s c r i p t  
into frame with the endogenous gene sequences to create a h y b r i d
construct  which is translated into a chimaeric protein which h a s
reporte r  protein activity and is expressed  in the tissues where t h e
endogenous  protein is expressed,  thereby reporting the e x p r e s s i o n  
profile of  the endogenous gene. Promoter traps do not have a sp l ice  
acceptor  and rely solely on integration near endogenous  p r o m o t e r s  
to drive expression of the marker  gene.
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1.4 A new direction.
There are other sequences  which are found in the co d in g  
sequence of genes which do not correspond to specific p r o t e i n  
domains  with defined function e.g. amino acid homopept ides .  T h e s e  
occur in a variety of protein types, but have been associated w i t h  
several general functions. There is a bias in the types of proteins in  
which they occur but this is independen t  of other specific p r o t e i n  
domains. This quality could allow them to be used in a general w a y  
to isolate new proteins with unknown structural motifs. For  
example  it is been suggested that certain hom opept ides  of a m i n o  
acids have general ised function. In part icular  polyg lu tamine  h a s  
been proposed to be involved in prote in  pro te in  interact ions b y  
adopting specific structures (Perutz et al, 1994). Polyglutamine h a s  
also been noted to occur in transcription factors (Gerber et al, 1994 ;  
Karlin and Burge, 1996). These transcription factors have a v a r i e t y  
of binding domains (c.^. POU binding domain. Brain 2; zinc f in g e r  
DNA binding domain; TATA binding proteins; steroid r e c e p to r s ;  
androgen receptor,  glucocorticoid receptor; homeobox d o m a i n  
p ro te in s ) .
Tr inucleotide repeats  are the simplest  nucleic acid s e q u e n c e  
that can be translated  into homopept ides  in proteins.  T h e r e f o r e  
probes based on trinucleotide repeats may be used to identify genes 
which contain homopeptides.  There are other reasons which m a k e  
t r inucleot ide  repeats  attractive structures for further  in v es t ig a t io n .  
These will be discussed in the rest of the introduct ion. A screen f o r  
genes containing trinucleotide repeats of the mouse may lead to t h e  
identificat ion of novel regulatory genes with functional roles fo r  
these repeats both as nucleic acid and/or as homopeptides.
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1.5 What are trinucleotide repeats?
Trinucleotide Repeats are a subclass of simple sequences  a n d  
are small tandem repeats of three nucleic bases in constant  o rd e r .  
They belong to a class of repetitive DNA, microsatel l i tes  (Weber  a n d  
May, 1989), that are widely dispersed th roughout  the genomes of  
eukaryotes.  Some classes of repeats have been observed to be o v e r ­
rep resen ted  in the genomes of certain organisms e.g. both CAG a n d  
OGGtrinucleotide repeats occur at a greater than expected n u m b e r  
in the genome of humans (Han et al, 1994).
Microsatelli tes are also characterised by their ability to change 
copy number , usually by increments  of the basic unit ( t h r e e  
nucleot ides in the case of trinucleot ides).  This has made t h e m  
invaluable as markers  for mapping purposes {e.g. Sheffield et al,
1995). they also have been used to create enr iched libraries  of  
clones from eukaryotes  bearing repeats  of a part icular  class {e.g. 
Ostrander  et al, 1992).
More recently tr inucleotides have been implicated in a n o v e l  
group of diseases, those associated with dynamic m u t a t i o n s .  
Tr inucleotide repeats  that occur in coding regions give rise to t h e  
simplest repeat possible in proteins,  homopept ides,  which may h a v e  
functions associated with them.
Recent research shows that organisms have used r e p e t i t i v e  
motifs of nucleic acid in their genes as useful functional p a t t e r n s .  
This occurs both at the nucleic acid (both in DNA and RNA) and a t  
the protein level. The following section will discuss that, in h i g h e r  
eukaryotes  and mammals  in particular,  triplet repeats  have b e e n  
used for a variety of functions.
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Legend for Figure 1.2 Models  for secondary  s t r u c t u r e s  
form ed  by tr in u c le o t id e  repeats.
A) Simplified version of hairpin structures that are possible w i t h  
the CAG/CTG trinucleotide repeat (adapted from Kang et al, 1995) .
B) An example of a quadruplex  structure involving b o n d i n g  
between four guanidine residues and how they may stack up on  
themselves  to form the quadruplex (adapted from W il l i am so n ,
1993). C) Representa t ion  of hydrogen bonding base pairs for AT 
and CG as proposed by Watson and Crick.
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1.6 Trinucleotide repeats in nucleic acids.
1.6.1 S tructures  that tr inuc leot ide  repeats  can adopt.
Nucleic acid tr inucleotide repeats can adopt s tructures,  o t h e r  
than the d o u b le - s t randed  anti-parallel  helix described by W a t s o n  
and Crick (Watson and Crick, 1953; Crick and Watson, 1954; s ee  
Figure 1.2.C). They can form pseudo-helical  s tructures  like h a i r p in s  
(Figure 1.2.A). This hypothesis  has been supported by in v i t r o  
evidence reported by various groups. For example, Gacy et al (1995) 
described the formation of stable hairpins by CG rich t r i n u c l e o t i d e  
repeats (CTG, CAG and CCG). According to them, the stability of t h e s e  
hairpins  is dependent  on both the length and sequence of t h e  
repeat.  Imperfections in these repeats de-stabil ise these s t r u c tu r e s .  
Pearson and Sinden (1996), using CTG and CGG trinucleotide repeats,
observed complexes with reduced mobility in po lyacry lam ide  gel
e lec trophores is  experiments .  The complexes appeared to be s t a b l e  
at physiological  strengths  and have a melting tem pera tu re  of 55°C. 
They also appeared to contain s ingle-s t randed DNA as they are in 
part  sensitive to mung bean nuclease.
Indirect  evidence that repeats form hairpins in v i v o  co m e s  
from the work of Daiiow and Leach (1995), who inserted  even a n d  
odd number  copies of a trinucleotide  ol igonucleot ide into a p o s i t io n  
in the lambda phage where the formation of a hairpin is n e c e s s a r y  
for the inhibition of plaque formation. Plaque inhibition was f o u n d  
with even numbers  of CAG.CTG and OGG.CCG but not with GAC.GTC 
inserts.  This suggests that not all types of t r inucleotide have t h e
potential to form hairpins structures.
What is happening at the molecular level to cause t h e  
formation of hairpins? One suggestion is that the nucleotide  ch a in s  
may bend back on themselves  to form a stable hydrogen b o n d in g  
pat tern between C and G bases (Smith et al, 1995; see also F ig u re  
1.2). Smith e t  al, (1995)  propose that CTG repeats are more s t a b l e  
than CAG repeats,  because of the difference in size of the m i d d l e  
base (see Figure 1.2.A). On both sides of the central base, two CD 
base pairs can form. Since thymidine  is smaller than adenine, i t  
does not interfere as much with the neighbouring GC h y d r o g e n  
bonding. This may cause infidelities in replication by a s l ip p a g e  
mechanism (Levison and Gutman, 1987; see Figure 1.3). This m o d e l  
has also been proposed to explain the variabi li ty observed in 
microsatel li te length, hairpin formation would cause the template o r  
newly synthesised DNA to detach from the par tner  strand w i t h  
reassociat ion at a non-cognate  position in the repeat s e q u e n c e ,  
leading to either shortening or lengthening of the repet i t ive DNA 
stretch. However  there are problems with this model: not all
microsatell i tes  form hairpins (e.^. see Darlow and Leach, 1995) a n d  
it has been recently shown that other t rinucleotide repeats  e x h ib i t  
dynamic  instabili ty (GAA trinucleotide repeats in F r i e d re ic h ' s  
ataxia,  Campuzano et al, 1996)
Other unusual base pairings have also been impl icated in t h e  
format ion of tr inucleotide repeats hairpins,  like G:G base pa i r s .  
Mitas et al (1995) suggested that G(syn).G(anti) base pairs a r e  
formed by CGG repeats which are associated with the fragile X sites.
Another  structure has been suspected to be involved in t h e  
reduced electrophoret ic  mobility of t rinucleotide  repeats;  there is a 
suggestion that CGG trinucleotide repeats  part ic ipate in q u a d r u p l e x  
( fou r -s t randed )  DNA structures (Fry and Loeb, 1994; Smith et al.
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1994; see Figure 1.2.B), as the properties  of these complexes a r e  
consis tent with quadruplex structures.  Fry and Loeb (1994) o b s e r v e  
slower than expected migrating species when (CGG)n:(CCG)n d o u b l e ­
s tranded duplexes are e lectrophoresed.  In te res t ing ly  t h e  
appearance  of these slowly migrating species is dependen t  on t h e  
m éthyla t ion  state of the cytosine residue, but only in s m a l l e r
oligonucleotides.  For instance, méthylat ion dependence  is o b s e r v e d  
where the repeat  number  is five {i.e. (CGG)5:(CCG)5), but there is no  
effect when the repeat  number  is seven. Méthyla tion i n v o l v e m e n t  
is further  implicated by the observat ion that t rea tm en t  w i t h
dimethyl sulphoxide (which inhibits méthylat ion by modificat ion of  
the N7 position on the pyr imid ine ring of cytosine) i n h ib i t e d  
complex formation. Smith et al  (1994) also observed t h e s e
complexes  when using 30mer  nucleotides (where the r e p e a t
number  is 10), they also suggest that there is a secondary  s t r u c t u r e
requ irem en t ,  as subst itution of guanine for ionosine ab o l i sh e s  
complex formation.
However ,  further experiments need to be done to c h a r a c t e r i s e  
the structures trinucleotide repeats can and cannot adopt. This m u s t  
include further  in v i v o  work, specifically in a mam m alian  s y s te m .  
This is necessary to unders tand  their importance to human t r i p l e t  
expansion diseases.  This is important  because recent research h a s
discovered that another  repeat,  which has hitherto b e e n
unsuspected  of invo lvement  in secondary s tructure formation,  h a s  
been found to be the cause of dynamic disease, which a r e
Figure  1.3
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Figure 1.3 A model for deletions and in ser t ion s  at the DNA  
s y n th es is  rep l ica t ion  fork, invo lv ing  hairpin  s tru c tu res .
Hairpin structures  are proposed to form at the replication fork on 
the lagging strand at the DNA replication fork. This leads to e i t h e r  
deletion, where hairpin formation occurs on the template DNA 
strand (see orientation 11) or insertion (or expansion) where t h e y  
occur on the newly synthes ised DNA (see orientation 1). This f ig u re  
was adapted from Kang et c//, (1995).
character ised by an unstable trinucleotide repeat. A GAA repeat  h a s  
been found to be implicated in Freidriech's Ataxia (Campuzano et al,
1 9 9 6 ) .
1 .6 .2  R e p e a t  d y n a m ics .
Several ideas have been put forward to explain the p r e c i s e  
m echan ism  of expansion of GC rich tr inucleotide repeats.  Ohta a n d  
Kimura  (1973) describe how tr inucleotide repeats  (and o t h e r  
repeats) could increase or decrease in length by single t r i n u c l e o t i d e  
units by m is-a l igm ent  of the template  with the DNA p o l y m e r a s e  
complex. Streis inger  et  al, (1966) proposed a m echan ism  of  
expansion that involves replication slippage in which Okazak i  
f ragments  disassociate from the template DNA strand a n d  
reassociate  at a position different from the original (see Figure 1.3). 
Crucial to this hypothesis  is the formation of hairpin s e c o n d a r y  
structure in the Okazaki fragments.  Experimental evidence (Smith e t  
al, 1995) using NMR spectroscopy supports this idea. Kang et  al
(1995) have proposed that this type of hairpin structure could occur 
in both RNA and DNA to give scenarios for both expansion a n d  
dele t ion  events .
All above hypotheses propose mechanisms which can act b o t h  
ways to create extra triplet repeats (expansion)  or to remove t h e m  
(deletion).  However all the human dynamic diseases appear  to b e  
due to an overall increase in numbers of t r inucleotide repeat  un i t s ,  
which suggests that other factors are influencing the fluctuations in 
repeat number. Kang et al (1995) observed expansion and d e l e t i o n s  
of t r inucleotide repeats  (those involved in the human d y n a m i c  
diseases)  in E. coli that was dependent  on the orientation of CTG
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repeats  rela tive to the direction of replication. Large units of a 
tr inucleot ide  repeat  were deleted in an orientation where CTG 
triplets were on the lagging strand relative to the origin of
replication of  the plasmid. In an analysis of individual bacteria f r o m  
one culture containing a plasmid with 180 CTG t r inucleotide r e p e a t  
units, it was observed that the deletions had a periodic ity  of 4 0 
repeats  (examples  of 180 (un-dele ted)  140, 100 and 60 CTG
trinucleot ide  repeat  units). When the CTG triplets were in t h e  
leading strand, increases in repeat size were observed.
1.7 Prote ins  that bind repeats  in DNA.
Proteins have been discovered which specifically b i n d  
repet i t ive  DNA in chromosomes.  An example of this is t e lo m e re s ,  
which are the physical ends of a chromosome.  They are f a s h io n e d  
from tandem hexanucleotide  repeats,  (TTAGGG)n (Van Der Ploeg e t  
al, 1984), which are conserved throughout higher e u k a r y o t e s  
(Moyzis et al, 1988). The sequences were first identified in
t rypanosom es  (Van Der Ploeg et al, 1984) and have been found to  
bind specific proteins. These proteins are distinct from o t h e r  
prote ins which exhibit  non-specific nucleic acid sequence b ind ing .  
This indicates a specific role for both the tandem repeats  and t h e  
proteins which bind to them. The proteins act as a bridge f o r  
in teractions between chromosomes and the cy to-skele tal s t r u c t u r e s  
(e.g. In te rm ed ia te  Filaments; see Traub, 1995 for a review.) w h ic h  
are formed after the chromosomes have been replicated,  in  
p repara t ion  for cell division. Telomeres  also adopt an u n u s u a l  
secondary structure. They form a quadruplex in a similar fashion as  
described above for the CGG trinucleotide repeats  associated w i t h
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human diseases (for review see Brahmachari  et al, 1995; Figure 1.2 
and Section 1.6.1).
1.7.1 Prote ins  that bind DNA tr inucleot ide  repeats .
Recent  work has identified several prote ins that interact in a 
specific fashion with both single and d o u b le - s t r an d ed  DNA 
trinucleotide  repeats.  T imchenko et al  (1996) and Y an o -Y a n a g i sa w a  
et al (1995) have biochemical ly  character ised individual p r o t e i n  
activities that bind to s ingle-s t randed CAG and CTG re p e a t s .  
Timchenko et al (1996) used a radio-labelled  DNA o l ig o n u c leo t id e  
ss(CTG)s, in conjunction with HeLa cell protein extract, in a b a n d  
shift assay experiment,  to show the formation of two complexes,  s s l  
(major) and ssll  (minor).  These were shown to be specific by u s in g  
unlabel led ol igonucleot ide competitor;  in their presence t h e s e  
complexes were abolished. Challenging the reaction with u n l a b e l l e d  
ss(CAG)k and ss(CGG)x oligonucleotides had no effect on c o m p le x  
formation. They also found specific prote in-DNA interact ions w i t h  
ss(CAG)8 and ss(CGG)x DNA oligonucleotides.  Four complexes  a n d  
two complexes appeared when using labelled ss(CAG)x and ss(CGG)x 
oligonucleotides,  respect ively. Comparison of mobilit ies of t h e  
complexes formed by the three oligonucleotides,  ss(CTG)x, ss(CAG)x 
and ss(CCG)x, lead Timchenko et al (1996) to conclude that t h e  
major CTG binding complex (ssl) was specific to CTG, and t h e y  
termed it s ing le-s t randed  CTG Repeat Recognising Protein (ssCRRP). 
This binding activity contains at least two polypept ides  of d i f f e r in g  
size because f ract ionat ion by size of the FleLa whole cell p r o t e i n  
extract abolishes the formation of the complex. Binding activity w a s
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re -es tab l i shed  by combining two fractions (4 and 5) of the cell 
pro te in  together .
In similar exper iments ,  using HeLa nuclear extract  as a 
prote in  source for ol igonucleot ide binding assays, Richards et al 
(1993)  found a protein activity that in teracted specifically with a 
d o u b le - s t r a n d ed  30mer DNA oligonucleotide, (CCG)io. This w a s  
com pet i t ive ly  inhibited in the presence of cold (CCG)io 
o l igonucleotide but not when cold competi tor  o l ig o n u c leo t id es  
representing the other 9 families of  trinucleotide repeats were used. 
This complex was unaffected when two d in u c l e o t i d e  
oligonucleot ides  were used in competitive assays. In te res t ingly ,  th i s  
complex is destabi l ised by méthyla t ion of the repeat at c y to s in e  
residues in CpG dinucleot ides.  The oligonucleotide  p(CCG)i{).p(GGC)io 
was methy la ted  enzymatical ly  by CpG methylase. In band s h i f t  
assays, the CCG.BPl complex (which consists of the d o u b l e - s t r a n d e d  
u n -m e th y la ted  oligonucleotide, p(CCG)i().p(GGC)io and s e q u e s t e r e d  
cellular proteins) is not formed, it is replaced by a new h i g h e r  
molecular  weight complex that is abolished not only by u n l a b e l l e d  
m ethy la ted  p(CGG)lo.p(GCC)lo, but also by other o l ig o n u c le o t id e s  
conta ining CpG dinucleotides  which were methylase  treated e.g. 
p(ACG)io.p(TGC)io).  Richards et al (1993) suggest that this may b e  
the previously  described protein, MeCPl (Meehan et al, 1990) ,  
which is a sequence non-specific methyl-CpG binding p ro te in .  
Richards et al  (1993) also took the other o l ig o n u c leo t id es  
rep resen t ing  the tri and di-nucleotide families and used them to  
identify complexes that were specific to other do u b le -s t ran d ed  DNA 
tr inucleot ide  and dinucleotide repeats.  Some of these c o m p le x e s  
have over lapping binding activity with respect to o t h e r
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oligonucleotides  which represent different  families of t r i n u c l e o t i d e  
r e p e a t .
As ment ioned  by Richards et al (1993), there are p r o t e in s  
which bind to t rinucleot ide repeats,  as part  of a broader  s p e c t r u m  
of binding to nucleic acid. The example described by Richards et al  
(1993), is MeCPl,  which has a high affinity for methy la ted  CpG 
pairs.  Other proteins have binding preferences  CpG d in u c le o t id e s .  
Another  protein which has an affinity for (h em i-m e th y la ted )  CpG 
d inucleot ides  is the protein DNA m ethyl  t ransfe rase  which is 
requ ired  for the main tenance  of méthyla t ion of cytosines in CpG 
dinucleotides (Taylor and Jones, 1982). It maintains méthyla t ion b y  
the recognition of h em i-m e thy la ted  d o u b le - s t ran d ed  CpG 
dinucleotides,  which are the product  of sem i-conse rva t ive  DNA 
replication, in which one strand is newly synthesised and does n o t  
contain methyla ted  cytosines but the parental strand retains its 
methy la ted  cytosine status.
CpG dinucleotides  are not randomly dis t r ibuted t h r o u g h o u t  
the genomes of vertebra tes .  Many CpG dinucleotides  a r e  
concentra ted  into regions which are known as CpG islands (for a 
review see Meehan et al, 1992). It has been shown that t h e s e  
islands are associated with genes and are known to influence t h e  
activity of the gene, dependent  on the méthyla t ion status of  
cytosines.  The importance of this covalent modificat ion of cy to s in e  
is that it thought  to either inhibit  the binding of proteins r e q u i r e d  
for transcr iption, recruit  factors which inhibit  transcr iption (Meehan 
et al, 1992), or even induce a regional conformational  shift  in DNA 
structure from B form to Z form (Meehan et al, 1992). It has b e e n  
shown that DNA helices which adopt a Z conformation,  r e p r e s s  
t ranscr ip t ional  activity of genes. It is proposed that this occurs b y
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the inabili ty of the t ranscript ional  machinery to access t h e  
appropr ia te  sites to initiate transcr iption.  This as well as the o t h e r  
theories have been invoked to explain the phenom enon  of
imprint ing (for review see Monk, 1995), where there is only o n e  
active copy of a gene, which is consistent ly inherited from o n e  
parenta l  sex.
More  recently, this mechanism of gene silencing has been used 
to explain the Fragile X syndrome of humans.  These a r e  
characterised by the expansion of CGG and GCC trinucleotide r e p e a t s  
(CGG for FR A X A and  FRAXE; Fu et al, 1991, Knight et al, 1993). T h e  
common denom ina tor  of these tr inucleot ide repeats is that t h e y
contain CpG dinucleot ides.  The upward expansion of these r e p e a t s ,  
which have been associated with these diseases, is proposed to  
create a new CpG island which is identified by the m é t h y l a t i o n  
m ach inery  of the cell, which acts to methyla te  the cytosines a n d  
leads to a regional inaccessibili ty and down regulation of g e n e  
expression. This leads to an apparent loss of function of a p a r t i c u l a r  
gene or genes in the region. In case of FRAXA, the gene affected is 
F M R l . The product of this gene is involved in RNA binding (Siomi e t  
al, 1993). In support of the loss of function model,  c e r t a in  
individuals  have been found to carry point mutat ions in the F M R l  
gene which leads to a loss of activity of the FMRl protein {e.g. 
Deboulle et al, 1993) and they have similar phenotypes  as th o s e
with expansions  of repeats.  Mouse f m r \  gene knockouts  c o n f i r m e d
this hypothesis  (Bakker et al, 1994). Candidates for the r e c o g n i t io n  
of expanded  repeats could be the proteins that par tic ipate  in t h e  
DNA-protein  complexes,  described by Richards et al (1993).
A functional role for repeti t ive DNA has recently b e e n  
d em o n s t ra ted  by Wang and Griffith (1995), who showed that long
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tandem repeats of the trinucleotide CTG, have a strong effect on t h e  
posit ioning of nucleosomes in DNA. This suggests that the CIG 
repeat  has a structural advantage in promoting in teract ions  w i t h  
the consti tu tive proteins of the nucleosome, thereby altering local 
chromatin structure. This could have an effect on the accessibili ty of  
p romoter  sequences to the cellular t ranscr ipt ional  m a c h i n e r y .  
Alternat ive ly, other  proteins as suggested by Richards et al  ( 1 9 9 3 ) ,  
T imchenko e t  al  (1996) and Yano-Yanagisawa et al, (1995) may b e  
allowed access to the repeat.
1.8 Prote ins  that bind repeats  in RNA.
Proteins that bind RNA trinucleotide repeats  have also b e e n  
described recently. Timchenko et  al (1996) found two activities in 
HeLa cell whole cell extracts that bound to an RNA o l igonuc leo t ide ,  
ss(CUG)x. The two complexes were inhibited by excess,  u n l a b e l l e d  
s s (C U G )x  oligonucleotide. The smaller complex had a similar mobility 
to that of the ssCRRP complex that exhibited binding to the DNA 
oligonucleotide ss(CTG)x- This RNA binding was abol ished by t h e  
addition of ss(CTG)x DNA oligonucleotide. In contrast,  the l a r g e r  
RNA-protein  complex was unaffected by the addition of the DNA 
oligonucleotide or cold ss(CGG) RNA oligonucleotide. T imchenko e t  al 
(1996) concluded that it exhibited a sequence specific RNA b in d i n g  
specificity and termed it CUG-BP (CUG Binding Protein).  CUG-BP 
protein, appears to be found predom inant ly  in the c y to p la s m ic  
fraction of HeLa cells. ssCRRP DNA binding activity was also found to 
be predominantly  cytoplasmic, although some binding activity cou ld  
be detected in the nuclear extract.  CUG-BP was also found in o t h e r
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cells types; for example, in extracts of f ibroblas ts  and m y o t u b e s  
(Timchenko et al, 1996).
The conclusions from the studies described in Sections 1.7 a n d
1.8 are as follows. 1) There are prote ins which have a n a t u r a l  
specific affinity for both s ing le-s t randed  (RNA and DNA) a n d  
do u b le - s t ran d ed  (DNA) triplet repeats;  CUG, CTG and CAG specif ic  
repeat  binding proteins have been observed.  2) Although these a r e  
specific, other proteins can also bind to t rinucleot ide  repeats  n o n -  
specifically.  3) Since Yano-Yanagisawa et al (1995) found proteins in 
the mouse brain that bound s ing le -s t randed  DNA repeats  a n d  
Timchenko et al (1996), focusing on human cell lines, found t h e s e  
type of activities,  it is probable  that the human proteins h a v e  
functional homologues  in mouse and vice versa.
1.9 H o m o p e p t id e s  in proteins .
The basic unit of information in the genetic code is the codon.  
This links the information held in nucleic acids to the protein g e n e  
products.  The codon is three nucleot ides in length and d e t e r m i n e s  
the amino acid content of peptides.  Hom opept ides  rep resen t  t h e  
simplest  repeti t ive pattern amino acids can adopt in proteins.  T h e y  
can also be accommodated  in existing genes without  dis turbing t h e  
frame in which the protein is read from the m essenger  RNA 
molecule.  Increments of t rinucleotides  are gained or lost in a s in g le  
step, thus conserving the frame on both sides of the ch a n g e .  
However,  not all homopept ides  are rep resen ted  in proteins.  S o m e  
hom opept ides  have functions within prote ins whereas  others h a v e  
not or have a negative effect on the function of the protein.
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Several amino acids are encoded by more than one codon t h a t  
does not belong to the same family. For example CAG e n c o d e s  
glutamine and is a m ember  of the repeat  family which will be t h e  
focus of the exper imental  work. However,  GAA also e n c o d e s  
glutamine but these two codons do not belong to the same group o f  
t r inucleotide on the basis of frame and c o m p l e m e n t a r i t y .
Homopept ides  of glutamine can be therefore either be encoded b y  
repeats of CAG or CAA, or even a mixture of the two codons .  
However,  Green and Wang (1994) note from a database survey, t h a t  
g lutamines  in repeat stretches are more likely to be encoded b y
CAG.
Homopeptides observed in proteins can be classified a c c o rd in g  
to which type of side chain the amino acid contains.  The l a r g e s t  
rep resen ted  group is the one compris ing uncharged polar s id e  
chains. According to Karlin and Ghandour (1985) and Karlin a n d  
Burge (1996), this group consists of glutamine (Q), asparagine  (N), 
serine (S), threonine (T), pro line (P) and histidine (H). The s e c o n d  
group consists of small aliphatic amino acids: alanine (A) a n d
glycine (G). The third group consisting of aspartate  (D) a n d  
glutamate (E) which have an acidic side chain. Karlin and B u rg e
(1996) also observed rare examples of leucine (L) repeats,  the o n ly  
amino acid homopeptide to have a large aliphatic side chain.
1.9.1 P u ta t iv e  fu nc t ion s  o f  h o m o p e p t id es .
Various ideas about what function these hom opept ides  m a y  
per form in proteins have been proposed. Some are general in  
respect  to amino acid homopept ide  whereas others rely on t h e  
nature of certain amino acid side chains.
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The first hypothesis  put forward to explain the occurrence of  
these hom opept ides  was that they were spacer domains b e t w e e n  
funct ional  domains of proteins.  Their role would be to separa te  t h e  
critical regions of proteins by an appropria te  distance, enabling t h e  
other domains  to interact in meaningful  way. This may account  fo r  
the occurrence of homopept ides  consisting of amino acids with s ide  
chains that are believed to be non-react ive  and non-polar,  i.e. 
alanine and glycine.
Another  hypothesis  is that they act as interactive d o m a i n s  
between proteins. This could explain the runs of acidic residues in 
general (Mitchell and Tjian, 1989) i.e. imperfect  or perfect s t r e t c h e s  
of e ither  glutamate (D) or aspartate (E). The cumulat ive  charge of  
these regions is believed to facilitate interaction with basic or p o l a r  
regions in other polypeptides (Sigler,  1988).
Polar amino acid homopeptides can also participate in p r o t e i n -  
protein interactions. Serine and threonine can exist  both as mixtures 
or pure homopept ides  that form strong polar regions ( f r o m  
accumulat ive  polarity), which could interact with other sections of  
the polypeptide or other proteins.
1.9 .2  P o ly g lu ta m in e  and p o ly p ro l in e .
These represen t  the two most studied homopept ides  w i t h  
respect to their possible influence on the function of proteins.  T h e y  
also appear  to be relatively more abundant  than other classes of  
homopept ides .  They are discussed below, relative to t h e s e  
o b s e rv a t io n s .
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1 .9 .2 .1  P o l y g l u t a m i n e
Polyglu tamine is the most commonly found hom opept ide  in  
eukaryotic proteins in reference databases  (Green and Wang, 1 9 9 4 )  
and has been implicated in the facili tation of p r o t e i n - p r o t e i n  
interactions. Green and Wang (1994) also noted that the m o s t  
common tr inucleotide encoding glutamine was GAG. P o l y g l u t a m i n e  
tracts are the best studied so far, not only because of their f u n c t io n  
but also because they have been associated with a novel type o f  
human disease, the dynamic mutat ion diseases  (Ross, 1 995) .  
Aspects of  these diseases will be discussed later.
There is exper imental  evidence of the functional i m p o r t a n c e  
of po lyglu tamine  tracts (Gerber et  al, 1994). As a prelude to d i r e c t  
exper im en ta t ion ,  Gerber et al, (1994) conducted searches t h r o u g h  
the protein database, Swiss-Prot  using a po lyglu tamine  s e q u e n c e  
( twenty residues, Q20) and the FAST A Program m e (Lipman a n d  
Pearson, 1985). They observed that a significant proport ion of t h e  
proteins that contained glutamine homopept ides  were t r a n s c r i p t i o n  
factors. From the 40 entries with the highest scores, 82% w e r e  
transcription factors and 17 were Drosoph i la  m e la n o g a s te r  proteins.
Extensive developmenta l  studies in this organism h a v e  
identified many transcript ion factors and other  d e v e l o p m e n t a l  
control genes (Karlin and Burge, 1996). The repeats  are also k n o w n  
in D r o so p h i la  as OP A repeats (Maginnis et al, 1984). They were f i r s t  
observed in Notch ,  a neurogenic gene. In a study conducted b y  
Wharton et al (1985), the authors also observed a c o m p le x  
hybrid isa t ion pattern on Southern analysis with a f r a g m e n t  
containing the repeat. They concluded that in the haploid genome o f  
Drosophila ,  there were about 500 individual OPA repeats.  A p r o b e
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containing the repeat also hybridised to multiple p o l y - a d e n y l a t e d  
messenger  RNA species.
The most abundant  type of amino acid encoded by OPA 
repeats  in Drosophi la  is glutamine. In this case the third base is 
either G or A, resulting in the two codons GAG and GAA. T h e s e  
g lu tamine repeats  can be in terspersed  with the amino acid  
histidine, which is encoded by one of two codons which are GAG o r  
GAT. Progress has been slower in mammals  and p r o p o r t i o n a l l y  
fewer  developmental control genes have been identified. It is l ike ly  
that many more mammalian  proteins containing p o l y g l u t a m i n e
hom opep t ides  remain to be discovered. Li et al, (1993), screened a 
human cerebral cortex cDNA library with a (GTG)io 3 0 m e r  
ol igonucleotide and found that of 50000 clones screened with a 
(GTG)io radioact ively  labelled probe, 0.28% contained GAG/GTG 
tr inucleotide repeats.  Of those which were sequenced and an o p e n  
reading frame identified (six), four contained p u t a t i v e
po lyg lu tam ine  tracts.
Gerber  et al  (1994) showed that the presence of
po lyg lu tam ine  tracts has a positive effect on activity using in v i t r o  
t ranscr ip t ion com plem enta t ion  exper iments  (Gerber et  al, 1992). A 
series of constructs,  containing glutamine stretches of v a r io u s  
lengths inserted between the GAL4 DNA binding domain (Giniger e t  
al, 1985) and the pro te in -pro te in  t ransact ivat ion domain of h e r p e s  
virus protein, VP16 (Sadowski et al, 1988) were generated.  T h e  
cognate proteins were produced in HeLa cells and were co-  
prec ip i ta ted  with a reporter  construct containing a GAL4 b in d in g  
site and a reporter  gene. Activity was measured by the ability to 
produce cle n o v o  transcr iption from a promoter  on the r e p o r t e r  
construct.  The HeLa cell nuclear extract also provided other p r o t e i n s
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Figure  1.4
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Figure 1.4 Proposed  s tru c tu re  of  a n t i - p a r a l l e l  p s h e e t
a d o p te d  by p o ly g lu ta m in e .
Two paired anti-paral lel  ^-st rands of poly (L-glii ta inine) l in k ed  
together  by hydrogen bonds between the main chain and side ch a in  
amides are shown. C, carbon, N, nitrogen and O, oxygen. The diagram 
was adapted from Periitz et al, (1994).
3 2
involved in t ranscr iption. These exper iments  show that there is a 
s timula t ion of basal reporter  gene activity with the addition of  
between 10 and 40 glutamines. Beyond 40 glutamines, there is n o  
observab le  increase in t ranscr ip t ional  activity. Glutamines a lo n e  
with a GAL4 DNA binding domain induced a decrease  in
t ranscr ip t iona l  activity if the copy number  exceeds 40 r e s id u e s .  
Control constructs  with g lu tam a te - le u c in e -g lu ta m in e  (ELQ)n, o r  
g lu ta m in e -g lu ta m in e - se r in e  (QQS) repeats  showed a w e a k e r  
response,  and activity was independent  of the number  of r e p e a t
units. In a third set of exper iments  various glutamine rich r e g io n s  
of known human proteins, Oct2 (Clerc et al, 1988), Spl (Courey a n d  
Tjian, 1988 and Courey et al, 1989), were fused to the DNA b i n d i n g  
domain  of GAL4 and they showed stimulation of t r a n s c r i p t i o n a l  
activity of  the reporter gene.
However,  an increase in length of (and in numbers of r e s i d u e s  
contained within) a glutamine homopept ide  does not always i n d u c e  
an increase in t ranscr ipt ional  activity. For instance, Chamberlain  e t  
al (1994) found that the deletion of a glutamine stretch in t h e  
androgen receptor  of humans lead to an increase in t r a n s c r i p t i o n a l  
act ivity and that the expansion of the glutamine repeat d e c r e a s e s  
the t ra n sc r ip t io n a l - s t im u la t in g  activity of the protein. T h e i r  
suggestion is that the positioning of the glutamine tract relative to  
other  functional regions of proteins may also be important .  For  
example,  the glutamine homopept ide  in rat and human a n d r o g e n  
receptors  is different. In the human protein, the polyglu tamine tract 
is ups tream  of the activation domain. In the rat prote in it is
Juxtaposed to the activation domain and deletion has l i t t l e
functional effect. It therefore appears that polyglu tamine  f u n c t io n  
may be context dependent ,  i.e. the influence of po lyg lu tam ine  is
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dependen t  either on its position in that protein, relative to o t h e r  
critical domains or perhaps on the target molecules with which i t  
i n t e ra c t s .
Recently,  polyglutamine stretches have been proposed to t a k e  
up a defined secondary structure (Perutz et al, 1994) which is an  
anti-parallel  beta sheet structure called a polar zipper (Perutz e t  al, 
1993: see also Figure 1.4). This occurs by the formation of h y d r o g e n  
bonds between the main chain and side chain amide groups. P o la r  
zippers are believed to be one way in which prote ins can i n t e r a c t  
with each other. Further  to this, Stott et al (1995) h a v e  
exper imental ly  shown that the insertion (or subst itution of ex i s t in g  
residues) of  a glutamine homopeptide, ten residues  in length, into a 
protein (CI2, Chymotrypsin  Inhibitor 2; McPhalen et al, 1 9 8 5 )  
promoted the formation of stable dimers and trimers.
1 .9 .2 .2  P o l y p r o l i n e .
Proline homopept ides  were first observed in proteins of t h e  
fruit fly. Drosophila m e la n o ^ a s t e r .  They are encoded b y  
tr inucleotide repet it ive  elements termed PFN repeats  (Digan et al, 
1986). This repeat also encodes other homopept ides ,  in c lu d in g  
polyglycine (Haynes et al, 1987). These amino acid tracts a r e  
encoded by GGN codons. Both polyproline  and polyglycine h a v e  
been noted by Karlin and Burge (1996) to occur in m a m m a l i a n  
species, such as rat, mouse and man as well.
Gerber  et al (1994) also identified a number  of prote ins f r o m  
the Swiss-Prot protein database which contain polyproline s t r e t c h e s  
and observed that a high proportion of them (78%) w e r e  
transcription factors.  The authors showed that medium sized proline
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stretches  could stimulate t ranscript ional  activity when they w e r e  
used in an in vitro complementation transcr iption assay; but beyond 
10 residues a reduction in activation was observed.
Karlin and Burge (1996) also noted that m u l t i p l e  
hom opep t ides  (encoding different amino acids) occur selectively in  
some genes. They found 68 Drosophi la  proteins,  36 human p r o t e i n s  
and 22 mouse proteins  with multiple long homopept ides .  T h e y  
suggested  that some proteins were more susceptible to t h e  
accumulat ion  of repet i t ive sequences or that, a lternat ively ,  t h e s e  
hom opep t ides  were acting in an accumulative m anner  to a d d  
functionali ty  to the proteins.
1.10 D iseases  a s so c ia ted  with CAG/CTG t r i n u c l e o t i d e  
r e p e a t s .
A whole new class of genetic mutation leading to disease h a s  
been found which is associated with expansion of t r i n u c l e o t i d e  
repeats in humans (for a review see Ashley and Warren, 1995). To 
date, a number  of different  t r inucleotide repeat expansions h a v e  
been described; 1) CAO (encoding a polyglu tamine in a f f e c t e d  
prote ins),  2) CTG (manifested as CUG RNA triplets),  3) GOG and Q3G 
(which create de n o v o  méthyla t ion islands and are independent  of  
position with respect to the affected gene) and 4) GAA (present  in 
non-coding intronic DNA). These diseases have been c h a r a c t e r i s e d  
by an upward expansion in the number  of triplet repeats  w i t h  
successive generations. This correlates  with an increasing s e v e r i t y  
of the part icular  disease and a decrease in the age of onset of  
clinical symptoms specific to that disease. This phenom enon is 
known as anticipation.
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Legend to Figure 1.5 Human d iseases  which are c a u s e d  
by C A G /C T G  tr inuc leot ide  repeat  expansions .
A) The left hand side indicates the major sites of n e u r o n a l  
degenera t ion  in each diseases. Dark red indicates the site of m o s t  
severe neuronal loss. Pink indicates areas where the loss of  
neurones is variable or less pronounced. The circles in the cerebral 
cortex represent  Purkinje cell. The open reading frames of t h e  
affected genes in each disease are shown schemat ical ly  on t h e  
right hand side with the glutamine repeats which cause a d i s e a s e  
phenotype  are indicated in red, with the numbers of g l u t a m i n e s  
shown at the side. AH, anter ior horn; Cer, cerebellar  cortex; C/P, 
c au d a te /p u ta m e n ;  Ctx, cerebral cortex; DN, dentate  nucleus; GP, 
globus pallidus; LCN, lateral cuneate nucleus; PN, pontine nuc leus ;  
RN, red nucleus; SN, substantia nigra; STN, subthalamic nuc leus ;  
VL, ventolateral thalamic nucleus; V, VI, VII and XII cranial motor 
nuclei. B) A represen ta t ion  of the genes DMPK, 59 and DMAHP 
which lie near the expanded CTG (CUG) triplet repeat which is 
associated with myotonic dys trophy. Adapted from Ross ( 1 9 9 5 )  
and Bailey et al ( 1 9 9 7 ) .
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The types of repeats which have been associated with OQG 
(e.g. Fragile X, FRAXA ) and GAA (Freidreich's Ataxia, Campuzano e t  
al, 1996) tr inucleotide repeat expansion will not be d i s c u s s e d  
further in detail, since the focus of this study is the CAG/CTG f a m i l y  
of repeats  and the pathological mechanism of the disease c a u s a t i o n  
is likely to differ from that of GAG and CTG (CUG) r e p e a t s .  
F u r th e rm o re  CAG/CTG repeats are more likely to be in the c o d in g  
regions of genes (Stallings, 1994). The explanation of this o v e r  
r ep re sen ta t ion  of CAG repeats  in genes may lie with the p o s i t i v e  
reasons for the existence of t rinucleotide repeats  discussed in  
Sections 1.7 to 1.9. Alternatively it may be because CAG repeats  a r e  
similar  to the splice acceptor te t ranucleot ide  CAGG (Shapiro a n d  
Senapathy,  1987), therefore CAG repeats  may become e x c l u d e d  
from intronic sequence, rather than positive selection. This has b e e n  
shown in another  case, where a mi ni satelli te containing a CAGG 
te t ranuc leo t ide  repeat  which became incorporated  into a h u m a n  
in terferon-induced gene by alternative splicing (Turri  et al, 1995).
1.10.1 C A G  repeats ,  po lyg lu tam ine  and hum an d iseases .
There are five diseases which are associated with t h e  
expans ion of CAG trinucleotides  that encode p o ly g lu t a m in e :  
Hunt ington 's  Disease (Huntington's  Disease Collaborat ive R e s e a r c h  
Group, 1993), Spinal Cerebellar  Ataxia type 1 (SCAl;  Banfi et  al,
1994), Spinal Cerebellar  Ataxia type 3 (SCA3, also known as  
M achodo-Joseph  Disease; Kawaguchi et al, 1994), D e n ta to - R u b r a l  
and Pall ido-Luysian Atrophy (DRPLA; Koide et al, 1994 a n d  
Nagafuchi  et  al, 1994) and Spinal and Bulbar Muscular  A t r o p h y  
(SBMA or Kennedy's Disease; LaSpada et al, 1991).
3 7
A selective loss of neuronal populations is observed in all 
these diseases.  The set of neurons which are lost is specific to t h e  
disease, although some overlap between some of the diseases is 
observed.  For example, in DRPLA (Dentato-Rubral and Pa l l ido-  
Luysian Atrophy) and MJD (Machodo-Joseph Disease or SCA3), 
lesions occur in the subthalamic nucleus, globus pallidus, r e d  
nucleus and denta tenucleus .  The pontine nucleus is the only r e g io n  
to show specific lesion in MJD (SCA3). The regions of lesion for e a c h  
disease can be found in Figure 1.5 (Ross, 1995).
1 .1 0 .2  P o l y g l u t a m i n e  p a th o lo g y .
All these diseases are dominant  disorders.  They require o n ly  
one copy of the expanded allele to express the disease p h e n o t y p e .  
Gene knockouts in mouse have not replicated the disease p a th o lo g y  
(e.g. Huntington Disease; Nasir et al, 1995), which suggests t h a t  
these diseases are caused by the gain of a new function by t h e
affected gene product rather than by haplo- insuff ic iency (i.e. a lack  
of  protein with normal function).
The new function could be the result  of a modificat ion of t h e  
structure of a protein. As discussed earlier in this in t ro d u c t io n ,  
polyg lu tamine  stretches are thought to promote p r o t e i n - p r o t e i n
interact ions (Perutz et al, 1994). A specific monoclonal a n t i b o d y  
made by J.L. Mandel and co-workers  (Trottier et  al, 1995a), w h ic h  
was raised against the glutamine repeat of TBP (TATA b in d in g  
protein; Trottier  et al, 1995a), detects specifically mutant  p r o t e in s
with an expanded polyglutamine stretch, but not the normal p r o t e i n  
in extracts from patients with HD, SCAl and SCA3 (MJD). T h e  
sensit ivity of detect ion is dependent  on the length of t h e
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polyg lu tamine  tract, which suggests that the po lyg lu tam ine  s t r e t c h  
consti tutes  a specific epitope and adopts a stable s tructure in  
proteins (as suggested by Perutz et al, 1994). This antibody h a s  
been now used successfully to detect proteins with e x p a n d e d
polyglutamine runs in two other sp ino-cerebel la r  ataxias, SCA2 a n d  
SCA7 (Trot tier et al, 1995a), which were expected to b e
polyglutamine triplet expansion diseases. Recently the existence of  a 
po lyg lu tam ine  expansion in the gene for SCA2 has been c o n f i r m e d  
(Imbert et al, 1996).
Another  suggestion (Green, 1993) is that the glutamine t r a c t  
acts as a target for the action of t ransg lu tam inases .  These e n z y m e s  
covalently  cross-link proteins by the formation of y-e g l u t a m y l -  
lysine dipeptide (Folk and Finlayson, 1977). The polar nature  of t h e  
homopeptide would position it to the outside of the protein m a k i n g  
it accessible to enzymatic  attack. It is suggested that the p r o t e i n  
product would be degraded  but the dipeptide  residue would b e  
resis tant  to proteolysis,  which may be lethal to the cell, in a 
cumula t ive  m anner  (Green, 1993). The neuronal specific cell d e a t h  
observed in the polyglutamine diseases may be explained this w a y  
since there is t ransg lu tam inase  activity in neurones,  which is 
involved in the regulation of catecholamine release (Pastuszko et al, 
1986) .
This raises another  question which is: why this does not l e a d  
to the catas trophic  loss of all neuronal and other t issues, since t h e
genes involved are all widely expressed and do not match the le s ion
dis tr ibution specific to the disease (see Figure 1.5.A, adapted f r o m  
Ross, 1995). For example the huntingtin protein is also e x p r e s s e d  
beyond the areas of lesion observed for the disease (Sharp et al, 
1995; Trottier et al., 1995b).
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There must be some specific component  to the p a r t i c u l a r  
subpopula t ions  that are lost in each disease. Recent work h a s  
started to unravel this conundrum. Various groups have used t h e  
yeast two hybrid systems to look for proteins which i n t e r a c t  
specifically with proteins that contain expanded p o l y g l u t a m i n e  
tracts. For  example, by using the the yeast two hybrid m e t h o d o lo g y ,  
Li e t  al (1995) have identified a rat protein, termed h u n t i n g t i n  
associated p ro te in -1 (HAP-1) which interacted specifically w i t h
huntingtin  prote ins which contained expanded glutamine r e p e a t s .  
This protein did not interact either with huntington 's  proteins t h a t  
contain glutamine homopept ides  that correspond to n o r m a l  
products  in humans or with an a t roph in - 1 protein containing a n  
expanded glutamine homopept ide  (a t roph in - 1 is the protein w h ic h  
contains an expanded glutamine in the disease, DRPLA). This  
interaction was also dependent  on the number of residues contained 
in the polyglutamine tract. A huntingtin protein with 82 g l u t a m i n e s  
showed stronger binding compared to Huntingt in  with 4 4 
glutamines. In the same study, co-immunoprecipi ta t ion exper iments  
were used to test if the interaction occured in v ivo.  T r a n s f e c t e d  
rHAP-1 was coprecip i ta ted with an antibody specific to H u n t in g t in .  
Coprecipi tat ion was also observed by repeating the exper iment  w i t h  
a HAP-1 specific antibody. This interaction was abolished by t h e  
introduction of a Huntingtin pept ide antigen. The authors used t h e  
rat sequence to isolate the human homologue of HAP-1 b y  
he te ro logous  screening.
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1 .10 .3  M y o to n ie  D y s tro p h y .
Myotonie dystrophy (DM) is an autosomal dominant  d i s e a s e  
with variable penetrance  (Harper, 1989) which is associated with a 
CAG/CTG tr inucleotide repeat expansion.  It is the most c o m m o n  
muscular  dys trophy in human adults,  affecting 1 in 8000 (H arp e r ,  
1989). The disease is character ised  by clinically var iab le  s y m p t o m s  
and age of onset. Symptoms include the progressive  wasting of  
muscle  tissue, myotonia, cardio respiratory abnormali t ies ,  c a ta r a c t s ,  
mental re tardat ion  and gonadal atrophy. The mutat ion r e s p o n s i b l e  
for DM occurs in the 3' UTR of a gene that shows homology to 
serine/threonine kinases (Brook ct al,  1992). This was confirmed b y  
Timchenko et  al, (1995) who expressed the proposed protein a n d  
dem ons t ra ted  serine kinase activity. DM is different  from t h e
CA G/polyglu tamine  diseases described in the previous section in
one main respect; the trinucleotide repeat is t ranscr ibed  but n o t  
translated (Brook et al  1992).
The effect of the expansion of the repeat  is not clear .  
Differences in DNA {e.g. Wang and Griffiths, 1995), RNA {e.g. O t ten  
and Tapscott ,  1995) or protein levels {e.g. Dunne et al, 1996) of  
DMPK have been observed by individual groups and these h a v e  
been put  forward to explain the disease. There is evidence of b o t h  
up and down regulation of mRNA and protein levels in DM.
1.10.3.1 Potent ia l  effects  on DNA.
The argument  for a DNA level effect centres round t h e
observat ion that CTG repeats exert a dominant  n u c l e o s o m e  
posit ioning effect (Wang and Griffiths, 1995). It is proposed t h a t
due to an altered chromatin structure in the region, t ranscript ion is 
repressed.  To support this, Otten and Tapscott  (1995) h a v e  
observed  a loss of a DNAse I sensitive site in DM patients with a n  
expanded  CTG tr inucleotide repeat. However, the lack of s e n s i t i v i t y  
may be the result  of other proteins binding to the r e p e a t .  
Candidates  for these may be the CTG binding protein observed b y 
Timchenko  et al (1996; see Section 1.8). It is therefore possible t h a t  
the de n o v o  binding of prote ins could play a role in d i s e a s e  
ae t io logy .
1 .10 .3 .2  Potent ia l  effects  on RNA function.
Conflicting evidence of messenger  RNA levels has b e e n  
described by various groups. Fu et al (1993) report that the level of  
DM PK mRNA was inversely proportional to the size of the repeat in 
adult  tissues. Carango and co-workers  (1993) fail to detect a n y  
alternatively spliced RNA forms, or reduced DMPK mRNA t r a n s c r i p t  
levels in somatic cell hybrids containing affected chrom osom e 1 9 
from a MD patient family. Carango et al  (1993) believe t h e  
difference lies in the m easu rem en t  of all transcripts  in the case of  
Fu et al (1993), who used a primer  pair for RT-PCR analysis w h ic h  
was C O - l inear with respect to primary and processed m e s s e n g e r  
RNA, and themselves  who used another  pr imer pair w h ic h  
straddled an intron. Contradictory evidence came to light; w h e n  
using tissues from the congenital form of DM (CMD), Sabourin et al 
(1993) observed an increase in the steady state levels of DMPK 
mRNA. This probably reflects differences in expression levels of t h e  
DM PK gene between adult and developing organisms. More r e c e n t l y  
Taneja et al (1995) observe foci of expanded repeat t ranscripts  in
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the nuclei of cells from DM patients. This was not observed in nucle i  
from unaffected individuals and was specific to the expanded al le le  
t ranscr ipts.  The authors suggest that the export  kinetics of t h e  
DMPK mRNA from the nucleus to the cytoplasm may be affected b y 
the expansion.
1.10.3.3  Potent ia l  effects  on D M P K  protein.
DM may also be due to a protein level effect. Since the DMPK 
has been shown to have kinase activity (Timchenko et al, 1995) i t  
has been proposed that it is involved in signal t r a n s d u c t i o n  
mechanisms  important  for correct muscle function. M is - r e g u la t i o n  
of DMPK, either by a loss of functional isoforms or an o v e ra l l  
reduct ion in protein levels, could possibly lead to some of t h e  
clinical phenotypes  associated with DM; for example,  m u s c u l a r  
atrophy, myotonia and heart failure.
Immuno-histoc  hemic al analysis has identified several proteins 
which cross react with anti-DMPK antibodies in muscles and o t h e r  
t issues. Van Dei Ven et al (1993) localised a 53 kDa protein to t h e  
intercalated discs of cardiac muscle and the n e u r o - m u s c u l a r  
junction of skeletal muscles, that might indicate some r e g u l a t o r y  
function. However,  the predicted molecular  weight of DMPK is 
between 70 and 80 kDa, and the 53 kDa protein is likely to b e  
either an isoform of the DMPK protein generated by a l t e r n a t i v e  
splicing (as described by Fu et al, 1993) or a closely related p r o t e i n  
which cross reacts with the antibody. Dunne et al (1996) h a v e  
reported a 64kDa protein from skeletal muscle and a 79kDa p r o t e in  
from brain which is detected by a DMPK specific antibody. T h e  
proteolytic profile of the 64kDa protein matches closely that of t h e
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recom binan t  DMPK protein. Fur thermore it has been shown t h a t
there is a redis t r ibut ion of this isoform in DM patients.  There is a 
shift from the triadic region (Dunne et al, 1996) to the p e r i p h e r a l  
sarcoplasmic masses (Sabourin et al, 1993).
The complex nature of DM is underl ined in recent  t r a n s g e n i c  
knockout  studies, in mouse, by Reddy et al, (1996). In this s tu d y ,
mice homozygous for the loss of mouse clmpk  gene were viable a n d
were found to have progressive muscle weakness  and m y o p a t h y .  
However  no myotonia  is observed and heterozygous mice did n o t  
display any overt phenotype.  This is contrary to the h u m a n
situation where heterozygous individuals are affected and the e f f e c t  
is dominant.  This difference may be due to d ifferences in m u s c l e s  
between species. Alternat ively  some other factor may be in v o lv ed ,  
e.g. other proteins being involved in the aetiology of  DM.
1 .10 .3 .4  Are  other genes  involved in m y oton ic  dystrophy?
It is known that the region around DMPK has a high density o f  
genes and it has been proposed that DM is an oligo-genic d i s e a s e  
(Johnson et al, 1996; Harris et al, 1996), in which several genes a r e  
implicated in the phenotype.  In support  of this is the c o n t r a d i c t o r y  
data so far obtained for the DMPK locus (see above). It is p r o p o s e d  
that the CTG repeat expansion may not only affect DMPK, but a lso  
other genes in the vicinity.
A novel homeodomain  protein, DMAHP (D M -asso c ia ted  
hom eodom ain  protein; Boucher et al, 1996) lies centromeric  to  
DMPK. It has become of interest to DM researchers  because of i ts  
close proximity to the DMPK locus and the expanded t r i n u c l e o t i d e  
repeat. The last exon of clmpk gene overlaps the promoter  region o f
4 4
DMAHP. In addition this gene has been shown to be transcr ibed in 
muscle,  heart and brain, both in controls and patients with DM.
These are tissues that are affected in DM.
The mutant  CTG repeat lies within a CpG island that occurs a t  
the 3' end of the DMPK gene and at the 5' end of DMAHP. CpG 
islands are known to affect gene expression and Harris et al ( 1 9 9 6 )  
suggest that an expansion of the repeat  would disrupt the action of  
the CpG island and affect DMAHP gene activity. In support  of this ,  
the previously mentioned DNAse I hypersensitive site that is lost in 
pat ients  with an expanded repeat (Otten and Tapscott , 1995), is
thought to lie in the DMAHP promoter (Harris et al, 1996).
There is another gene on the telomeric side of  the DMPK locus, 
gene 59 (Jansen et al, 1995) in mouse or DMR-N9 in man (Shaw e t  
al, 1993). It has no known function but is expressed strongly in t h e
testes and brain in mouse. These are also sites of pathology in DM
(Harper,  1989).
1.11 Other d iseases  caused by CAG/CTG t r i n u c l e o t i d e  
r e p e a t s .
The discovery of the cause of this kind of disease is recent a n d  
it is likely that more diseases will be found to be caused by the 
expansion of CAG/CTG type trinucleotide repeats.
Attention has also centred on other diseases which d i s p l a y  
anticipation. This includes some major psychiatric diseases.  T h e  
discovery  of dynamic mutations  has lead people to assess t h e  
genetic l inkage data accumulated on familial forms of s c h iz o p h re n ia  
and bipolar affective disorder  (Bassett  and Honer, 1994; P e t ro n i s  
and Kennedy, 1995) which challenges the idea that these are oligo-
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genic and poly-genic diseases.  Family, twin and adoption s tu d i e s
have indicated that there is a strong genetic component  in t h e s e  
diseases (Gottesman and Shields, 1982; Kendler et al, 1985) .  
However,  the search for individual loci for these diseases has b e e n  
ham pered  by the inabili ty to replicate initial reports  of l inkage b y  
other groups (Bassett  and Honer,  1994). Data reassessm ent  h a s  
concluded that the dynamic muta t ion/  anticipat ion model does a lso  
fit the data available for these diseases (Bassett  and Honer, 1994 ;
Petronis  and Kennedy, 1995).
Initial work identified that repeats were expanded in s o m e  
patients suffering from psychiatric disorders.  For example,  L in d b la d  
et al, 1995 observed an overall increase in CAG repeats  a t  
individual sites in genomic DNA from patients with BP AD (b ip o la r  
affective disorder),  compared  to normal controls.  However,  s o m e  
initial data has ruled out certain classes of t r inucleotide repeat  as  
having involvem ent  in these diseases.  Kauffman et  al, ( 1 9 9 6 )  
working on some schizophrenic pedigrees found no evidence of  
expansion of CGG trinucleotides,  using the Repeat F x p a n s io n  
Detection (RFD) method (Schalling et al,  1993). Other repeats may be 
the cause of disease and not only those already associated w i t h
dynam ic  mutat ions.
The screening of human brain cDNA libraries w i t h
tr inucleotides  which have previously been shown to be a s s o c ia t e d  
with dynamic diseases have also identified candidate  genes. For  
example, a cDNA for the affected gene in the disease DRPLA, w a s  
identi fied by Li et al, (1993) from a human cerebral cortex cDNA 
library which was screened with a (CTG)io oligonucleot ide.  It is 
l ikely that other genes that are susceptible to dynamic mutation
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will be found within the subset of genes which contain t r i n u c l e o t i d e  
r e p e a t s .
1.12 C A G /C T G  trinucleot ide  repeats  and the mouse.
The mouse has an unrivalled position in modern m o l e c u l a r  
biology. It is the best studied m ammalian  organism and acts as a 
model  in which to study normal function and disease. This is no less  
true for trinucleotide repeats.
Trinucleotide repeats have been util ised ex tensively  in m o u s e  
as microsate l l i tes  to map genes (Love et al, 1990). Triplet r e p e a t s  
have also been found to occur in mouse genes. In a nucleic ac id  
database  search (Genbank and EMBL), Abbott and Chambers,  1 9 9 4  
found a number  of mouse genes that contained CAG/CTG t y p e  
repeats  within cDNA sequences. Their position within the g e n e s  
varied. They were found in the 5' untransla ted region, and in b o t h  
intronic and coding (exonic) sequences.
1.12.1 The mouse genom e is rich in u n - c h a r a c t e r i s e d  
expressed  C A G /C T G  repeats.
Furtherm ore  there appear to be many more triplets of th is  
type expressed than has been previously character ised.  In s u p p o r t  
of  this, Duboule (1987) took an OPA repeat probe der ived f r o m  
Drosophila m e l a n o g a s te r  gene Notch,  and used it to probe a 
northern  blot containing Poly-A enriched mouse RNA and found a 
multiple banding pattern. This suggests that there are m a n y  
examples  of OPA type repeats  in expressed  mouse s e q u e n c e s .  
Although OPA repeats  are described as repeats of CAN, a subset  of
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those detected by Duboule ct al (1987) will contain perfect r e p e a t s  
of CAG trinucleotides.
More recently, Chambers  and Abbott (1996) have screened a n  
adult  mouse brain cDNA library with oligonucleotides  containing 5 
copies of each of the 10 tr inucleotide families. They found 3 CAG 
repeat positive clones per 1000 recombinant  phage screened. This is 
similar to the results obtained by Li et al  (1993) and Riggins et al  
(1992). Of the five clones presented in the paper  (Chambers a n d  
Abbott, 1996), only one has similarity to a known gene, a h u m a n  
mitochondrial malate dehydrogenase. Of the remaining four, 3 h a v e  
similar ity to human ESTs, which are the product of random m a s s  
sequencing of cDNA libraries.  These sequences have no a s s ig n e d  
function. The remaining clone shows no similarity to any s e q u e n c e  
in the Genbank or EMBL databases. Three of the clones had a r e p e a t  
sequence which contained 10 tandem copies of CAG/CTG. T h e  
remaining trinucleotide  repeats were greater than or equal to t h e  
size of the probe, (CTG)s. Chambers  and Abbott (1996) also lo o k e d  
at the variabili ty of four of the CAG/CTG repeats.  Three e x h i b i t e d  
variabili ty  between different mouse strains der ived from M. 
m u s c u l u s . The fourth, containing five copies of CTG/CAG, did n o t  
show any variabili ty even between different  species of mouse {M. 
musculus, M. spretus and M. caroli  ). Overall, Chambers  and A b b o t t  
(1996) found that 24% of all repeat loci tested (a variety of loci 
from all ten families of repeat) were found to vary between s t r a i n s  
of M. m u s c u l u s  and that 64% varied between M. m u s c u l u s  a n d  
another  species {M. spre tus ) .  For CAG repeat containing clones, 60% 
were found to vary between inbred strains. These data w e r e  
compared with the author 's previous results (Abbot and C h a m b e r s ,  
1994), where previously characterised mouse cDNAs from nucleic
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Table  1.1
r e s i d u e s / t r i n u c l e o t i d e s
D i s e a s e g e n e r e p e a t h u m a  11 m o u s e r a t
DRPLA a t r o p h i n CAG/Q 7-35 1 n / a 5 2
SCAl a tax in CAG/Q 6-39 3 2 4 n / a
HD H u n t in g t in CAG/Q 25 3 7 n / a
SBMA a n d r o g e n CAG/Q 12-33 7 5 » n / a
r e c e p t o r
MJD/SCA3 CAG/Q 14-34 ^ n / a n / a
m y o t o n i c DMPK CTG/ 3' 5-40 ' « { ( T ( i ) , ( ( ' A G ) : ( T ( i " n / a
d y s t r o p h y UTR
Table  1.1 C om p ar ison  of  CAG/CTG repeats  in hum an a n d  
rod en t  genes ,  which are associated  with hum an disease.
The numbers  in human,  mouse and rat columns represent  t h e  
num ber  of glutamines  (in the case of SCAl,  s p in o  c e r e b e l l a r  
atrophy, type 1; DRPLA, dentato-rubral and pallido-luysian a t r o p h y ;  
HD, Huntington 's  disease; MJD, Machado-Joseph disease (SCA3) a n d  
SBMA, spinal and bulbar muscular atrophy) or trinucleotides (in t h e  
case of DM, myotonic dystrophy)  at identical positions in the s a m e  
gene, in different  species. References, which are indicated b y  
numbers  in bold type, are: * Li et al, 1993;  ^ L oe v  et al, 1995; ^ 
Banfi et al, 1994; ^ Banfi et al, 1996; ^ Huntington 's  D isease
Collaborative Research Group, 1993; ^ Barnes et al, 1994; L a S p a d a  
et al, 1991 ; * Faber et al, 1991 ;  ^ Kawaguchi  et al, 1994; Brook e t  
al,  1992; Jansen et al, 1992. n/a indicates that the h o m o lo g o u e  
gene sequence is not available for that particular species.
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acid databases (Genbank and EMBL) were selected on the criteria of  
having at least 7 CAG trinucleotide  repeats.  Of the 12 cDNAs w h ic h  
fitted these criteria,  55% varied between inbred strains and 78% 
varied between M. m u s c u l u s  and M. sp re tu s .  The figures for b o th  
studies,  55% (Chambers and Abbott,  1996) and 60% (Abbott  a n d  
Chambers,  1994) are similar.
Polyglu tamine stretches appear  to have a positive effect on  
protein-protein interactions, probably due to the polar nature of  t h e  
amino acid residues. A high proportion of proteins from a variety of 
species that contain long stretches of glutamines  are t r a n s c r i p t i o n  
factors (Gerber  et al, 1994). This is may be the case in mouse as  
well, since a number  of mouse transcrip tion factors c o n ta in  
polyglutamine.  These include Brain 2 (an octamer  repeat b in d in g  
POU domain protein; Hara et al, 1992) and the g lucocor t ico id  
receptor (a steroid receptor; Nohno et al, 1989). Expressed CAG/CTG 
repeats  in mouse are not exclusively translated and of those t h a t  
are t ranslated,  not all encode polyglutamine.  An i l l u s t r a t i v e  
example is that described by Theodosiou et al (1996) who d e s c r i b e  
a mouse MAP kinase phosphatase  (M3/6) which contains an AGC 
repeat which is translated as polyser ine (AGC is a m em ber  of t h e  
CAG/CTG codon family). This repeat is part of a greater p o l y s e r i n e  
tract, which is made up with the addition of an AGT repeat. I n  
addition to this AGY repeat,  where Y is a pyrimidine base and can  
be ei ther  cytosine (C) or thymidine,  (T), there is a jux taposed  GGN 
repeat  which is presumed (by Theodosiou et al, 1996) to encode a 
polyglycine repeat. The full length of this repeat is 
(AGC)4(GGT)7(GGC)|,(AGC)4AAC(AGC),3(AGT)^, at the nucleot ide level.  
This repet i t ive  region is translated as S4G 1SS4N S 19. This is a n o t h e r
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example of the existence of a CAG/CTG type repeat and a GGN 
repeat in close proximity.
Using the str ingent conditions of Li et  al (1993, h y b r id i s a t i o n  
solution: 50% formamide, 5xSSPE, 42°C and washes at 60°C in IxSSC, 
0.5% SDS, thrice 20 minutes) will facilitate the isolation of t r a n s l a t e d  
CAG type repeats. Compared with the results of Riggins et al ( 1 9 9 2 ) ,  
Li et  al  (1993) isolated larger CAG (and CCG) tr inucleotide r e p e a t s ,  
among which there were a large proportion of clones in which t h e  
t r inucleotide repeat is p resum pt ive ly  translated. Eurthermore,  66% 
of those which were translated encoded glutamine stretches. I n d e e d  
this exper im ent  isolated the protein which is associated with t h e  
human disease, DRPLA (CTG-B37, Li et al, 1993; Kawaguchi et al,
1994). There is no information about possible translat ion a v a i l a b le  
for the mouse repeats isolated by Chambers  and Abbott (1996) b u t  
they used a smaller probe, which is probably more sensitive to  
hybridisa t ion conditions. It is known that for o l igonuc leo t ides ,  
annealing is dependent  on the length of the ol igonucleotide, as wel l  
as tempera tu re .  This may limit the size of tr inucleotide r e p e a t  
iso la ted .
1 .12.2  H u m a n -m o u s e  co m p a r iso n s  in genes  a s so c ia ted  w i t h  
d y n a m ic  m u ta t io n  d ise a se s .
In a major effort in trying to understand the nature of gene t ic  
diseases involving dynamic mutat ions in humans genes, the m o u s e  
homologues  have been cloned to develop animal models.  H o w e v e r  
CAG repeats found in the human genes (Table 1.1) affected are n o t  
generally conserved in the mouse homologues. For example t h e  
mouse HD gene homologue contains only seven repeats (Barnes e t
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al, 1994), whereas the human HD gene isolated from u n a f f e c t e d  
control patient  contained 25 repeats (Huntington 's  Disease  
Collaborative Research Group, 1993). Furthermore the CAG repeat in 
the mouse  gene is corrupted with a CAA trinucleotide,  which also
encodes  glutamine. These corrupt ions have been shown to have a 
stabilising effect on trinucleotide repeats (Weber,  1990). It has been 
noted that in the trinucleotide repeats which are associated w i t h
human diseases, stability is conferred by such in terrupt ions.  For  
example  Fichier et al  (1994) noted that the GGCrepeat  of the f m r \
gene (which is affected in FRAXA) is in terspersed  by two AGG
trinucleotides .  Instabi li ty  of this repeat was only observed w h e n
one or both of the AGG repeats were replaced with 03G 
t r i n u c le o t id e s .
Gene knockouts  have confirmed that the po lyglu tamine  class  
of disease is likely to be due to gain of function mutations, since t h e  
lack of the proteins in the organism does not replicate the d i s e a s e  
phenotype.  For example,  separate  groups which have d e v e l o p e d  
targeted disruptions  have found that mice lacking the H u n t in g t in  
protein do not display the HD phenotype (Duyao et al, 1995; Nasir e t  
al, 1995 and Zeitlin et al, 1995).
1.12.3  H u m a n  tra n sg en e  studies .
In a further  at tempt to unders tand  the nature of t h e
polyg lu tam ine  associated diseases, human transgenes  with t h e  
appropria te  expanded glutamine tracts have been introduced in to
the mouse to replicate the disease pathology.
Attempts  by different  groups, working on different  d i s e a s e s  
have had varying results.  For example, the introduction of h u m a n
5 2
androgen  receptor  transgenes with expanded polygli i tamine t r a c t s  
into the mouse failed to replicate the SBMA disease p h e n o t y p e  
(B ingham  et al, 1995). However this transgene was not expressed in  
the same tissues as the endogenous AR protein. Fur thermore ,  l o w e r  
levels of  the t ransgenic protein were detected (relative to n o r m a l  
AR prote in  expression levels). These differences may account fo r  
the lack of observable  phenotype.  For instance, a critical amount of  
mutant  AR protein may be required for the disease phenotype  a n d  
the lack of mutant protein in the affected tissue types may p r e c l u d e  
the disease  from occurring.
In contrast to the AR transgene experiment,  a d i s e a s e  
p h eno type  that is similar to that found in man has been o b s e r v e d  
for ataxin (the effected gene in SCAl)  transgenes (Burright  et al,
1995). The authors used the transgene in conjunction with a 
Purkinje  cell specific promoter  of the gene pcp2 (Purkinje  cell 
protein 2), which had been shown previously to direct Purkinje cell 
specific express ion (Vandaele et al, 1991). It is known that t h e s e  
cells are one of the cell populations that degenera te  in SCAl.  T h e  
age of onset of ataxia in these mice correlated with the level of  
expression of a t ransgene containing an expanded glutamine r e p e a t  
(82 residues).  Two transgenic lines which did not display an o v e r t  
ataxic phenotype in heterozygotes (but in homozygotes)  were f o u n d  
to have cons iderable  Purkinje cell degeneration.  This o b s e r v a t i o n  
corre la tes  with previous Purkinje cell disruption in e x p e r i m e n t s  
using an SV40 T antigen transgene, where no phenotype  w a s  
observed until up to 50-75% of the Purkinje cell population was lo s t  
(Feddersen et al, 1992). This effect is dependent  on the level of t h e  
expanded glu tamine transgene because these transgenic mice, w h e n  
bred to homozygosi ty , display an ataxic phenotype.
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No ataxic phenotype  was observed with a control t r a n s g e n e  
which contained 30 glutamines, which correlates to a repeat  l e n g th  
which gives a normal phenotype in man. This is interesting b e c a u s e  
it is 28 residues  larger than that found in the mouse homologue of  
Ataxin. This indicates that the pathological mechanism that is 
activated in the presence of expanded glutamine to cause cell d e a t h  
in humans  is also present  in the mouse. However no var iation in  
repeat  length through the generat ions of t ransgenic mice w a s  
observed; therefore there may be differences between man a n d  
mouse in the level of expansion rates and mice may be protected in  
some way from run away style expansion observed in humans. This  
phenom enon  was also observed in study using a human t r a n s g e n e  
carrying an expanded glutamine in the AR, the protein involved in 
SBMA (Bingham et al, 1995). Candidates for these d ifferences w o u ld  
be proteins involved in recombinat ion mechanisms.
It has been observed that in some cases of colorectal cancer ,  
microsatel l i te  loci become hypervar iab le  in size in tumour cell 
popula t ions  (Ionov et al, 1993). The basis of this is likely to be a 
defect in the fidelity of recombinat ion or repair. This is similar to a 
class of  bacterial mutations, known as mutator mutations.
It has been found that the repeat in these human t r a n s g e n e s  
does not vary from generat ion to generation as is the case in t h e  
human genes. It has from this been suggested that the mouse in 
some way differs from humans in respect to repeat variability.  This  
is ques t ionable  because of the existence of large repeats  in m o u s e  
and that they are variable in a f requency not too diss imilar  to  
humans (Chambers and Abbott,  1994). Fur thermore ,  the g e n e s  
which have been in troduced into the mouse, are human and lack
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introns. It could be possible that important  co-sequences  a r e  
m iss ing .
The effect of random integration of the t ransgene c o n t a in in g  
the affected human gene may also be an importan t  factor in  
determination of the variabili ty of trinucleotide repeats.  It is k n o w n  
that the position of integration can have an effect on the e x p r e s s i o n  
of  transgenes. This position affect has been observed in m a n y  
eukaryotic  species where transgenes are introduced and is t h o u g h t  
to be an effect of local chromat in  structure, regula tory  s e q u e n c e s  
and other co-sequences  which affect regional t r a n s c r i p t i o n a l  
ac t iv i ty .
For Myotonic Dystrophy in v/hich there is thought to be a loss  
of  functional protein, two knockouts of the mouse gene (Jansen et  al,  
1996; Reddy et al,  1996) gave phenotypes  which are partially w h a t  
is observed in the human disease. Fur thermore ,  no phenotype  w a s  
observed in heterozygotes  carrying the clmpk  deficiency. This is 
contrary  to DM in humans in which dominance is observed. O v e r ­
express ion of DMPK protein in mice did not show any o b s e r v a b l e  
phenotype; there were no histological d ifferences o r  
electrophysiological changes (Jansen et al,  1996). This data s u p p o r t s  
the proposition that other genes may be affected in DM (Johnson e t
al,  1996). There is a high degree of conservation of genes in the DM
region between mouse and man and it is likely that the mouse wil l
be an important model to examine the co-effectors in DM.
1.12.4 Models  for C A G /C T G  binding proteins.
There are now three independent  groups which have i s o l a t e d  
t r inucleotide specific binding proteins.  Richards et  al (1993) a n d
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Timchenko  et  al (1996), both working in humans, found p r o t e in s  
which were specific to doub le -s t randed  and s ing le -s t randed  DNA 
and RNA triplets. Since Yano-Yanagisawa et  al (1995) found GAG 
specific proteins in mouse, it is likely that the human proteins h a v e  
their homologues in mouse. This will provide an animal model in  
which the function of these proteins can be analysed to see w h ic h  
roles they play in cells as well as repeat expansion mechanisms a n d  
disease  pathology.
1.13 Aim s o f  this project.
The objective of this research is to isolate, identify a n d  
character ise  mouse genes which contain CAG/CTG t r in u c l e o t i d e  
repeats.  This is an interesting approach to take because of t h e i r  
potential functions, as described in Sections 1.5 to 1.9 of th is  
Chapter. A general study of CAG triplet repeats in mouse would lay  
the ground work for an understanding of the biology of this class of  
repeat in the mouse and in other organisms. Fur therm ore  this c lass  
of t r inucleotide repeat has become associated with a new form of  
human disease. An examination of mouse triplet repeats,  could h e lp  
in the unders tand ing  of these diseases if any cross spec ies  
correlation could be made. Finally these triplet repeats can be u s e d  
to identify new genes which may be involved in r e g u l a t o r y  
p r o c e s s e s .
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Chapter  2 
M ater ia ls  And M ethods
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2.1 Stra ins  and vectors.
2.1.1 B a c ter ia l  s trains .
S t r a i n G e n o t y p e R e f e r e n c e
N o v a B L U E
enclAl hsclRl?  ( r k l 2 ’ m k l  s u p E 4 4  
supF58 thi-1 recAl  ^yrA96  re lAl  lac 
( f  proA'^B'^ lacBlZAMJ5 : :Tn 10
N o v ag en
T G I
supE hsclD5 thiD(lac-proAB) F(traD36  
pm AB"^  lacBl l a c Z A M i 5)
Gibson, 1984
X L l  - B l u e
siipE44 hsclRl? rccAI end A I  ^ y r A 4 6  
thi re lA l  l a c  F' (proAB'^ lacBl 
lacZAM 15 T n lO ( te tn )
Bullock et al, 
1 9 8 7
Q 3 5 8
siipE hsdR fHO^
Karn et al, 
1 9 8 0
c b O O h f lA
siipF44 hsdR thi-J leuB6' h f lA I50  
{chr::TnlOite t^ l ) lacY]  tonA21 F
Young and 
Davis,  1983
D H 5 a
]
supF44 AlacJjlOO (\i/HO lacZAM I5)  
HsdR 17 recAl  endA l  ^yrA96  th i -1  
re lA  1 /
H a n a h a n ,
1 9 8 3
Table  2.1 List  o f  bacterial strains.
Refer  to the individual references for the details of the origin of  
each strain. /
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2.1 .2  cDNA l ibraries .
T i s su e so u rce s t r a i n p r i m e r v e c t o r r e f e r e n c e
8.5dpc
m ouse
whole
em bryo
C57BL () l ig() - (JT ÀgtlO Hogan B., 
u n p u b l i s h e d
12.5dpc
m ouse
whole
embryo
C57BL r a n d o m  
p r i m i n g 
( h e x  a m c r s  )
Xgtl 0 Logan et al, 
1 9 9 2
13.0dpc 
m ouse
whole
embryo
C57BL ol  i g o - d T Xunizap Allen N., 
u n p u b l i s h e d
adult  mouse  
b r a i n
C57BL ()1 i g o - d T pSPORT M e i e r - E w a r t
SB.,
u n p u b l i s h e d
Table 2.2 cDNA l ibrar ies  s creen ed  with the o l i g o n u c l e o t i d e  
( C T G ) i« .
20-40000 clones from each library were plated and screened with a 
y-^2p_ATP end-label led  ol igonucleotide, (CTG)k). Column 1) 
represen ts  the tissue source for the mRNA from which cDNA 
libraries were constructed;  Column 2 (strain) represents  the m o u s e  
inbred strain from which the tissue was taken; Column 3 ( p r im in g )  
describes the method of  first round cDNA synthesis priming; Column
4) (vector) DNA vector in which library is maintained; Column 5)  
R e fe ren ces .
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2 .1 .3  P la sm id  V ectors .  
p B lu e scr ip t  KS vectors.
Phageinid vectors which contain an ampicillin resis tance g e n e  
((3-lactamase) for selection, a (3-galactosidase p o l y p e p t i d e  
eng ineered  with an extensive polyl inker  in s i tu  contain ing u n i q u e  
restr ic t ion sites for cloning, and an origin of replication for s ing le  
s tranded DNA production. The full sequence for these p h a g e m i d s  
can be accessed through Genbank (accession numbers: X52327, KS+ 
and X52329, KS-).
p S P O R T l .
Available from Gibco BRL-Life Technologies.  This plasmid  w a s  
used as the parent plasmid vector backbone of the adult  m o u s e  
brain cDNA library described in Table 2.2.
2 .1 .4  L a m b d a  vectors .
X g t lO .
Parent lambda vector used in the construct ion of the 8.5 d p c  
and 12.5 dpc whole mouse embryo cDNA libraries used in this work. 
It was created by Huynh et al, (1985) for the purposes  of c lon ing  
cDNA inserts up to 6 kb in size into a unique Err;RI site in the i m m  
434 gene which renders recom binan t  phage cL.  N o n - r e c o m b i n a n t  
cl+ lysogenise very efficiently in h f lA  E. coli strains (e.g. C 6OO/1/ /A ,  
see above), c L  phage cannot, but go on to re infect other b a c t e r i a  
and will form plaques on a bacterial lawn.
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ÀZAP II.
This lambda phage based vector was used in the c o n s t r u c t io n  
of the 13.0 dpc whole mouse embryo library (N. Allen, 
unpubl ished) .  It contains a number  of modifica tions to the bas ic  
phage structure. Discrimination of recombinant  and n o n ­
recom binan t  phage is based on the disruption of a lacZ a  
po lypept ide  when material is cloned into the multiple cloning s i te  
conta ined  within the lacZ sequences. This vector is available f r o m  
Stratagene and was constructed by Short et al, 1988. It also contains 
sequences which allow for the in v iv o  excision of p h a g e m i d s  
containing the cDNA inserts, using a helper phage.
2.1.5 DNA ol igonucleot ides  used in this study.
The sequence of each of the oligonucleotides used in this w o r k  
is indicated in Table 2.3.
2.2 G rowth and m aintenance  of  bacteria and vectors.
2.2 .1 Bacter ia l  growth media .
2 Y T
For 1 litre, dissolve 16 g of bacto- t ryptone,  10 g of y e a s t  
extract and 5 g of NaCl into 800 ml dH2 0 . Adjust to pH7 with 5 M 
NaOH. Adjust to 1 litre with distilled H2O and autoclave to sterilise.
Table 2.3
P r i m e r s e q  u e n c e r e f e r e n c e
n e o  1 0 C G G A A A A C G A  T T C C G A A ( ; C C Gossler et al, 
u n p u b l i s h e d
n e o  11 A G C C G  A T T G J  c  k ; t t ( ; t g c c Gossler et al, 
u n p u b l i s h e d
n e o 1 g g a g a a c c t ( ; c ( ; t g c a a i c c Gossler et al, 
u n p u b l i s h e d
n e o 2 ( ; A G T A C ( ; A C C  T C A A G A A G C G Gossler et al, 
u n p u b l i s h e d
T 3 A T T A A C C C T C A C T A A A ( ; G G A Promega,  1995
T 7 T A A T A C G A C T C A C T A T A ( ; ( ; ( i Promega,  1995
b T 7 ( ; T A A T A C t i A C  r C A C T A T A ( ; ( ; ( ; C S t r a t a g e n e ,  
1 9 9 5
T 3 / T 7 a A G C G G A T A A C A A  H  T G A C A C A G G BRL-Life
t e c h n o lo g ie s
( C A G ) io C A G C A ( ; c A ( ; c A ( ; c A ( ; c A ( i C A ( ; c A ( ; c A ( i C A ( ; Chapter 2, 
Section 2.20
(C T G )io C T (  ; C T (  ; c T (  ; C T (  ; c  k  ; c  k  ; c  k  ; c  k  ; c  k  ; c  i x  ; Chapter  2, 
Section 2.20;
Table  2.3 List  of  DNA ol igonucleotides  used in tbis work.
Sequences represent the 5' to 3' sequences of each o l ig o n u c leo t id e  
named. The origin of the primers are indicated by the exp l ic i t  
reference. For further details refer to these references.
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LB
For one litre, dissolve 10 g tryptone, 5 g yeast extract, 10 g 
NaCl, 1 g glucose and 20 mg of thymine in to 800 ml of dH2 0 . M a k e  
up to 1 litre with distilled H2 O and autoclave. LB was used where i t
was necessary to propagate with the antibiotic tetracycline,  w h ic h  
has been shown to be inhibited by the presence of  magnesium ions.
NZCYM
This medium was used in the preparat ion of phage c o m p e t e n t  
bacteria,  except for strain X Ll-Blue  (Bullock ct al, 1987). This s t r a i n  
requires  te tracycl ine selection and therefore requires  to be g r o w n  
in Mg^+-free  medium for the reason detailed above. To 950 ml of  
d H 2 0 , add 10 g NZ amine, 5 g NaCl, 5 g bacto-yeast extract,  c a s a m in o  
acids and 2 g of MgS0 4 .7H 2 0 . Mix to dissolve solids and adjust to pH 
7.0. Make up to one litre with dH20  and autoclave.
Solid and semi-so l id  media  for bacteria .
As required, the different media were prepared as above. J u s t  
before autoclaving bacto-agar  was added to the concentrat ion of  
either 15 g/ litre or 7 g/ litre for plates and top agar respectively.
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2.2.2 Growth conditions for Bacteria and Phage.
L iq u id  cu l tu re s .
Bacterial samples were inoculated into the appropria te  s t e r i l e  
l iquid media (in a flask) and put at 37°C, in an orbital s h a k in g  
incubator  at 200 rpm, for a period of 16 to 20 hours.
Solid  M edia .
Solid agar was melted in a microwave oven until t o t a l l y  
dissolved. The molten agar was allowed to cool until 55°C. 
Antibiot ics were then added (if required)  to their w o r k i n g  
concentration (see Section 2.6). The agar was then poured into p e t r i  
dishes and allowed to solidify. Before use the agar was dried to  
remove excess moisture. The plates were stored at 4°C if not u s e d  
directly.  Bacteria were streaked out on to plates containing t h e  
appropr ia te  selective antibiotics and colorimetric  indicators if  
r e q u i r e d .
2.3 S ter i l i sa t ion  o f  media .
All solutions were sterilised for 20 minutes  at 15 Ib/sq. in. on  
liquid cycle. Heat labile mater ials were sterilised by f i l t e r in g  
through a 0.2 pm filter (Sartorious) and stored in p r e v i o u s l y
s ter i l ised  containers.
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2.4 Transformation of Bacteria.
2 .4 .1  P r e p a r a t io n  o f  e l e c t r o -c o m p e te n t  b acter ia .
Elec tro -com pe ten t  bacteria were prepared using the m e t h o d  
descr ibed  in Current Protocols (Ausubel et al, 1990). The cells c a n  
be r e - su sp en d ed  directly into H2O and used directly f o r  
electroporation, but it is wise to test each batch of cells with a s e r i e s  
of s tandard  dilutions of plasmid before proceeding to use them in  
any experiments .  With the testing procedure lasting 2 days a f t e r  
the preparation of the cells it is better to preserve them at -70°C in 
the way described below as the cells deter iorate  rapidly if left a t  
4°C or on ice.
P r o c e d u r e .
1)  A single colony from a fresh plate was inoculated into 5 ml o f  
appropr ia te  growth medium with selective antibiotic and w a s  
grown for 16- 20 hours (i.e. overnight).
2 )  Dilute 2.5 ml of the overnight  culture in 500 ml of p r e - w a r m e d  
2YT medium in a 2 litre flask (for maximum aeration),  without  a n y  
antibiotics.  Measure  the O.D. (optical density) at wavelength  of 6 0 0  
nm of  the culture regularly until it reaches 0.5-0.6 .
3 )  Chill the culture for 15 minutes in an ice-water  combinat ion a n d  
decant  into 2x 250 ml polypropylene centri fuge tubes. Balance t h e  
tubes to within 0.01 g with a fine balance.
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4)  Pellet  the bacteria by spinning the tubes at 4200 rpm for 2 0 
minutes  in a JA-14 rotor (Beckman). The rotor must be p r e - c h i l l e d  
to 2°C.
5)  Decant the superna tan t  and keep the bacterial pellets at 2°C fo r  
the rest of  the subsequent procedures.
6 ) Resuspend the cells gently but fully in an equal volume of p r e -
chilled disti lled H2O (2°C). This is best done by first res  us p e n d i n g
the pellets in 5 ml of water by extensive swirling action and on ice. 
Once bacterial suspension is achieved add the rest of the water.  Do 
not pipette as this mechanically sheers the cells and will result  in a 
reduced number  of cells at the end of the procedure  and hence a 
lower  t ransformation efficiency.
7) Spin the bacterial suspension at 4200 rpm at 2°C for 20 minutes.
8 ) Decant the supernatant  and re su spend in an equal volume of
d H 2 0  in the manner described above.
9) Centrifuge the resuspended bacteria at 4200 rpm for 20 m i n u t e s  
(2°C).
1 0 )  Decant the supernatan t  and resuspend each pellet in 5 ml of  
10% glycerol solution. Place in a fresh 45 ml polypropylene  tu b e .  
Make the volume up to 45 ml with water ice cold 10% (v/v) glycerol 
solution and spin against a balanced tube (containing water) for 1 0 
minutes at 4200 rpm (2°C) in a JA-20 rotor (Beckman).
11)  Pour off the supernatant and replace the tube on ice.
1 2 )  Add 500 pi of 10% glycerol and resuspend the bacterial p e l l e t  
g en t ly .
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This procedure should yield about 1 ml of competent  b a c t e r i a  
which can be used directly for e lectroporat ion or can be frozen fo r  
later use. Freezing the e lec t ro -com pe ten t  bacteria can be a c h i e v e d  
by placing 40 pi aliquots in pre-chilled 1.5 ml m icrocen tr i fuge  t u b e s  
followed by snap-freezing on dry ice for 15 minutes  before p lac ing  
them at -70°C for long term storage.
2 .4 .2  E le c t r o - tr a n s fo r m a t io n  o f  b acter ia .
The bacteria were prepared  as descr ibed above a n d  
t ransfo rm ed  in the following way. The equ ipm ent  was the c u s t o m  
elec tropora t ion  unit manufac tured  by Biorad and e l e c t r o p o r a t i o n  
was carried out using the manufacturers  cuvettes and conditions.
P r e p a r a t i o n .
Fill the appropria te  amount of 1 ml syringes with 2YT
medium, flaming to retain sterility. Dilute the DNA solution if 
required to reduce the concentration of salt.
P r o c e d u r e .
1)  Take the appropriate  numbers  of fresh or frozen aliquots of  
e lec tro-competent  bacteria (usually corresponding to the num ber  of
individual t ransformat ions  to be done). Thaw an extra aliquot in
case one electroporation attempt fails. Place on ice to thaw slowly.
2 )  Once thawed, pipette 1 pi of DNA containing solution into t h e
cells. Mix by pipetting up and down twice with a micropipette set a t
20 pi and leave on ice for 5 minutes.
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3)  Transfer  the DN A/bacteria solution into an e l e c t r o p o r a t i o n  
cuvet te  (which has been pre-chilled on ice). Avoid the i n t r o d u c t i o n  
of bubbles into the cuvette chamber  as this will produce pockets  o f  
conductiv i ty  which will cause the reaction to fail and kill the cells.  
Tap the DN A/bacterial mixture to the bottom of the chamber.
4) Wipe the outside of the cuvette to remove excess moisture w h ic h  
builds up due to condensat ion when the cuvette is t ransfe r red  to  
room temperature  after pre-chill ing.
5 )  Place the cuvette in the e lectroporat ion chamber , slide i n to  
position between the electrode contacts and apply a pulse. For a 0.1 
cm diameter  cuvette,  use the following settings: 1.6 kv, 400 o h m s  
resis tance and 25 pF capacitance. 0.2 cm d iameter  gap c u v e t t e s
require 2.5 kv, 400 ohms and 25 pF .
6 ) Immediately resuspend the cells in 1 ml of 2YT and transfer  to a
sterile 20 ml universal.
7)  Incubate the transformed mixture for 1 hour at 37°C shaking a t  
200 rpm.
8 ) Plate out the appropria te  amount of t ransformed bacter ia on to  
p re -p repared  plates containing the required antibiotic a n d
color imetr ic  indicators as required. Incubate the plates overnight  a t  
37°C. The rest of the t ransformed mixture can be stored at 4°C a n d  
plated out the next day, if necessary.
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2.5 L a m b d a  phage  m an ip u la t ion .
2.5 .1 P r ep a ra t io n  o f  phage  c o m p eten t  bacter ia .
A fresh colony of  bacteria was used to inoculate 100 ml of LB 
with tetracycline to a final concentrat ion of 50 pg/ml, 10 ml of 20% 
(w/v) maltose (filter sterilised). Maltose is included to s timulate  t h e  
accumulat ion of the maltose receptor  (malB),  which is the b i n d in g  
site for bacter iophage lambda on the bacterial cell surface, prior to  
in fec t ion .
2.5 .2  Infect ion  of  bacteria  with lambda phage.
P hage-com peten t  bacteria were initially mixed with an  
appropriate amount of phage then incubated for 20 minutes at 37°C 
to allow the phage to absorb to the bacteria.  This mixture was t h e n  
mixed with top agar at 48°C in a sterile p re -w arm ed  u n iv e r s a l ,  
swirled to mix, and then plated onto a square 10x 10 cm p l a t e  
containing bottom agar (pre-dried to remove excess m o is tu r e ) .  
After leaving the top agar mixture to solidify for 10 minutes on t h e  
bench, the plates were then t ransferred to the 37°C incubator  to  
allow growth of the bacteria and phage. The plates were left at 37°C 
until the phage plaques were visible but not touching each other.
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2.6 A n t ib io t ic s  and co lo r im e tr ic  indicators ,
2 .6 .1  A n t ib io t i c s
A n t i b i o t i c w o r k i n g
c o n c e n t r a t i o n
S to r a g e c o n d i t io n s
A m pic i l l in 100 p g / m l 100 mg/ml 
at -20°C.
in H2O and s t o r e d
T e t r a c y c l in e 50 p g / m l 50 mg/ml 
at -20°C.
in ethanol.  S to re d
2 .6 .2  C o lo r im etr ic  ind icators .
X-gal (5 -b ro m o -4 -c h lo ro -3 - in d o ly l -p -D -g a la c to s id e ) ,  a c h r o m o g e n ic  
subst rate  for the p-galactosidase enzyme,  was used with IPTG 
( isop ropy l-P -D - th ioga lac topyranos ide ) ,  an inducer of the E. coli lac 
operon. In the presence of active p-galactosidase,  X-gal is c o n v e r t e d  
into a product which gives a strong blue colour.
Xgal Stock. X-gal is made up to a stock solution of 20 mg/ml in 
H2O, filter sterilised by the method described above (Section 2 .3 )  
and stored at -20°C.
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IPTG . IPTG is made up to a 20 mg/ml stock in DMF ( d i - m e t h y l  
formamide) and stored at -20°C. IPTG is light sensitive and it is b e s t  
stored in a sterile universal bottle, wrapped in silver foil.
2.7 Long term m aintenance  of  bacteria l,  p lasmid and phage  
s t o c k s .
2.7.1  B acter ia l  s tocks.
Parent strains of bacteria and bacteria containing in d iv id u a l  
plasmids were kept in long term storage as 50% (v/v) g lyce ro l  
solutions of overnight cultures derived from single colonies f r o m  
fresh plates. These stocks were stored at -70°C in 2 m l  
polypropylene screw cap tubes (Nunc).
2 .7 .2  M a in te n a n ce  o f  lam b d a  b ac ter iop hage .
Individual plugs (and individual plaques) were stored at 4°C 
in 1 ml of SM with 50 pi chloroform.
2.7 .3  B a c te r io p h a g e  reagents  and so lut ions .
SM  Add 5.8 g NaCl, 2 g MgS0 4 .7H2 0 , 50 ml IM TrisHCl, pH 7.5 to  
800 ml of dH2 0  and allow to dissolve. Add sterile gelatine to a f ina l
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concentration of 0.01% (w/v) and adjust to one litre. Aliquot the SM 
into glass bottles and sterilise by autoclaving (Section 2.3).
2.8 N u cle ic  acid isolat ion and m anipulat ion .
2.8.1 Isolat ion o f  p lasmid  DNA.
Miniprep of plasmid DNA was performed using a m o d i f i e d  
method of the BD miniprep using Wizard miniprep columns (G a re th  
Griffith,  unpublished data; Promega).
1)  Inoculate  5 ml of 2YT culture containing the a p p r o p r i a t e  
antibiotics with a single bacterial colony from a fresh p la te .  
Incubate for 16 to 24 hours in a shaker (200 rpm) at 37°C.
2)  Pellet  3 ml of above culture into a 1.5 ml Eppendorf  tube. To d o  
this, add 1.5 ml of culture and then spin for 15 seconds at full s p e e d
in a bench top microfuge. Decant the superna tan t  and then a d d
another  1.5 ml of culture into the same tube. Decant t h e  
superna tan t  again and remove any remaining medium b y  
a s p i r a t io n .
3) Add 250 pi of PI solution to each tube. Vortex to re -suspend  t h e  
pellet  fully.
4)  Add 250 pi of P2 solution and mix by gentle inversion of t h e
tube six times. Do not shake the tube or contaminat ion  of t h e
recovered plasmid DNA by bacterial genomic DNA will occur.
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5) Add 250 pi of P3 solution and mix as in step 4. A viscous w h i t e  
precipi ta te  should appear.
6 ) Spin at 14000 rpm in a microcentr i fuge for 20 minutes.  R e m o v e  
pelleted white scum with a sterile toothpick and spin for a f u r t h e r
10 minutes.  For DNA to be sequenced spin times should be a d j u s t e d  
to 30 and 20 minutes respectively.
7 )  Attach 2.5 ml syringes (Becton Dickinson) to Wizard m i n i p r e p
columns without plungers.  Set up the syringe barrel on the v a c u u m  
manifold  (Promega),  if you have one. Otherwise you will have to  
retain the plunger for use later.
8 ) Pour the cleared supernatant into a fresh tube containing 750 pi 
of Wizard miniprep resin. Mix by inversion and stand for o n e  
minute. Pour the mixture into the syringe and apply a v a c u u m  
through the manifold or insert the plunger  into the syringe a n d  
push the liquid through.
9)  After the buffer in which the resin was suspended has c l e a r e d
the column, apply 3 ml of wash buffer to the syringe. Re-apply t h e  
vacuum to draw the liquid through. Continue to draw air t h r o u g h
the syringe barrel for a further  10 minutes after the wash b u f f e r
has passed through. Detach the syringe, remove the column a n d  
place it in a fresh 1.5 ml Eppendorf  tube. Spin for 30 seconds in a 
microfuge. Remove the column and place in a fresh tube. Let s t a n d
for 15 minutes  to dry off excess ethanol. If doing this with a
plunger, spin immediate ly  after pushing the wash solution t h r o u g h  
and stand for 15 minutes in a fresh tube.
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10)  To each tube add 20 pi of T,„,„mEi,„m, pH 8.0 (pre-heated to 85 C)  
and immedia te ly  spin for 15 seconds at 14000 rpm. Repeat e lu t io n  
with a further 20 pi of hot T|,),„mE,,„m and spin again. For s e q u e n c in g  
grade DNA substitute distilled H2O for T,,„„mEi,„m, pH8.0.
11)  Analyse 1 pi of the miniprep DNA on a 1.0% agarose gel with 7 
pi of H2O and 2 pi of agarose gel loading buffer (x 5).
R eg en era t io n  o f  Wizard m in iprep  columns.
It is possible to re-use the Wizard min iprep columns b y  
washing them in sterile water. This is done by placing them in a 
heat resis tant  flask, shake, and heating the water in a m i c r o w a v e  
oven. Shake again, cool and replace distilled water with clean ba tch .  
Repeat the procedure  above, until all the old resin has b e e n  
removed. Dry the columns in a incubator  and mark the columns so 
as to distinguish them from new ones. Syringes and plungers can b e  
cleaned and dried in the way described above except that it is 
better to do it in a Pyrex dish rather than in a beaker.
Solutions  for Prom ega  Wizard miniprep.
P I  50 mM TrisHCl (pH 8.0), 10 niM EDTA and 100 pg/ml RNAse 
(low grade. Sigma). Store at 4°C.
P 2  0.2 M NaOH, 1% SDS. Make this up fresh by combining 8 m l  
H2O, 1 ml 2M NaOH solution and 1 ml of 10% SDS. If the SDS 
precipitates,  gently warm this solution.
P 3  3 M CH3COOH. pH 5.2. Store at room temperature.
7 4
C olu m n  W ash Solution.
20 mM TrisHCl (pH 7.5), 200 mM NaCl, 5 mM EDTA, 50% ( v / v )  
ethanol.  To make 1 litre of stock solution (without  ethanol),  add 10  
ml of 2 M TrisHCl (pH 7.5), 50 ml of 4 M NaCl and 10 ml of 0.5 M 
EDTA (pH7.5). Make the volume up to one litre with disti lled w a te r .  
Steril ise by autoclaving. Add an equal volume of ethanol before use.
2.8.2 Isolation of  X phage DNA.
X DNA was prepared  in the following way (page 1.13.6, 
Ausubel et al, 1990).
2 .8 .2 .1  L y sa te  p ro d u ct io n .
A sample of freshly grown phage strip was put into 400 pi of
SM and left for a minimum of 2 hours at 4°C. 50 to 100 pi of th i s
suspension was mixed with 100 pi  of phage competent  bacteria a n d  
incubated for 15 minutes at 37°C to allow infection of bacteria b y  
the phage particles.  This phage-bacter ia  mixture was added to 5 0 
ml of NZCYM broth. This was incubated at 37°C in a s h a k in g
incubator  (200 rpm) until lysis was observed. This was g e n e r a l l y
between 6 to 9 hours post infection. After lysis, 500 pi of  
chloroform was added to kill off the remain ing bacterial cells a n d  
aid lysis.
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2.8.2.2 X DNA extraction.
The prepared phage lysate was t ransfe rred  to N a lg en e  
po lypropylene  tubes and DNase and RNAse were added to the f ina l  
concentra t ions,  5 mg/ml and 10 mg/ml, respectively.  The t u b e s
were then incubated for one hour at 37°C.
Afterwards  the tubes were centr ifuged at 4°C in a B e c k m a n  
J20 rotor at 20000 rpm for 2 hours 15 minutes,  to pellet  the p h a g e .
The superna tan t  was disposed of and the pellet  of phage p a r t i c l e s
was resuspended in 500 pi 50 mM TrisHCl pH8.0. Protein and l ip ids
were removed by a series of phenol extract ions (aqueous p h e n o l .  
Tris buffered to pH 8.0) until no more white waste material w a s  
observed on spinning this mixture at 14000 rpm. A final c h l o r o f o r m  
extraction was performed to remove any residual phenol.
2.8.3 Iso lat ion  of  M am m alian  genomic  DNA.
Genomic DNA was extracted from a variety of sources (e.g. 
cul tured cells, adult mouse tissue, cell lysates) with the aid of t h e  
Nucleon II kit from Scotlab Bioscience. The m a n u f a c t u r e r ' s
condit ions were used throughout.
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2.8.4 Isolation of total RNA.
Total RNA was extracted by the acid p h en o l -guan id in ium  method of  
Chomczynski and Sacchi (1987). This procedure  was used to e x t r a c t  
total RNA from whole embryos, adult tissues and cul tured cells. T h e  
protocol  is described below.
You will need a mortar  and pestle, 2 Nalgene 45 m l  
p o lypropy lene  tubes, blue and yellow tips and 1.5 ml m ic r o f u g e  
tubes. All solutions and materials must treated in the a p p r o p r i a t e  
way to render  them Rnase-free.
Glass-ware and other heat resistant mater ials must be h e a t -  
baked at 180 °C for two hours. Heat labile materials must be t r e a t e d  
in a 0.01% DEPC solution overnight  and autoclaved the fo l low ing  
day .
P r o c e d u r e .
1)  Measure the weight of starting material on silver foil on a f in e  
ba lan ce .
2)  Transfer  to mortar,  add liquid nitrogen and grind with p e s t l e  
until t issue is reduced to a fine powder. Add more ni trogen a n d  
transfer to an RNAse-free  polypropylene tube.
3)  Evaporate the remaining liquid nitrogen and add solution D in a 
proport ion of 600 pi of solution D to 100 mg of tissue. Mix b y
in v e r s io n .
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4) Homogenise  the solution by three 30 second pulses at the y e l lo w  
setting (8000 rpm, Ultra-Turrax  T25 homogeniser  (Janke a n d  
Kunkel). Keep the tube on ice while this is being done.
5 )  Add sequentially: 0.2 M NaOAc, pH 4.0 (60 pi per 100 mg of  
or iginal material),  mix by inversion and add water-saturated phenol 
(600 pi per 100 mg) and chloroform (120 pi per 100 mg). Mix 
thoroughly and then stand in ice for 5 minutes.
6 ) Spin for 15 minutes  in a Beckman JA-20 rotor at 12000 rpm a t  
4°C.
7 )  Transfer  upper, aqueous layer to a fresh polypropylene  tu b e ,  
taking note of the total transfer volume.
8 ) Add equal volume of propan-2-ol,  mix and stand on ice for m o r e  
than 2 hours.
9) Centrifuge at 12000 rpm at 4°C for 15 minutes.
1 0 )  Discard supernatan t  and dry the pellet with tube inver ted fo r  
10 minutes .
1 1 )  Resuspend RNA pellet in RNase-free 70% ethanol (500 pi p e r  
100 mg of original t issue) and aliquot into 1.5 ml microfuge tu b e s .  
Store at -70°C until required.
2.9 S y n t h e s i s  o f  o l i g o n u c l e o t i d e s .
All oligonucleotides  described in this work were s y n t h e s i s e d  
on a DNA synthes iser  by the s tandard p h osphoram ida te  c h e m ic a l  
synthesis.  The bases were added in a 3' to 5' manner.  O th e r  
ol igonucleotides  were purchased from commercial  sources w h e r e  
in d ic a ted .
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2.10  Q uanti f ica t ion  o f  nucle ic  acids.
M easurem ents  of DNA quanti ties  in solution were p e r f o r m e d  
using a sp ec t ropho tom e te r  set at the wavelength  260 nm. At th i s  
wavelength  it has been calculated that the absorption u n i t  
coefficients of various nucleic acids have a rela tionship to t h e i r  
concentrat ion.  For one absorption unit, d o u b l e - s t r a n d e d  
deoxyr ibonucle ic  acid is at a concentrat ion of 50 pg/ml, s i n g l e ­
s tranded DNA at 40 pg / ml and RNA 40 pg /  ml. Readings at t h e  
wavelength of 280 nm was also measured. The ratio of 260 nm a n d  
280 nm absorbtions for a particular sample gives a m e a s u rem e n t  of  
the purity of the nucleic acid in solution. Both pure DNA and RNA 
have a ratio of between 1.8 to 2.0 (Maniatis &t al, 1989) .
2.11 R estr ic t ion  en d on u c lease  d igest ion  of  DNA.
All restriction endonucleases  described in this work w e r e  
supplied by Life Technologies and used with the REact b u f f e r  
system supplied with these enzymes.
2.11.1 P lasmid  and lambda phage DNA.
These were digested with a 4-5 fold excess in units of e n z y m e  
with the appropriate  restriction buffer and in a final volume w h ic h  
diluted the enzyme 10 fold. Enzymatic activity can be inhibited b y  
glycerol concentrations of >5%. Glycerol is a major com ponent  of t h e  
enzyme storage buffer (50% v/v).
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2.11.2 Mammalian genomic DNA.
Genomic DNA was allowed to diffuse in an appropria te  v o l u m e  
of sterile H2O and restriction buffer left on ice or at 4°C. To a id  
diffusion of  the DNA it was mixed regularly with a sterile pipette tip 
and replaced on ice. When the DNA had diffused, half of t h e  
intended amount of  enzyme to be used for the digestion was m ix e d  
in slowly to the DNA/buffer  solution. The tube was then left at 4°C 
for 5 minutes  before being t ransferred  to 37°C for 30 minutes.  T h e  
rest of  the enzyme was then added in the manner  described above .  
When the digestion had been allowed to proceed for 5 hours,  a 1 pg 
sample was taken and used for gel electrophoresis ,  to see if  
digestion was complete.
2.12 G enerat ion  o f  a delet ion series  using exonuc lease  III.
This procedure  was carried out according to t h e  
m anufac tu re r s  protocol with the omission of the step to r e m o v e  
nicked and linear plasmid prior to restriction e n d o n u c l e a s e  
digest ion (Erase-a-base  System, Promega).
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2.13 Agarose gel e lectrophoresis of  nucleic acids.
2.13 .1  A garose  gels for DNA e lec trophores is
S o lu t io n s  and m ater ia ls .
lOx T.B.E.
Dissolve 108 g Tris base, 55 g boric acid and 40 ml 0.5M EDTA
(pH8.0) in 800 ml of dH2 0 . Adjust to 1 litre final volume. Use at Ix
strength as the working concentration.
50x T.A.E.
Dissolve 242 g Tris base and 37.2g Na2E D T A .2 H 20  in 800 ml of  
d H 2 0 . Add 57.1 ml glacial acetic acid to adjust the pH to 8.5. A d j u s t  
the volume to 1 litre, decant into glass bottles and sterilise b y  
autoclaving (Section 2.3).
A g a r o s e .
Electrophoresis  grade agarose was supplied by BRL-Life 
technologies.  Low melting point agarose (used for DNA b a n d  
recovery from agarose gel matrices) was obtained from Nusieve.
lOx gel load ing  buffer.
Make up to 20% Eicoll 400; 0.1 M EDTA, pH 8.0; 1% SDS; 0.25%
bromophenol  blue and 0.25% xylene cyanol.
P r o c e d u r e .
The appropria te  amount of agarose (BRL-Life t e c h n o lo g ie s )
was mixed in a Ix T.B.E. buffer solution to give the f ina l
concentra t ion  relative to the size of DNA molecules being used .
Generally 1.0% (w/v) agarose was used for plasmid DNA s e p a ra t io n ;  
0.7% agarose for the separat ion of digested genomic DNA and 0.3%
was used for undigested genomic DNA.
S a m p l e  p r e p a r a t io n .
The appropriate amount of DNA was mixed with dH2 0  and 1 Ox 
loading buffer to a final concentration of one times. Genomic and X 
DNA was heated to 65 C for 10 minutes then allowed to cool on ice 
briefly before being loaded into the wells of a p r e f o r m e d  
submerged agarose gel.
R u n n in g  the gels.
A constant voltage was applied to the submerged agarose gel 
for the appropria te  length of time, or until the DNA had m i g r a t e d  
su f f ic ien t ly .
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2.13.2 RNA gels.
P r e p a r a t io n  of  d e n a tu r in g  agarose  gel for RNA  
e l e c t r o p h o r e s i s .
For 200 ml of gel mix, add 2.96 g of agarose to 148 ml of  
DEPC-treated dH2 0 . Microwave to dissolve the agarose and cool to  
80°C, add 20 ml of lOx M.O.P.S., mix and leave to cool to 65°C. In a 
fume hood add 32 ml of formaldehyde ,  mix thoroughly and p o u r  
into the prepared gel cast.
Preparat ion  o f  RNA gel sample  buffer.
For the stock solution, add sequentia lly  2 ml of R N A se - f re e  
glycerol,  3 ml of DEPC-treated H2O with 20 mg each of m e t h y l e n e  
blue and bromophenol blue and 2 ml of 1 Ox M.O.P.S. buffer. Mix a n d  
store at room temperature .  Just before use mix 340 pi of the s tock  
solution with 160 pi of formaldehyde.
Prep a ra t io n  o f  samples  for loading.
The appropria te  amount of RNA was mixed with a 1:1 r a t io  
with the gel loading buffer (containing fo rm aldehyde)  a n d  
incubated for 10 minutes at 65°C. The samples were chilled on ice 
before being loaded onto a formaldehyde gel.
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R u n n i n g  f o r m a ld e h y d e  gels .
10 pg samples of total RNA was loaded into each well a n d  
electrophoresed in a 1.5% agarose, Ix M.O.P.S. buffered gel in a fume 
hood for 4 hours at 200 volts. A peristaltic pump was used to  
ci rculate the buffer during this time.
2 .14  S ta in ing ,  v i su a l i s a t io n  and p h o to g r a p h y  of  n u c l e i c  
a c i d s .
2 .14 .1  D NA v isu a l i sa t ion .
Agarose gels containing DNA samples were soaked in a d i l u t e  
solution of ethidium bromide (50 ng/pl) for 30 minutes,  after w h ich  
the gel was transferred  to fresh H2O for rinsing. The gel w a s  
visual ised under UV light. If over-s ta in ing occurred, the gel w a s  
allowed to soak in dH20  for 30 minute intervals until b a c k g r o u n d  
staining was lost. Permanent  records of the gels were e i t h e r  
photographs  taken by a Kodak polaroid instamatic camera or by a 
v ideo- im aging  facility.
2 .14 .2  RNA v isu a l i sa t ion .
After transfer  of the RNA from the fo rm a ld eh y d e -ag a ro se  gel 
and fixation to nylon membrane (Dupont Genescreen+),  the RNA w a s  
visual ised in the following way. The m em brane  was washed in 2%
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SDS to remove migrating dyes, then in DEPC-treated dH20  a n d  
im m ersed  in an excess volume of 0.5 M sodium acetate (pH 5 .2)  
with 0.04% methylene  blue, for 10 minutes.  The m em brane  w a s  
then destained with a series of 25% ethanol solutions until the n o n ­
specific background staining was removed. The stained m e m b r a n e  
was wrapped in cling film and photocopied to provide a p e r m a n e n t  
record of  the distribution of the RNA.
2.15 Recovery  o f  DNA fragments  from agarose  gels.
Where it was necessary to isolate restr icted DNA f r a g m e n t s ,  
the DNA was digested and the fragments  were separated  b y 
elec t rophores is  in low melting point (LMP) agarose using Ix T.A.E. 
buffer at 4°C. The appropria te  band(s) were dissected with t h e  
minimal  amount  of agarose and DNA was extracted by s p in n in g  
through COSTAR spin-X columns in the manner  descr ibed by t h e  
m anufac tu re r .  As a final step, the DNA in the column eluant w a s  
ethanol precipi ta ted  in the manner  described in Maniatis et al  
(1989). The recovery of DNA was checked by taking a sample of t h e  
re-d isso lved  precipita te and subjecting it to agarose gel 
e lectrophoresis  with the relevant DNA molecular  weight markers.
2.16 Ligation o f  lam bda cDNA inserts into pBluescript .
5 pg  of lambda phage DNA was digested by the enzyme Ec o RI 
(as described in Section 2.11.1). After the digestion of the X DNA 
had been completed, restriction enzyme activity was destroyed b y
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heating the reaction to 65°C for 10 minutes.  1 pg of the res tr ic ted X 
DNA was mixed with 0.2 pg of l inearised pBluescript plasmid DNA. 
This DNA mixture was added to a cocktail solution which c o n t a i n e d  
the appropria te  amount of T4 phage DNA ligase (1-3 U/pl,  
Promega),  buffer (xlO: 300 mM Tris-HCl, pH 7.8, 100 mM MgCli  a n d  
100 mM DTT; Promega),  10 mM rATP and d H 2 0  in a final r e a c t io n  
volume of  10 pi. This reaction was incubated at 4°C for a m i n i m u m  
of 16 hours.
2.17 Transfer  o f  nucleic  acids to nylon m em branes .
2 .17 .1  E le c t r o p h o r e t i c a l ly  sep arated  DNA fra g m en ts .
D énaturat ion  o f  DNA.
Prior to the transfer  of the DNA to nylon m em brane ,  it is 
necessary  to denature  the doub le -s t randed  DNA. To achieve this,  
the gel containing the DNA was placed in a 0.4 M NaOH solution f o r  
30 minutes  (in the case of plasmids) or 45 minutes (for g en o m ic  
DNA). The gels were thoroughly rinsed in dH20  and immersed in t h e  
electro-blotting buffer ( Ix  T.B.E.) for 20 minutes.
E lectrob lo t t in g  DNA from agarose  gels.
The DNA was t ransferred by constant electric current  (1 .5  
Amp) using an electroblot apparatus in Ix T.B.E. buffer so lu t ion.  
This was allowed to proceed for 2 hours in the case of lambda a n d
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plasmid DNA digests. For genomic DNA a 1.0 amp current w a s  
applied for 6 hours (or longer) to allow for the larger DNA 
fragments  to transfer  to the membrane.
2.17 .2  D enatured plasmid DNA for slot blots.
One microgram (spec t ropho tom etr ica l ly  de te rm ined)  p l a s m i d  
DNA was dena tured  with a 0.1 M NaOH solution, in the presence of  
Ix agarose gel loading buffer (see Section 2.13.1.1) for 10 m in u te s .  
The samples  were drawn by a vacuum onto dry nylon m e m b r a n e  
(Dupont  Genescreen+) .  The vacuum was continuously  drawn for a 
further  30 minutes  to allow the DNA to dry on to the m e m b r a n e .  
The DNA was cross-l inked to m em brane  using the UV c r o s s - l in k in g  
apparatus as described below (Section 2.18).
2.17 .3  RNA
This was done by the standard capillary method as d e s c r i b e d  
in Maniatis ct al, (1989), Chapter 7, page 49.
2.18 C ova lent  c r o s s - l in k in g  of  t r a n sferred  nucle ic  acids t o  
n y lo n  m e m b r a n e .
Nucleic acids (DNA and RNA from agarose gels and s lo t - b l o t t e d  
denatured  plasmid) were covalent ly cross-l inked to D u p o n t  
G enesc reen+  nylon m em brane  by UV exposure for 3 minutes in a 
custom cross-l inking apparatus (Stra tagene Stratal inker) at a p o w e r  
setting of 1200 W.
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2.19 Inverse polymerase chain reaction.
PCR is the selective amplificat ion of DNA between two p o in t s  
defined by sequence specific primers.  IPCR (a variation of s t a n d a r d  
PCR) uses a circularised template from which outwardly  d i r e c t e d  
primers can be used to amplify sequences in the opposite or i n v e r s e  
direction relative to normal PCR (which generally a m p l i f i e s  
sequences between two convergent  primers).  This technique h a s  
been used successfully by Korn et al  (1992) to identify f l a n k in g  
sequences from enhancer trap integration site positive cell line DNA.
Digestion o f  enhancer  trap site (ETS) genomic DNA.
Template DNA was digested to completion with an a p p r o p r i a t e  
restriction enzyme. Digestion was monitored by applying a s a m p l e  
of the DNA to agarose gel e lec trophoresis  (see Sections 2.11.1 a n d  
2.13.1.1).  The restriction enzyme was removed by a phenol (pH 8 .0)  
extraction and once with chloroform. The DNA was precipi ta ted (as  
described by Maniatis et al, 1989) and re suspended in dH2Û.
C ircu lar isa t ion  of  digested DNA.
The DNA was resuspended  to a concentrat ion of 1 p g /m l .  
These conditions favour the formation of circularised monomers  o f  
restricted DNA rather than intermolecular  ligations reactions. Collins 
and Weissman (1984) first described these conditions and M a n ia t i s  
et al  (1989) describe the re lationship  between the concentra t ion o f  
DNA (c, measured in pg/ml),  the size of the molecule (in base p a i r s )  
and the likelihood of in t ram olecu lar  ligation. The rela t ionship is 
described by the expression,  19 0 0 / c ( b p )  ^^ 2 Generally if t h e  
calculated value of this ratio is less than 1, circu lar isat ion will b e  
f a v o u re d .
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Therefore the previously  digested DNA was allowed to l iga te  
at a concentra t ion of 10 pg/ml in the presence of T4 ligase at a 
concentra t ion  of 1 U/pl.  The ligation was allowed to p r o c e e d  
overnight at 16°C. The ligase enzyme was heat killed at 68°C for 15 
minutes .  The DNA was precipi ta ted and re suspended  to a 
concentration of 25 pg/ml,  after a phenol (Tris buffered, pH 8.0) and 
ch lo ro fo rm  extract ions.
A m p l i f i c a t i o n  c o n d i t i o n s .
100 ng (4 pi) of ligated DNA was combined with 30ng each o f  
primers neolO and n e o l l  (1 pi each), 4 pi of 1.25 mM dNTPs, 2.5 pi 
Taq  amplification buffer (TAB) x 10 (Promega),  0.5 pi (5U) Taq  DNA 
polym erase  (Promega)  and dH20  was added to adjust the f ina l  
reaction volume to 25 pi.
First round PCR.
DNA was denatured with the appropria te  amount of H2O f o r  
10 minutes at 98°C. The DNA/H2O solution was placed on ice to cool 
and any condensate  was spun down in a microfuge. lOxTAB a n d  
dNTPs were added along with the appropria te  primers  to the DNA 
solution. This mixture was overlaid with mineral oil (Sigma) a n d  
placed in a Perkin Elmer DNA thermocycler and heated to 80°C for 5 
minutes .  Taq  DNA polymerase  was then added and the w h o le  
mixture was heated to 94°C for 3 minutes.  This was followed by 3 0 
rounds of: Anneal ing 60°C, 30 seconds; Extension 72°C, 2 m in u te s ;  
dénaturation: 94°C 30 seconds. PCR was completed with a 7 m i n u t e  
extension at 72°C, after which reactions were stored at -20°C u n t i l  
r e q u i r e d .
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Second round PCR.
This was carried as first round PCR except that the t e m p l a t e  
was 1 pi of a 1/1000 dilution of the PCR reaction from round o n e  
(see above) and a nested set of primers,  neol and neo2 were used.
2.20 R adioact ive  label l ing  of  nucle ic  acids.
2.20.1 R andom  priming o f  DNA fragments .
This procedure  was carried out according to t h e  
m anufacturers  recommendation using the Prime-It  random p r im i n g  
kit (Stratagene). Generally 50 ng of double stranded, l inearised DNA 
was labelled with 50 pCi of dCTP (specific activity = 3000 C i /m m o l )  
in a final volume of 50 pi. The reaction was incubated for 3 0 
minutes at 37°C.
2.20.2  End labell ing of  o l igonucleot ides  with y - 3 2 p _ A T P .
1 pmol of oligonucleotide to 10 pCi of yATP (3000 C i /m m ol ,  
NEN) in a 20 pi reaction of Ix T4 polynucleotide  kinase b u f f e r  
(Promega)  and 8 units of T4 Polynucleotide kinase (Promega).  T h e  
reaction was incubated at 37°C for 30 minutes.
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2.20.3 Labell ing of first strand cDNA.
A n n e a l in g  and labe l l ing .
This was performed on 10 pg  of total RNA, to which 500 ng of  
o l i g o - d T i 2-is primers (Pharmacia)  had been annealed.  To th i s  
mixture,  1 pi reverse  t ranscriptase.  Superscr ip t  II (Life 
Technologies)  and 4 pi of the 5x first strand buffer were added f o r  
the synthesis  of com plem enta ry  first strand molecules.  1 pi cold  
dNTPs (10 mM each dATP, dGTP and dTTP; final concentrat ion,  2 
mM) and 2 pi 0.1 M DTT were also added. 70 pCi of a - label led  dCTP 
(deoxycytosine  t r iphoshphate ,  3000 Ci/mmol, NEN Dupont) w a s  
used per reaction to label the newly synthes ised first s t r a n d  
products.  This reaction was allowed to incubate at 42°C for 2 hours.
Cold chase  react ion.
After the labelling, a chase step was performed with co ld  
dCTP, to maximise the length of products  from the reaction. 2 pi 5x  
first strand buffer, 2.5 pi 10 mM dCTP, 4.5 pi dH 20  and 1 pi of  
Superscript II were added sequentially.  The reaction was i n c u b a t e d  
at 42°C for 90 mins.
Removal o f  RNA by NaOH hydrolysis .
RNA was removed by alkaline hydrolysis  by adding IM NaOH 
(1.5 pi IM NaOH and 1 pi 0.5 M EDTA pH 8.0 were added). T h e  
treated reaction was then incubated at 50°C for 75 minutes.  T h e
alkali was af terwards  neutral ised with the addition of t h e
appropriate molar amount of 1 M HCl (1.5 pi IM HCl).
2 .20 .4  S ep a r a t io n  of  labe l led  nucle ic  acids f r o m  
u n i n c o r p o r a t e d  r a d io a c t iv e ly  labe l led  d e o x y  n u c l e o s i d e  
t r i p h o s p h a t e s .
Labelled probes (from random priming, first strand cDNA 
synthes is  and oligonucleotide end-label l ing reactions; see Sect ions
2.20.1 to 2.20.3 above) were separated  from u n i n c o r p o r a t e d  
radioact ively-label led  deoxynucleos ide  triphosphates  by passing the 
reaction over a column containing G50 (or G25 in the case o f  
ol igonucleotide seperat ion)  Sephadex (Sigma) which was e i t h e r  
purchased  from the m anufac tu re r  (Pharmacia)  or on a home m a d e  
column. The home made G50 column was constructed from a s te r i l e  
Pasteur pipette blocked with siliconised glass wool and filled to t h e  
top half cent imetre  with G50 Sephadex slurry which was r e  - 
hydrated and autoclaved in STE ( 100 mM NaCl, 10 mM TrisHCl a n d  
1 mM EDTA, pH 8.0). The G-50 Sephadex slurry was prepared b y  
adding dehydrated G-50 Sephadex to the STE solution. This m i x t u r e  
was autoclaved (Section 2.3) to re-hydrate the Sephadex.
The probe was loaded onto the column and this was fo l lo w e d  
by 3 ml of S.T.E. Fractions, each containing five drops, were collected 
as the probe made its way through the column. 1 pi of each of t h e  
fractions was then taken to be measured in a scintillation c o u n t e r  
(Beckman) using Cherenkov counting. Dpms (dis in tegra t ions  p e r  
minute)  were recorded. From this a profile of the elution of
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rad ioac t iv i ty  from the column was determined.  The first peak of  
radioact iv ity  corresponds to the labelled fragments.
2.21 H y b r id isa t io n  analysis  o f  nucle ic  acids.
M a te r ia l s  and so lut ions .
2 0 x S E T
3 M NaCl, 0.4 M TrisHCl (pH 8.0), 20 mM EDTA. To make 2 litres, add
350.6 g NaCl to 1 litre of distilled H2O, dissolve, then add 800 ml 1 
M TrisHCl, pH 8.0 and 80 ml of 0.5 M EDTA, pH 8.0. Adjust t h e  
volume to 2 litres and sterilise by autoclaving.
10% SDS.
Add 10 g of SDS to 80 ml H2O. Dissolve the SDS and adjust to 100 ml.
50x D e n h a rd t ' s  so lut ion .
For 500 ml of stock solution: Add 5 g Ficoll 400, 5 g
po ly v in y lp y r ro l id o n e  and 5 g of BSA to 450 ml H2O. Adjust to 5 0 0  
ml, filter sterilise and store at -20°C.
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D e i o n i s e d  For  m am  id e.
This was prepared freshly for each exper im ent  by the fo l lowing  
procedure .  20 g of de ionising resin was added per litre of  
fo rm am ide  and was left to mix with the aid of a magnetic stir b a r  
for at least one hour. The solution was then fil tered t h r o u g h  
W hatm an  paper and used immedia te ly  for the h y b r i d i s a t i o n  
so lu t ion .
Sheared  sa lm on sperm genom ic  b locking DNA.
Salmon sperm DNA was prepared according to the p r o c e d u r e  
described in Maniatis et al (1989, Appendix B, p i 5) and adjusted to  
a final concentrat ion of 10 mg/ml. The sheared DNA was a l i q u o t e d  
into 1 ml samples and stored at -20°C until required.
H y b r i d i s a t i o n  s o lu t io n .
All probing experiments  were conducted in the fo l low ing  
solution: 4x SET, 50% formamide,  0.5% SDS, 5x Denhardt 's  so lu t io n  
and 1 M phosphate buffer, pH 6 .8 .
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M e t h o d .  
P r e h y b r i d i s a t i o n .
Nylon m em branes  containing the fixed nucleic acid w e r e  
treated  with an excess amount  of hybrid isat ion solution with h e a t -  
d ena tu red  sheared Salmon sperm DNA at a concentra t ion  of 1 0 0  
pg/ml for a min im um  of 2 hours in a cylindrical flask in a T e c h n é  
hybr id isa t ion  oven.
H y b r i d i s a t i o n .
Prehybr id isa t ion  solution was replaced with f r e s h  
hybrid isa t ion  buffer along with freshly denatured  blocking DNA.
The probe was first denatured then added to a concentra t ion  of
1X 10^ cpm/ml relative to the volume of hybridisation solution used.
C alcu lat ion  o f  the length of  incubation.
The length of hybrid isation was allowed to proceed for t h e  
length of time corresponding to 3x C o t i /2 (Anderson and Young,  
1990). Cot 1/2 was calculated by the equation where Cot 1/2 = N= ( 1/% 
X Y/5 X Z/io)  X 2 where N is time (in hours), X= the weight of p r o b e  
added (in mg), Y is equal to the complexity of the probe (for u n i q u e  
sequences , in kilobases) and Z is the total volume of t h e
hybridisation reaction in ml.
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W ashing  regime.
Filters were washed in solutions of 0.1% SDS and first Ix SET 
and then O.lx SET at the appropria te  tem pera tu re  indicated in t h e  
specific  experiment .
S p ec i f ic  m o d if ica t io n s  for reverse  n orth ern  h yb r id isa to n .
Slot-blotted plasmid DNA panels were p rehybr id ised  a n d  
hybridised with the appropria te  radio actively labelled first s t r a n d  
cDNA probes under  identical conditions as descr ibed above, e x c e p t  
for the addition of 100 pg/ml unlabelled tr inucleotide r e p e a t  
oligonucleot ides,  (CAG)io and (CTG)k). This was done to b lock  
CAG/CTG repeat loci which may encourage misleading c r o s s ­
hybr id isa t ion  react ions.
2 .2 2  A u t o r a d i o g r a p h y .
Autorad iography  was performed either using cassettes a n d  
film where the membranes  were exposed for an appropria te  l e n g th  
of time at -70°C (in the case of labelled probes) with i n t e n s i f i e r  
screens with Fuji RX film (Fuji) or the filters were exposed to a 
l ight-sensi t ive  screen. The screen was analysed using the MacBAS 
phosphoim aging  system. The files that were generated  were s to r e d  
as Bas type files and manipula ted  therein. In the case of the use o f  
a -^^S-dCTP (manual sequencing),  no intensifying screens were u s e d  
and casset tes  were left to expose at room tempera ture .  Exposed  
autorad iographic  film was developed with the aid of a X-OGRAH 
Compact  X2 automated film processor.
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2.23 DNA sequencing.
2 .2 3 .1  M a n u a l  seq u e n c in g .
This was performed throughout  by the d i -  
deoxynuc leo t ide  sequencing method (Sanger et al  , 1977) using T7 
polymerase in a kit as described by Pharmacia (Pharmacia). D o u b l e ­
s tranded DNA templates  were used and the primers which p r i m e  
DNA synthesis  were obtained either from commercial  sources o r  
made on the automated ol igonucleot ide synthesiser.  Samples w e r e  
run on 7% polyacrylamide gels using the Base Runner gel kit (IBI) at 
40 watts power setting in a 1 .Ox T.B.E. buffer. After the s a m p l e s  
were run for the appropria te  time, the gel apparatus  was d i s ­
mantled and the gel was recovered by transfering it to a sheet of  
3MM W hatm an paper. A vacuum was drawn through (and h e a t  
applied) the gel to dry it. The gel was exposed to a u t o r a d i o g r a p h i c  
film in the manner described in Section 2.22.
2 .2 3 .2  F lu o r e s c e n t  lab e l led  a u to m a te d  s e q u e n c in g .
This was performed using the Dye-deoxy te rminator  cycle  
sequencing kit (Applied Biosystems)  using the s tandard p r o c e d u r e s  
as described by the manufacturer.  DNA templates were prepared  as  
above (Section 2.8.1). The primers  which were used were t h o s e  
which met the criteria for automated sequencing by this m e t h o d  
(Applied Biosystems). The reactions were performed as d e s c r i b e d
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below. Plasmid DNA was adjusted to give the approximate  a m o u n t  
of DNA (0.1 to 0.2 pg) as required.
Reaction example:
6.0 pi DNA (= 0.1-0.2 pg DNA)
9.5 pi Reaction mix, ddNTP, dNTP and Taq  polymerase
4.5 pi H i O 
Total vol. 20 pi
These ingredients  were mixed in a thin wall tube and p l a c e d
in a Perkin Elmer GeneAmp 9600 thermocycler,  pre heated to 96°C. 
The thermocycle  was performed 25 times as: a rapid thermal r a m p  
to 96°C and held at 96°C for 15 seconds; a rapid thermal ramp to  
50°C and held at 50°C for 1 second; a rapid thermal ramp to 60°C 
and held at 60°C for 4 minutes.  The labelled DNA was recovered b y  
ethanol precipi tation, followed by spinning, washing (in 70% 
ethanol),  spinning for 15 minutes at drying. The pellet was then r e -  
suspended  in 4 pi of gel loading solution. The samples  were l o a d e d  
on to a 7% polyacry lamide  gel after heating to 85°C for 5 m in u te s ,
followed by quenching on ice. The gel was run according to t h e
m a n u fa c tu re r ’s recom m endat ions .  The data was in terpre ted  b y  
using the software provided by the manufacturer.
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2.24 C om puter-Aided  Sequence Analysis .
2.24 .1  U W G C G  sequence  analysis  so ftw are  package .
This was available for use in the laboratory via a Telnet l in k  
to UNIX machines (Lenzie and Newton) at the Universi ty  of G lasgow 
and the VAX server Sc2a at the Universi ty  of Geneva. Access w a s  
via NCSA Telnet programme on Macintosh computers using a V T 100 
terminal  emulat ion configuration. See "Programme manual  for GOG" 
for re ferences  to specific p rogram m es  in the UWGCG (Univers i ty  of  
Wisconsin Genetics Computing Group; Devereux 1984) package
version 8.0 and UNIX users guide (Universi ty of Glasgow c o m p u t i n g  
services publication) for a list of commands  for the UNIX. Sc2a VAX 
server in Geneva had UWGCG Version 8.1 installed.
2 .24 .2  N uc le ic  acid and protein databases .
Access to the Genbank, DDBJ and EMBL nucleic acid d a t a b a s e s  
and Protein databases  (Swissprot and PIR) was gained through t h e  
UWGCG package.
2 .24 .3  D a ta b a se  search  a lgor i thm s.
Two main search algorithms were used in this work. T h e s e  
were the FASTA hash-coding local alignment algorithm (Lipman and 
Pearson, 1985) and the BLAST (Basic Local Alignment Search Tool, 
Altschul et al, 1990). Both use local a lignment protocols to build u p  
regions of similarity.  FASTA was used generally for nucleic ac id
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database  searches. The BLAST derivat ive p rogramme BLASTX w a s  
used to search non- red u n d an t  da tabases  with a s ix - f r a m e  
transla t ion  of the sequence derived from a par t icular  clone. T h e  
output was in an amino acid format.
2 .2 4 .4  M a c V e c to r  s eq u e n c e  m a in te n a n c e  p r o g r a m m e .
Manual DNA sequence data was t ransferred  into the s e q u e n c e  
analysis package via a sequence gel reader from IBI.
2 .24 .5  M a cA l ig n  S eq u e n ce  a l ig n m e n t  p r o g r a m m e.
This p rogram m e was used in conjunction with the M a c V e c to r  
p rog ram m e to align sequence into contiguous sequence to g e n e r a t e  
full sequence of clones to enable work on the nature of the o p e n  
reading frame of these clones and to assign the p u t a t i v e  
homopolymer  the repeat encodes if it proved to be in an ORF.
2 .24 .6  G e n e j o c k e y  (Vers ion  2).
Sequence derived from automated sequencing was handled b y  
this software as it could interpret the ABI derived files.
2 .24 .7  ABI au to m a ted  s eq u e n c e  in te r p r e ta t io n  s o f t w a r e  
p a c k a g e .
This was used to interpret e lec t rophore tog ram  data of s ing le  
p r imer  sequence reactions from the automated sequence protocol.
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Chapter  3
Screen ing  O f  Mouse cDNA Libraries  For Inserts  Containing  
C A G /C T G  Family O f  Repeats;  Initial Fxpress ion  Analysis .
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3.1 In troduct ion .
As described in chapter  one, human cDNA libraries (Li et al, 
1993; Riggins et al, 1992) that were screened with CTGio
ol igonucleotides  yielded many clones containing triplet r e p e a t s .  
These studies showed that cDNA libraries derived from brain t i s s u e
(foetal brain, Riggins et al, 1992 and adult  cerebral cortex, Li et al,
1993) are rich in CAG/CTG repeats, compared to libraries from other 
t issues (Riggins et al, 1992). From this it can be concluded t h a t
complex cDNA libraries are a good source of CAG/CTG triplet r e p e a t  
containing genes. Duboule et al (1987) detected a large number  of  
RNA species in mouse poly-A enriched RNA that cross h y b r i d i s e d  
with a D r o s o p h i l a  O P A repeat-rich probe. This indicates that there is 
a large num ber  of CAG/CTG-type repeats in the mouse g e n e  
reper toire.  OPA repeats are CAN (where N= A, C, G or T) n u c l e o t id e  
repetitions, which are found in numerous D r o s o p h i l a  proteins w h e r e  
they encode amino acid homopeptides.  The two most f r e q u e n t
repeated trinucleotides are CAG and CAA, which are the two c o d o n s
for the amino acid glutamine. The majority of these repeats  e n c o d e  
po lyg lu tam ine  stretches, others encode alanine and s e r in e
h o m o p e p t i d e s .
To de te rm ine  exper im enta l ly  if expressed  gene sequences of  
the mouse contain CTG/CAG tr inucleotide repeats,  three w h o le
embryo mouse cDNA libraries,  derived from 8.5 dpc (Hogan et al  
unpublished) ;  12.5 dpc (Logan et al, 1992) and 13.0 dpc (N. Allen,  
1993) embryos  were screened. In addition, an adult mouse b r a i n  
cDNA library (Meier-Ewert  et al, 1992) was screened. Clones w e r e  
purified from the 8.5 dpc (Hogan et al, 1984) and 12.5 dpc (Logan et  
al, 1990) embryonic  cDNA libraries. Reverse dot-blott ing w a s
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per fo rm ed  to identify clones with different  express ion levels a t  
d i f fe ren t  t imes in development .  This provided a basis for f u r t h e r  
study of  selected clones. The results of these initial exper im ents  a r e  
detailed in this Chapter.
3.2  Screen ing  o f  mouse  cDNA libraries .
Various  libraries were screened with an o l ig o n u c leo t id e  
compris ing ten copies of the repeat CTG, as described by Li et al  
(1993). The part icular  conditions used by Li et al  (1993) w e r e  
chosen because they yielded a high proport ion of longer  r e p e a t s ,  
many of which were in coding regions, whereas  condit ions used b y  
Riggins et al (1992) gave smaller repeats,  which were f r e q u e n t l y  
found in 5' untranslated regions (UTRs) of mRNA. A summary of t h e  
results can be found in Table 3.1.
The mouse embryonic  cDNA libraries,  8.5 dpc (Hogan et al,
unpub l ished)  and 12.5 dpc (Logan et al, 1992) were screened in
tandem, because they share the same vector,  ÀgtlO. All c lone  
numbers  are given as follows: plate numbers  1-5 were p l a q u e s
derived from the 8.5 dpc mouse whole embryo cDNA library; p l a t e s  
6, 7, 8 and 9 contained clones from the 12.5 dpc mouse w h o le  
em bryo  cDNA library. The remaining numbers  in the clone n a m e s  
are arbi trary  and relate to the order in which the plaques w e r e
picked from the individual plate. For instance. Clone 210 is d e r i v e d  
from plate 2 and is the tenth clone picked from that plate.
Fifteen thousand plaques from the 8.5 dpc mouse e m b r y o  
cDNA library (B. Hogan et al, unpubl ished)  were screened and 4 4 
replicat ing signals were identified. This translates  to a p e r c e n t a g e  
occurrence of 0.29%, relative to the total plaques screened.
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Table  3.1
L i b r a r y V e c t o r p . f .  u .  
s c r e e n e d
p r i m a r y  
p o s i t i v e  s
p e r c e n t a g e
o c c u r r e n c e
8.5 dpc
e m b r y o n i c
m o u s e
Xgt  1 0 1 5 0 0 0 4 4 0 . 2 9
12.5 dpc
e m b r y o n i c
m o u s e
]lgt  1 0 2 5 0 0 0 1 9 0 . 0 7 6
13.0 dpc
e m b r y o n i c
m o u s e
^ u n i z a p 2 0 0 0 0 3 3 0 . 1 6 5
ad u lt  bra in  
m o u s e
pSPORT 2 0 0 0 0 5 3 0 . 2 6 5
Table  3.1 Sum m ary  o f  results  o f  primary l ibrary screens.
The results are discussed in this Chapter,  p.f.u. refers to the n u m b e r  
of plaque forming units; pr imary positives to the signals found in  
the primary screen of the libraries and percentage occurrence is t h e  
num ber  of primary positives, as a proport ion of total p l a q u e  
forming units screened. Further  details of the individual l ib ra r ie s ,  
the vectors and hybridisation conditions of the library screen can be 
found in Chapter 2, Section 2.20.
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Tw enty-f ive  thousand plaques from the 12.5 dpc m o u s e  
whole embryo cDNA library (Logan et al , 1992) were screened a n d  
19 replicat ing signals were identified in the pr imary screen. This  
equates to a percentage abundance of 0.076%.
A 13.0 dpc whole mouse embryo library was obtained f r o m  
Nick Allen in Cambridge (unpublished)  and was screened to c h e c k  
that the reduct ion in numbers  obtained from the 12.5 dpc m o u s e  
em bryonic  library compared to the 8.5 dpc mouse e m b r y o n i c  
library was real (Logan et al, 1992). Twenty thousand plaques w e r e  
screened and 33 replicating signals were identified in the p r i m a r y  
screen. Thus, 0.165% of the recombinant  phage screened c o n t a i n e d  
putative CAG/CTG triplet repeats.
An adult mouse brain cDNA library (Meier-Ewer t  et al, 
unpublished)  was also screened. Fifty-three replicating signals w e r e  
identified in the primary screen. Twenty thousand clones w e r e  
screened and this equates to a 0.26% incidence of CAG/CTG t r i p l e t  
repeat  conta ining inserts.
3.3 S u b c lo n in g  of  phage inserts  from the 8.5 and 12.5 d p c  
whole  m ouse  e m b ryo  l ibraries  into the p h a g e m i d  
p B l u e s c r i p t .
To enable further  manipulat ion and analysis of the p u t a t i v e  
t r inucleotide repea t -con ta in ing  cDNA clones described in Sect ion
3.2, the inserts putat ively containing CAG/CTG repeats  were s u b ­
cloned into the phagemid  vector,  pBluescript  KS- (Stratagene) .  A 
shot-gun sub-cloning strategy was adopted. This was because of t h e  
large numbers  involved. This strategy makes use of g e n e r a l  
observat ions  about cloning experiments .  For example,  it is k n o w n
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that small DNA molecules are preferential ly  cloned compared w i t h  
larger DNA molecules and secondly, lambda arms will not be s u b ­
cloned as they have a single restriction enzyme cut at one end. T h e  
other  end of these f ragments  contains the lambda phage specif ic  
sticky end (cos) and is not compatible with restrict ion e n z y m e  
cleavage sites in a ligation reaction. Because of the p r o c e d u r e ' s
simplicity,  this strategy also allowed for the rapid cloning of m a n y
inserts in a set of parallel exper iments  which are easy to set up. 
Details of the procedure can be found in Section 2.16 of Chapter 2.
Fourteen sub-cloned inserts were used in the p r e l i m i n a r y
analysis of gene expression described in the next section of th i s  
c h a p t e r .
3.4 A n a ly s i s  of  gene e x p r es s io n  d e tec ted  by s e l e c t e d  
clones  from the 8.5 and 12.5 dpc mouse  whole e m b r y o
cDNA libraries  dur ing  d e v e l o p m e n t  and in adult  brain a n d  
l i v e r .
This section describes  the initial work to i d e n t i fy  
d e ve lopm en ta l ly  expressed  clones from fourteen of the initial s u b ­
cloned inserts from the 8.5 and 12.5 dpc whole mouse e m b r y o  
libraries. This group represents  the first clones purified and s u b ­
cloned in the phagemid vector, pBluescript KS- (Stratagene).
3.4.1 R esu l ts  of  reverse  northern  exp er im en ts .
Reverse dot blot exper iments  were performed to id e n t i fy  
potential ly  deve lopm enta l ly  regulated genes. The clones used h e r e  
were the first 14 positive lambda clones purified and shotgun s u b ­
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cloned (Section 3.3) into the phagemid vector, pBluescrip t  KS- 
(Stratagene) ,  from the 8.5 dpc (Hogan et al, unpubl ished)  and 12.5 
dpc (Logan et al, 1992) whole mouse embryo libraries.  Those u s e d  
from the 8.5 dpc library were Clones mCTG 23, 24, 26, 28, 210, 43 ,  
45, 411, 56 and 59. Clones mCTG 61, 63, 82 and 86 derive from t h e
12.5 dpc cDNA library screen. One m i c r o g r a m  
( sp ec t ropho tom etr ica l ly  de term ined)  of denatured  plasmid DNA 
containing cloned inserts was fixed to nylon m em brane  s t r i p s  
(Dupont (3enescreen+) The m em branes  were probed w i t h  
radioact ively  labelled heterogeneous  first strand cDNA, s y n t h e s i s e d  
from total RNA extracted from 8.5 dpc, 12.5 dpc and 17.5 d p c  
mouse embryos (Chapter 2, Section 2.8.4). A probe was also  
prepared  from embryonic  stem (ES) cells (Doetschman et al, 1985) .  
This probe represents  a time in deve lopm ent  of the embryo w h e r e  
little or no organogenesis  has taken place. ES cells r e p r e s e n t  
totipotent cells from the inner cell mass of the p r e - i m p l a n t a t i o n  
embryo and are equivalent  to 3.5 dpc (Doetschman et al, 1985) .  
Probes were also prepared from two adult mouse tissues, brain a n d  
liver. The results are shown in Figure 3.1 and q u a n t i t a t i v e l y  
(densitometric readings) in Figure 3.2.
A total of 5 clones (mCTG 23, 26, 411, 63 and 82) have a h igh  
level of steady state mRNA expression and show some variation in 
expression during development.  mRNA from three clones (mCTG 26,  
63 and 82) was highly abundant  at all deve lopm enta l  time p o in t s  
tested (including ES cells). These genes are also expressed in a d u l t  
t issues. Of these three clones, mCTG 26 and 63 have r e d u c e d  
expression levels compared to Clone mCTG 82 in the adult  t i ssues .  
In addition, messenger  RNAs from mCTG 26 and 63 have l o w e r  
abundance in adult liver than in brain. mRNA from Clone 82 is
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Legend to Figure 3.1: Reverse  d o t -b lo t  an a lys is  o f
e x p r e s s io n  of  se lec ted  c lones  from the 8.5 dpc and 1 2 . 5  
dpc w hole  mouse  em b ryo  l ibraries  (oppos i te  page) .
Denatured plasmid DNA was slot-blotted on to nylon m e m b r a n e  
and probed with rad ioac t ive ly - labe l led  heterogeneous  first s t r a n d  
cDNA derived from total RNA extracted from ES cells (3.5dpc); 8.5,
12.5 and 17.5dpc whole embryos; adult mouse brain and l iver ,  
horizontal series of numbers  represent blotted DNAs from 1 
pBluescript  KS-; 2 GluT, glutamine transporter ;  3 GABA r e c e p t o r  
subunit g2; 4) GABA receptor subunit a6. Clones mCTG 23, 26, 4 1 1 ,  
63 and 82 are indicated.
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Figure 3.2 Expression of  Clones niCTG 23, 26, 411 and 63.
The expression of the Clones mCTG 23, 26, 411 and 63 w e r e  
measured by MacBas imaging program m e (Fuji) and their level o f  
expression relative to the express ion of Clone mCTG 82 w a s  
calculated (vertical axis, a value of one equals the level o f  
expression of Clone mCTG 82; see also top section of this Figure). The 
horizontal axis refers to the source of the total RNA from which t h e  
first strand cDNA probes originated. These were; 1) embryonic  s t e m  
cells, 2) 8.5 dpc whole mouse embryos,  3) 12.5 dpc whole m o u s e  
embryos,  4) 17.5 dpc whole mouse embryos,  5) adult mouse b r a i n  
and 6) liver.
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expressed consistently in all developmental stages and adult  t i s s u e s  
tested. This was used as a base line to calculate the abundances  o f  
the four clones (mCTG 23, 26, 411 and 63), relative to t h e  
express ion of Clone mCTG 82. mRNA from Clone mCTG 23 can o n ly  
be de tected in adult  liver. Clone mCTG 26 appears to equal o r  
exceed that of Clone mCTG 82 throughout  deve lopm en t  and in a d u l t  
brain. However  there is a reduction in the liver. mRNA from Clone 
mCTG 411 is present during deve lopm ent  and is more abundant  a t
12.5 dpc. It was not detectable in adult tissues. mRNA from all other
clones tested were undetectable by probes from any d e v e l o p m e n t a l
time point or adult tissue probes used (brain and liver). The cDNA
clones used as post 8.5 dpc positive controls (GABA r e c e p t o r  
subunit,  y2 (David Livingston, personal gift) and the g l u t a m a t e
transporter ,  GluT, (M. Sutherland,  personal gift) failed to g ive  
signals. The negative controls,  the parent phagemid,  pBluescr ip t  KS- 
acted as a control for background.  The GABA receptor,  a 6  w a s  
included as another  negative control,  except for post n a t a l  
cerebellum, where its expression is restr icted to cerebellar  g r a n u l e
neurones. Both of these yielded no signal in this set of experiments.
3.5 D iscu ss ion  and analysis .
3.5.1 L ib ra ry  screens .
The primary screens of the mouse embryonic  cDNA l ib r a r i e s  
with an oligonucleot ide,  (CTG)io, yielded large numbers  of p o s i t iv e  
signals. This is true for the adult mouse brain cDNA library as well .  
However  the numbers  of clones isolated from each library are n o t  
the same. A three fold reduction in positive clones is observed f r o m  
the 12.5 dpc whole mouse embryo cDNA library, in terms o f
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percen tage  occurrence, compared to the percentage occurrence in 
the 8.5 dpc whole mouse embryo cDNA library. In the 13 dpc w h o le  
mouse embryo library (Nick Allen, Cambridge)  a r e d u c t i o n  
compared  to the 8.5 dpc mouse embryo cDNA library (Hogan et al, 
unpub l i shed)  is also observed, but only 1.5 fold. Between the 12.5 
and 13 dpc whole embryonic  cDNA libraries, there is a two fo ld  
increase in observed percentage occurrence of tr inucleotide p o s i t i v e  
repl icat ing signals. The incidence for the mouse adult brain cDNA 
library (0.26%) is similar to the incidence of replicating signals in 
the 8.5 dpc mouse embryo library (0.29%). What is the e x p l a n a t i o n  
of this changes? There are various possibilit ies to be c o n s id e re d .  
These explanations  are not mutually exclusive and may overlap in 
contr ibution to the phenomenon.
First, these data might just reflect qual i tat ive  d i f f e r e n c e s  
between the individual l ibraries used for this study. I n f lu e n c in g  
factors to be considered here are the type of vector used {i.e. 
lambda vectors or plasmids, or even different  lambda vectors), a n d  
the bacterial strains; e.g. whether  these tolerate simple r e p e t i t i v e  
sequences in plasmid vectors. It is known that E. coli strains w h ich  
are deficient in the Mut proteins MutS, MutL and MutH are m o r e  
tolerant of triplet repeats (Kang et al, 1995; Bowater  et al, 1996 a n d  
Rosche et al, 1996). In addition it has been reported that o t h e r  
proteins which are involved in mutation repair, replication a n d  
recombinat ion show varying effects on repeat stability. These g e n e s  
include recA, ssb and gyrase (Bowater et al, 1996 and Rosche et al, 
1996) .
The method of priming the first strand cDNA product m a y  
also have an effect on numbers of clones containing t r i n u c l e o t i d e  
repeats.  For example, if CAG/CTG trinucleotides  w e r e
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d isp ropor t iona te ly  found in the 5' end of genes, oligo-dT p r i m e d  
librar ies  would be u n d e r - r e p re se n ta t iv e  in terms of t r i n u c l e o t i d e  
repeats.  This, however ,  is unlikely as there is a large d i f f e r e n c e
between the whole embryo 8.5 dpc, whole embryo 12.5 dpc a n d  
mouse adult  brain cDNA libraries which are all oligo-dT primed.  I n  
addition, the mouse adult  brain cDNA library (which is also o l igo-dT 
pr imed)  appears  to contain as many CAG/CTG triplet repeats  as
described for the human libraries (Li et al, 1993; Riggins et al,
1992). In te res t ingly ,  a recent study by Chambers and A b b o t t  
(1996) who screened an independent  mouse adult brain cDNA 
library, which was oligo-dT primed, yielded the same proport ion  of  
posit ives as the mouse adult  brain cDNA library described here. I n  
the Chambers and Abbott (1996) library, 60 clones per  20000 p.f.u. 
screened was observed,  whereas 53 clones (of 20000  p.f.u.
screened) were identified in the mouse adult brain cDNA l i b r a r y
screened in this work. This can be taken as a guide to t h e
effect iveness of the exper iments detailed here because the n u m b e r s  
of CAG/CTG repeat containing clones isolated from two adult  m o u s e  
brain cDNA libraries, relative to the total number  of clones in i t ia l ly  
screened in two independent  exper iments,  is similar.
Another  interesting point to consider  is that this reduction is 
not the result of changes in expression levels of  genes, but a dilution 
of transcripts of genes from one specific region or organ. The b ra in ,  
which is known to be a rich source of CTG containing genes (Li et al, 
1993; Riggins et al, 1992), becomes proport ional ly  less in terms of  
overall volume of the developing embryo.  If the levels of
t ranscr ip t ional  activity are assumed to be constant,  a reduction in
positive clones as a percentage of total clones would be o b s e r v e d  
p rogress ive ly  th roughout  developm ent .
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Taken at face value, the level of primary replicat ing p o s i t iv e s  
for the mouse adult brain cDNA library screening (0.265%) is similar 
to that observed for the human foetal and adult  (cerebral co r tex )  
brain cDNA library screens, conducted by Li et al (1993) and Riggins 
et al, (1992). Respectively,  the results in terms of p e r c e n t a g e  
replicat ing positives for these human exper iments  were 0.26% a n d  
0.28% for the foetal brain (Li et al, 1993) and the cerebral co r te x  
(Riggins et al, 1992) libraries. A direct comparison cannot  be m a d e  
because of the differing regions and time points that separa te  t h e  
mouse and human data. However,  it seems that brain cDNA l ib r a r i e s  
from both species are in general a rich source for CAG/CTG 
trinucleot ide  repeats.  What  is the basis of this? Is it t h a t  
t r inucleotide repeat containing RNA is selectively isolated m o r e  
readily from this source than from other tissues; this seems unlikely 
as it is known that RNA is more difficult to obtain from brain t h a n  
from other tissues. An al ternat ive answer  to the higher numbers  of  
CAG/CTG repea t-con ta in ing  clones found in brain cDNA l ib r a r i e s  
may lie in that the brain is very complex in terms of num ber  of cell 
types. The larger number  of different cells and the larger  the b r a i n  
specific reperto ire  of genes, leads therefore in a random model of  
t r inucleotide occurrence in genes, to an increased number  of  
trinucleotide repeat containing positives in a l ibrary screen.
In addition to brains being a rich source of CAG/CTG r e p e a t  
containing inserts,  from the results presented here, mouse e m b r y o  
cDNA libraries are an additional rich source of CAG/CTG t r i p l e t  
repeat positive clones. This has provided a useful pool of c lo n e d  
genes to analyse in terms of development.
It has been observed in the human cDNA library s c r e e n in g  
studies that brain cDNA libraries yield more CAG/CTG c o n ta in in g
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clones (Riggins et al, 1992). The results presented here a r e  
consis tent  with this observation.  The mouse adult  brain cDNA 
library yielded as many positives as the human brain libraries,  as  
well as the 8.5 dpc whole mouse embryonic  library screened in th is  
work. The whole embryo cDNA libraries also contain a s ig n i f ic an t  
proport ion of cDNAs derived from the developing brain. It is 
possible to suggest that a large proportion of the embryo d e r i v e d  
transcr ip ts  are expressed in the brain. To test this a set of  
exper im ents  was required to de termine  the t ranscr ip tional  a c t iv i ty  
of positive clones derived from embryo library screens w a s  
constant and if they were expressed in adult t issues, specifically t h e  
brain. These experiments  are discussed below.
3 .5 .2  A n a lys is  o f  reverse  dot blot  exper im ents .
The aim of the reverse  dot-blot series of exper iments  was to 
identify genes which had variable levels of mRNA t r a n s c r i p t i o n  
levels during development ,  implying developm enta l  regulation of  
their expression.  In addition, two other t issues were looked at to
test for different ia l expression of the cloned genes in the a d u l t  
mouse. Initial expression analysis of selected clones by reverse d o t -  
blotting showed that mRNA from five of the Clones, mCTG 23, 26,  
411, 63 and 82, was highly abundant.  Fur therm ore  some v a r i a t io n  
in abundance of mRNA was observed between the d i f f e r e n t  
d eve lopm enta l  stages and also between brain and liver from a d u l t  
mouse. Four of the Clones (mCTG 26, 411, 63 and 82) do not a p p e a r  
to be associated with organogenesis  because their expression leve l  
is the same when tested with p re-organogenes is  first strand cDNA
probe, derived from ES cell RNA. Some have significant d i f f e r e n c e s
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in messenger levels between adult tissue types. Clones mCTG 26 and 
63 are more abundant  in the adult brain compared to adult  m o u s e  
liver. There is no detectable expression of Clone mCTG 23 messenger  
RNA at the developmental time points tested or in adult brain of the 
mouse. However ,  Clone mCTG 23 mRNA was detected in the l iver .  
This suggests that the gene product  of Clone mCTG 23 may have a 
role in the adult liver. The expression of the other clones tested w a s  
below the level of sensitivity of these exper iments .  O th e r  
experimental procedures will have to be used to analyse the level of 
express ion of these clones. For example PCR based technology w i t h  
increased sensitivity,  could be used. RT-PCR using first strand cDNA 
products as templates to drive PCR could detect very rare p r o d u c t s .  
This technique however requires that sequence information d e r i v e d  
from the clones is available to design suitable primers for PCR. This  
is quickly done for one or a few clones, but laborious for m a n y  
clones. Run-on exper iments  could be used to detect t r a n s c r i p t i o n a l
activity,  but requires the isolation of nuclei from dif fe rent  cell
types. This is easier for certain cell types than for others.  For  
example,  nuclei of white blood cells can be easily re t r ieved  b u t  
nuclear isolation from neurones  is difficult because of the l a rg e
proport ion of extra-cel lu lar  material and lipid m e m b ra n e s  f r o m  
glial cells.
Because the reverse  dot-blot exper iment  did not g ive  
information about the numbers of distinct m essenger  RNA sp ec ie s  
t ranscr ibed from a specific gene, it cannot be ruled out that th i s
apparent  difference in expression levels may be due to a l t e r n a t i v e  
splicing. The result of this would be the reduced rep re sen ta t io n  o f  
individual or sub-groups of messenger  species containing s e q u e n c e s  
with the up-regulation of others.
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The controls described here, {i.e. GluT and y 2 )  are e x p r e s s e d
beyond 8.5 dpc embryos,  specifically in the brain (GluT, M. 
Sutherland, Pers. Comm.; y 2 ,  Luntz leybman et al, 1993). This s h o u ld
allow for selection of clones displaying pre and post 8.5 d p c  
expression, because it is observed that there is an increase in  
d if ferent ia t ion  of the nervous system at this stage (Kauffman a n d  
Kauffman,  1992). However these genes are not widely o r  
abundant ly  expressed and in retrospect  it would have been b e t t e r  
to include moderate ly  and highly expressed  well c h a r a c t e r i s e d  
genes as positive controls so as to have a benchmark  for m e a s u r i n g  
the results {e.g. GAPDH or p-actin). The GABA receptor subunit a 6  is 
negative  apart from the post natal cerebellum (R.W. Davies Pers .  
Comm.),  where it is expressed in low amounts. However, Clone mCTG 
82 is consis tent ly  expressed through all deve lopm enta l  stages a n d  
tissues tested, relative to the activity of the probe in each case. This  
clone was used as a s tandard  to test differing levels of e x p r e s s i o n  
amongst  the other clones which were detected in this series o f  
experiments .  The background control,  the phagemid pBluescr ipt  KS- 
(Stratagene)  did not return any signal, therefore it must b e  
concluded that the signals that are detected from hybrid isation o f  
probe to the fixed plasmid containing the cDNA inserts are genuine.
Interes t ingly ,  the genes corresponding to Clones mCTG 26, 6 3 
and 82 were shown to have detectable  amounts  of mRNA in 
development ,  were also expressed in the brain. This c o r r e s p o n d e n c e  
of deve lopm enta l  and brain expression has been noted also fo r  
Drosophi la  proteins with large homopept ides  (Karlin and Burge,  
1996). They postulate that fewer mammalian genes contain t h e s e  
cont inuous runs of the same amino acid, because of a negative b ia s
due to the fact that relatively few deve lopm enta l  or r e g u l a t o r y  
genes have been sequenced in mammals,  compared to Drosophila.  
which has been studied extensively  by molecular  genetics in
development .  A screen of mam m alian  cDNA libraries w o u ld
therefore  identify novel genes involved in development .  To a s se s s
this, the putat ive CAG/CTG triplet repeat  positives described a b o v e
were subjected to sequencing analysis to identify novel s e q u e n c e s  
and characterise the repeat loci of these inserts.  That is the s u b je c t  
of the next Chapter.
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C hapter  4
Sequence  Analysis  O f  CAG/CTG Repeat Conta ining  cDNAs.
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4.1 In trod uct ion
In Chapter 3, a number  of recombinant  clones, from the 8.5 
dpc (Hogan  et al, unpubl ished)  and 12.5 dpc (Logan et al, 1 9 9 2 )  
mouse embryonic  cDNA libraries were sub-cloned. These w e r e  
purif ied by consis tent hybridisation to a tr inucleotide repeat  p ro b e ,  
(CTG) 10- Some of the first sub-cloned inserts were shown to h a v e  
high express ion during deve lopm en t  and in adult  tissues. To 
establish  if these clones indeed contain CTG tr inucleotides,  DNA 
sequencing was performed to identify the repeat(s)  in each clone. 
Some clones may have multiple independent  repeat units. This  
approach was used by both previous human studies (Riggins et al, 
1992; Li et al, 1993) to establish the existence of and identify triplet 
repeats.  The unique sequence which flanks the repeat can be u s e d  
to identify related sequences found in the large d a t a b a s e  
repositor ies .  The last point is important  because we can id e n t i f y  
repeats which are conserved between species. This is i m p o r t a n t  
when trying to establish if the mouse could be used as a model, in 
respect to possible diseases.  The most relevant c ro s s - s p e c ie s  
analysis would be to human sequences. This is because man is t h e  
only species which has been shown to date to develop n a t u r a l l y  
diseases associated with trinucleotide repeat expansion. Any c r o s s ­
species conservation would help in assessing the possibili ty  of u s in g  
the mouse genes as models for triplet repeat expansion diseases and 
for studying the role of the triplet repeat in normal function of t h e  
gene products.
The two human studies also found a number  of novel g e n e s  
containing CAG/CTG trinucleot ide repeats.  It is likely that a 
proportion of the clones sequenced will belong to previously u n -
charac ter ised  genes. More recently, a new study by Abbott  a n d  
Chambers  (1996), identified a number  of t r inucleotide r e p e a t  
containing clones from a mouse adult brain cDNA library. This  
provides a source of material which can be used as a comparison fo r  
the mouse sequence data presented in this Chapter.
4 . 2  Partial  n u c le o t id e  s eq u e n c e  of  su b -c lo n e d  inserts  f r o m  
the 8 .5dp c  and 12 .5dpc  whole  mouse e m b ryo  cD N A
l i b r a r i e s .
As descr ibed in Chapter 3, clones were isolated from tw o  
mouse embryo cDNA libraries. These libraries were derived f r o m  
RNA from 8.5 and the 12.5 dpc embryos. Some purified l a m b d a  
positives  were sub-cloned into pBluescript KS- p h a g e m i d
(Stratagene) .  Due to the large number  of potential clones, it w a s  
decided to first sequence from the ends of the clones, u s in g  
s tandard primers  which flank the multiple cloning site of
pBluescript.  These clones were sequenced first using a manual  T7 
polymerase  kit (Pharmacia),  following Sanger 's d i - d e o x y n u c l e o t i d e  
method (S a n g e r  et al, 1978). Double or s ing le -s t randed  DNA 
templates  were used. The automated sequencing system f r o m  
Applied Biosystems (Perkin Elmer) was used subsequen t ly  to
extend the sequence data. For manual sequencing,  T3 and T7 
primers  (Promega) were used; in the case of au tomated  s e q u e n c e  
generated  data, the extended primers T 3 / T 7 a  (BRL-Life 
Technologies)  and bT7 (Stratagene)  were utilised. The sequences of  
the four primers described above are described in Chapter  2, T a b le
2.3.
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4.3 Initial manipulation of sequence data.
DNA sequences were analysed using Mac Vector (IBI) a n d
Gene Jockey version 2 (Cambridge Bioscience) sequence a n a ly s i s  
packages. Searches using the nucleic acid databases,  Genbank a n d  
EMBL were done using UWGCG (D ev e re u x  et al., 1984) Version 8.0. 
To avoid in terference with t r inuc leo t ide-con ta in ing  sequence f r o m  
the database,  comparison with sequences from outside the r e p e a t  
region were used to conduct searches against the databases.
4.3.1 A n a ly s is  o f  R epeats  Ident if ied .
Repeats were identified in a large proport ion of c lones
sequenced. Table 4.1, which lists the repeats discovered by th i s  
study, shows that CTG/CAG tr inucleotide  repeats were su ccess fu l ly  
identif ied in 21 of the first 23 clones. Fur ther  sequencing s h o u ld  
identify repeats  in the remaining two clones. There was a w i d e  
range of sizes of repeats found, ranging from 6 up to 26 (see F igu re
4.1) t r inucleotides  per repeat tract. The average t r i n u c l e o t i d e
num ber  per independent  repeat is calculated to be 13 (3 9
nucleot ides) ,  which is greater  than the size of the o l ig o n u c leo t id e  
probe used in the library screening, which was 30 nucleot ides in 
length ((CTG)io).
Three clones have multiple CTG/CAG type repeats.  These a r e  
clones mCTG 28, 210 and 92. The repeats all tend to be in the s a m e  
strand and exist as the same subset of repeats.  For example a GAG 
repeat will be followed by CAG/AGC/GCA. This is consistent with the 
multiple repeats in some human genes found by Li et al (1993).
2 1
Figure 4.1 CTG repeats identif ied from clones  d er iv ed  f r o m
8.5 and 12.5 mouse em bryo cDNA libraries .
Repeat  sizes are derived from sequence data for individual mCTG 
clones, as descr ibed in Section 4.2. Commas indicate d i s c o n t in u o u s  
repeats.  Brackets enclose cryptic repeats.  + indicates an  
indeterminate  repeat  number  due to template  anomalies.
CLONE (CTG)n
S in g le rep ea ts
2 4 4
5 6 6
1 2 7
4 1 0 8
4 5 8
8 2 9
5 9 1 1
2 3 1 2
4 1 1 1 2
8 1 1 5
4 6 2 5
6 1 2 5
6 3 2 6
M u lt ip l e re p e a ts
8 6 7,3+ and 3+
5 7 6 7
2 8 (L 7 ,2 ,4 ) and (1 ,2 ,4 )
9 2 (1,3 ,1,11) (2,5)  (1 ,1,4)
2 1 0 ( 1 , 7 , 2 , 4 )
C ry p t ic repeats
4 1 4 ( 7 , 1 )
2 6 (7,2,2) (1,2,4)
4 3 ( 2 , 9 )
2 2
Figure 4.2 c lones  with s im i la r i ty  to other genes  w i t h  
prote ins  o f  def ined  function .
Homology was identified using PASTA or BLAST prog ram m es  to  
search non-redundant  nucleic acid and protein databases . S im i la r i ty  
indicates the gene to which the mouse sequences are related.
C l o n e S i m i l a r i t y F u n c t i o n R e f e r e n c e
2 3 70kDa subunit s sD N A  binding Erdile et al,  1991
2 4 nuclear receptor 
co-receptor
d sD N A  binding Horlein et  al, 1995
2 9 ASF-2 like sequence R N A  binding Wang and Manley, 1996
4 3 a) Rad21
b) PW 29
c) p -l ,4 ,-ga lactosy l-  
transt’erase
unknown  
Ca2+ binding 
en/ymatic
McKay et  al,  1996  
Yu et al,  1995 
Nakazawa et al, 198S
4 1 0 rat nucleoporin, P54 RN A  binding H u f f  al, 1996
4 1 1 rat nucleocytoplasmic 
protein
R N A  binding Meier and Bio bel, 1992
5 6 a) C W 17 mouse protein
b) Zl’m I transcnption 
factor
c) SFl splicing factor
unknown  
d sD N A  binding
RN A  binding
Wrehkle cr r//, 1993 
Toda et al, 1994
Arning et al,  1996
5 7 a) P300 transcriptional 
adaptor
b) CREE binding protein
d sD N A  binding  
d sD N A  binding
E ck m v et  al, 1994  
Chiivia et al, 1993
6 3 JC310, suppressor o f  
RAS
RAS binding Colicelli e t a l ,  1993
2 3
Legend to Figure 4.3. Sum m ary  of a l ign m en t  analys is  o f
c lones  which show s imilarity  to other sequences.
The degree of s imilar ity (% homology) to other sequences  is 
expressed as a percentage of the total region used in the ana lys is .
NA indicates a comparison made between nucleic acid s e q u e n c e s  
and AA indicates a comparison between amino acid s e q u e n c e s .
The columns headed comparison region is the size of the r eg io n  
over which the % similarity was calculated. The Species c o lu m n  
indicates the origin of the comparison sequence (Mm being M u s  
musculus; Hs, Homo sapiens; Rn, Rattus Norvégiens", XI, X e n o p u s  
l a evu u s ) .  Note also that the sequence analysis of clone mCTG 24 is 
split into different segments to indicate the likelihood that th i s  
comparison is made between two related genes from the s a m e  
species,  rather than the same gene because of the higher degree of  
similarity between these sequences within the coding, c o m p a r e d  
to the putat ive 5 ’ UTR sequences. The appendix to clone mCTG 4 3 
shows the overall  degrees of similarity of Miis m u s c u l u s  Rad21 to 
the three other sequences which show similarity to clone mCTG 
43. Note also that Zfml isoform 111 is omitted from the analysis of  
clone mCTG 56 as these sequences do not overlap with each o th e r .
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Figure 4 .4  Com parison  of repeat num bers  in d i f f e r e n t  
species .  Numbers indicate the size of the repeat in cognates of t h e  
same or similar protein in different organisms. Numbers that a r e  
in terrupted  by commas indicate intervening amino acids w h ic h  
represen t  deviations  from the trinucleotide  repeat.  A s te r ic e s  
indicate that the information on the cognate protein in t h a t  
organism is not available.  Column N represents  the CAG/CTG r e p e a t  
size identified in sequence identified in this study. The m o u s e  
column represents  previously character ised mouse sequence f o u n d  
in the GenEMBL database.
R epeat  N u m b er
c l o n e P r o t e i n  
or  NA
N r a t m o n  se b u m a n X e n o p u s
2 3 R e p A 1 2 * 1 1
4 3 R il d 2 1 
PVV29
2 , 9
H:
2 . 4 . 1
2 . 4 . 1
2 , 1 , 3 , 1
4 1 0 N o p p 1 4 0 8 8
5 6 CW17 6 :|: 6
Z t ni I :|: 6
SFl 6
5 7 P300 6 :|: H: 2
CREH-HP
( h 11 111 il 11 )
* :|: 3
CREH-HP 
( 111 o u se ) 3
1 2 EST
VV7X3 37 7 6
1 2 9
It is not possible to gauge the overall proport ion of c lones  
that contain multiple repeats because sequencing has not b e e n  
pursued to fill in the gaps of sequence. Clone mCTG 43 contains,  in  
addition to a CTG trinucleotide, a GAG type repeat which is a d j a c e n t  
to a hexanucleot ide  repeat,  GAGAAG (Figure 4.8). Clone 92 has a 
high probabili ty  of encoding a polyprol ine stretch (CCN) p r e c e d i n g  
the first CAG trinucleotide.
A proportion of these clones correspond to novel genes. Of 
the initial 23 clones analysed, which were chosen arbitrar ily f r o m  
the 8.5 and 12.5 dpc whole mouse embryo cDNA libraries,  t h e r e  
were found to be 11 sequences which had no s im i la r i ty / iden t i ty  to  
any known sequence. A further  three sequences had similarity to  
Expressed Sequence Tags (ESTs). These were: clone mCTG 12, w i t h  
similarity to a group of related human ESTs (see Figure 4.14); mCTG 
46, with similarity to a single mouse EST (see Figure 4.15) a n d  
mCTG 59, with similarity to a single human EST (see Figure 4 .16) .  
Within the clones with similarity to known gene sequences, 9 h a d  
similarity to proteins of known function. These are clones mCTG 2 3 
(replicat ion protein A, 70 kDa subunit),  mCTG 24 (mouse n u c l e a r  
receptor  co-repressor);  mCTG 29 (al te rnat ive splicing factor), mCTG 
43 (Rad21, b e t a - 1,4 -g a lac to sy l t ran s fe ra se  and PW29 c a lc iu m
binding protein); mCTG 410 (nucleoporin p54); mCTG 411 ( N o p p l 4 0  
nucleophosphoprotein);  mCTG 56, (Zfml transcription factor,  splicing 
factor 1 and CW17); mCTG 57 (P300 cellular t r a n s c r i p t i o n a l
activator)  and mCTG 63 (JC310 RAS protein inhibitor). A d e t a i l e d  
account  of each clone and the genes which they are related to is 
given in Sections 4.4 and 4.5 of this Chapter. Alignments  for e a c h  
clone are shown in Figures 4.5 to 4.16.
3 0
Amongst  these 9 clones with similarity to genes e n c o d in g  
proteins of known function, 7 are nucleic acid binding proteins.  T w o  
of these are known to bind double-stranded DNA (mCTG 24, n u c l e a r  
receptor  co-repressor; mCTG 57, P300 t ranscr ip t ional  a d a p t o r
protein), three are RNA-binding proteins (mCTG 29, ASF-2 like gene; 
410, nucleoporin p56 and mCTG 411, nucleocytoplasmic  p r o t e i n  
N o p p l4 0 )  and one is a s ing le-s t randed  DNA bind ing-pro te in  (mCTG 
23, 70kDa subunit  of replication protein A). The r e m a i n i n g  
sequence,  mCTG 56, has both similarity to a do u b le - s t ran d ed  DNA 
binding protein (Zfml,  a t ranscription factor) and RNA b in d i n g  
protein (splicing factor 1). Clone mCTG 63 was chosen for f u r t h e r  
study and will be discussed further in Chapter 5.
A comparison of the occurrence and location of t r i n u c l e o t i d e  
repeats  in these genes between species, particularly  with m a n ,  
could be useful in assessing the likelihood of mouse t r i n u c l e o t i d e  
repeats  acting as models for human disease. In five of the six 
examples  in which a cross-species  compar ison could be m a d e ,  
human sequences were available to make such a compar ison. In all 
these examples the mouse repeat is larger (clones mCTG 12, 23, 4 3 
and 57) or equal (clone mCTG 56) in size to the human repeat.  A 
sum m ary  of these comparisons  are described in Figure 4.4. W i th in  
the examples where the mouse trinucleotide is larger there is a 
spec trum of differences. For example, in the case of clone 12 t h e r e  
is only 1 triplet difference compared to the human s e q u e n c e  
whereas  for clone mCTG 23 (which shows similarity to the 7 0 k D a  
subunit of replication protein A), the mouse CAG tr inucleotide is 1 1 
repeats larger than both the human and X e n o p u s  sequences, w h ic h  
only have one CAG trinucleotide, encoding a single glutamine,  at t h e  
equivalent  position in their proteins (see Figure 4.4 and 4.5). In t h e
3 1
case of clone mCTG 410, which displays similarity to a rat g e n e
nucleoporin p54, there is no change in the number of repeats (8).
Novel sequences are classed into 2 subgroups: those w h ic h
are genuinely unknown (i.e. those which show no similarity  to a n y
sequence in the nucleic acid databases)  and those which are s im i l a r  
to unidentified,  incomplete sequences in the database deriving f r o m  
large total l ibrary sequencing projects. For this study, most  a r e  
assessed to be novel, since no known function can be assigned to the 
gene product.  One exception is mCTG 29 which has similari ty to a
group of FSTs which have similarity to the splicing factor ASF-2. 
This is likely to correspond to a new splicing factor.
4.4 Clones  with s imilarity  or identity to other sequences .
This section describes  the clones which have similarity to o r
are identical to sequences already deposited in the nucleic ac id
(Genbank,  dBFST and FMBL) or protein (PIR and S w is s - P r o t )  
databases.  Similarit ies were elucidated by using the s e q u e n c e  
generated from the clones, in conjunction with the s e q u e n c e  
analysis programmes,  FASTA (Lipman and Pearson, 1985) a n d  
BLAST (Basic Local Alignment Search Tool; A l tschul  et al, 1990) to  
search nucleic acid and protein databases. The individual details f o r  
each case are outlined below and summarised  in Figures 4.2 a n d
4.3.
4.4.1 Clone niCTG 23.
This gene was isolated from the 8.5 day cDNA library. It w a s  
found to have significant similarity to a gene encoding the 70 kDa
1 3 2
polypept ide  subunit of a human s ingle-s t randed D N A -b ind ing  
protein (Kim et al, 1992), replication protein A (Erdile et al, 1991) .  
This is the largest of three associated polypept ides  and has b e e n  
shown to contain the DNA binding property (Kim et al, 1992) .  
F u r the rm ore  in a model system, the activation of the SV40 DNA 
replication reaction, this subunit cannot i tself drive the reaction b u t  
has been shown to interact with other proteins,  including the DNA 
polym erase  a -p r im ase  complex (D o rn re i t e r  et al, 1992). T h e  
he te ro t r im er ic  complex has been implicated in processes w i t h i n
cells which require the DNA to be t ransiently  s i n g l e - s t r a n d e d ,  
namely replication (Frdile et al, 1991), and repair (Liu and W e a v e r ,  
1993). It may also have a role in transcr iption and r e c o m b in a t io n .  
This protein is probably an essential gene, as homologous p r o t e i n s  
have been found in other eukaryotes {e.^.  yeast, X enopus) .  E v id en c e  
to support  this idea is that Parker  et al (1997) have reported t h a t  
this gene is essential for the viabili ty of cells of the fission y e a s t ,
Sch izosaccharom yces  pom he .  The cloned region is part  of the 5' e n d
of the open reading frame (Figure 4.5). The mouse t r i n u c l e o t i d e  
encodes a polyglu tamine  tract (n=12; see Figure 4.5) as the r e a d i n g  
frame is continuous on both sides of the repeat. In the f r a m e  
generating the glutamines the greatest similarity to the human a n d  
X e n o p u s  proteins is found (Figure 4.5), but the repeat does n o t
appear  in the homologue in these species, just a single g l u t a m i n e  
codon.
4.4.2 C lone  n iC T G  24.
This clone was derived from the 8.5dpc whole mouse e m b r y o  
library. It was found to contain significant similarity to a p r e v i o u s l y
1 3 3
characterised mouse gene, nuclear receptor co-repressor  (Horlein e t  
al, 1995). This protein is involved in the ligand i n d e p e n d e n t  
repressor  activity associated with the thyroid hormone and r e t in o ic  
acid receptors .  The level of identity was found to be 79.4% at t h e  
DNA (see Figure 4.6) and 89% protein levels (not shown). This  
indicates that this sequence may derive from a gene, related to t h e  
nuclear receptor  co-repressor ,  which has been previously  u n ­
character ised,  becuase the sequence of Clone mCTG 24 would b e  
expected  to be identical to that of the M. m u sc i i lu s  p u b l i s h e d  
sequence (Horlein et al, 1995) if they were derived from the s a m e  
gene. Analysis of the al ignment shows that a deletion has o c c u r r e d  
in the sequence of Clone mCTG 24 (nucleotides  431-581 of F ig u re  
4.6). This may represen t  an al ternat ive ly  spliced exon. T h e  
sequence presented here also extends upstream relative to t h a t  
published for the nuclear receptor  co-repressor.
4.4.3 C lone  m C T G  29.
This clone was initially isolated from the 8.5 dpc w h o le  
embryo.  No repeat  has been identified yet in this clone from t h e  
available sequence. BLASTN and FASTA database searches w i t h  
sequence from this clone identified eight human FSTs which all 
exhibit homology to another  human gene, encoding a l t e r n a t i v e  
splicing factor, or splicing factor 2 (ASF/SF2), subunit p33 (K ra in e r  
et al, 1991; for review see Lamond, 1991). The protein product  o f  
this gene, in conjunction with another  polypeptide (ASF-1, s u b u n i t  
p32), has a role in the prevention of exon-skipping  to ensure t h e  
accuracy of splicing and regulation of alternative splicing of pre-
1 3 4
Figure 4.5
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Figure 4.5 A l ig n m e n t  of  protein s e q u e n c e s  that s h o w  
s im i la r i ty  to tra n s la te d  s e q u e n c e s  der ived  from C l o n e  
m C T G 2 3 .
Replication protein A, 70kDa subunits  from Xenopus l a e v u s  
(XlRepA) and human (HsRepA) aligned to a t ranslation of s e q u e n c e s  
derived from clone inCTG 23 (23). The putat ive glutamine repeat is 
indicated in red text.
1 3 5
Legend  to Figure 4.6. A l ig n m e n t  of s e q u e n c e s  d e r i v e d  
from Clone mCTG 24 and the mouse nuclear  receptor  c o -  
r e p r e s s o r  p r o te in .
The red coloured sequence represents the triplet repeat as CAG in  
the DNA sequence. Note that a deletion has occurred in the rnCTG 
24 sequence presented  here, relative to that of the n u c l e a r  
receptor  co- repressor  gene. The methionine encoding ATG is 
indicated in green text and represents  the N-terminal of t h e  
protein. Clone mCTG 24 sequences are dist inguished in b lu e  
coloured text.
Figure 4.6
1 5 0
2 4 G A A T T C A T G T C T T A C G G T C A A G G G G CG G CT A A G G TG G C G A A G C T G C G G C G
C o R
5 1 1 0 0
2 4 G C G G C G G C TG G A A TG A G CG C C C A G C T C G C C G C G C T G C C G A A CG A G G G CCG
C o R
1 0 1 1 5 0
2 4 GGCGG AG G GC C G C G C G C C G G G G C C G C G C C C C G G T C G T C C G G CCG TG G G G C
C o R . C C G T G G A C T TC A G C G G G G A
1 5 1 2 0 0
2 4 G C G C C G G C TC T C A C T C C G C C A G C T C C C G G T T G C T T C C T A A A A A C A T G G T T
C o R G C G T C T G C A A A G G C C C C C G A C G T C C T G A G T G A T T T C C T A G A A G C A T G G T T
2 0 1 2 5 0
2 4 G T T T G T T G G A C T T G A T C T C A C A G C C C A A T G A G G C G T C T T T A C T G A T A A T
C o R T T T T G T T G C C C T T G A C C T C C C A G C C T G G T G A G G C C T C T G T C C T G A G A A T
2 5 1 3 0 0
2 4 G T C A A G T T C A G G T T A C C C T C C CA A CCA G A G G A C T T T C A A C A CA A A G CA A A
C o R G T C A A G T T C A G G T T A T C C T C C CA A CCA G G G G G C G T T C A G C A CA G A G CA G A
3 0 1 3 5 0
2 4 G T C G T T A T C C T T C A C A T T C T G T C C A G T A T A G C T T T C C G A G T A C C C G A C A C
C o R G T C G C T A C C C T T C G C A C T C G G T T C A G T A C A C C T T T C C C A G C G C C C G T C A C
3 5 1 4 0 0
2 4 C A G CA G G A A T T T G C A G T T C C T G A C T A C C G C T C T T C T C A T A T T G A A A T T A G
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Figure 4.7 S e q u en c e  a l ig n m e n t  of  s e q u e n c e s  d er ived  f r o m  
the m ouse  Clone niCTG 29 and a l t e r n a t iv e  sp l ic ing  f a c t o r  
2-like  ESTs.
These sequences were der ived from the nucleic acid d a t a b a s e s  
(dBEST). Alignment was performed using the PILEUP p r o g r a m m e .  
Sequences rep resen ted  are: H92640 (327bp 3' EST), A A 0 5 3 6 6 7
(443bp 3' EST from a colon cDNA library clone), T55469 (469bp 3 '  
EST), N39431 (430bp 3’ EST), T63434 (404bp 3' EST), W 3 9 1 6 2
(417bp 5' EST from a cDNA clone derived from a library c o n s t r u c t e d  
from para thyro id  adenomas),  H50597 (353bp 3' EST) and H 9 4 6 3 4  
(403bp 3' EST). Clone mCTG 29 sequences are indicated in b l u e  
coloured text.
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mRNA molecules in the nucleus (Lamond, 1991). It is known t h a t  
this gene belongs to the SR (se r ine-a ig in ine)  family of sp l ic ing  
factors.  The se r ine-arg in ine  rich domain, which gives this g e n e  
family its name, is required for the selection of splicing e v e n t s  
(Wang and Manley, 1995). Recently a transgenic knockout  study has 
shown that ASF/SF2 is essential for cell viability (Wang et al, 1996).
4.4.4 Clone mCTG 43.
This clone was originally isolated from the 8.5 dpc l ib ra ry .  
Overlapping sequence was produced from both ends of the i n s e r t  
from this clone. By using the Mac Align program m e a c o n t in u o u s  
sequence was built. This was re-exported to Mac Vector and t h e  
UWGCG sequence analysis packages  for further  analysis.  The i n s e r t  
was found to be 531 nucleot ides in length and contained a c ry p t ic  
CAG trinucleotide repeat, 11 triplets in length. It was interrupted by 
a CCA trinucleotide. In addition this insert was also found to c o n ta in  
a polypurine  tract, 54 nucleotides in length. This has an i n t e r n a l  
s tructure  consisting of a GAG repeat, 7 repeats long. This in turn is 
adjacent to a cryptic hexanucleotide  repeat GAGAAG, which is 5 
repeats in length with the middle repeat corrupted to GAAAAA. A 
continuous open reading frame was found throughout  this s e q u e n c e  
by application of Pickett's testcode algorithm (Pickett, 1982). U p o n  
translation of this ORF from nucleotide to amino acid sequence, t h e  
CAG repeat was found to encode a polyglutamine tract. Because o f  
the presence of a flanking CAA trinucleotide and the i n t e r r u p t i n g  
CCA repeat the s tructure of the polypeptide was Q2PQ9- In  the c a s e  
of the poly purine tract, it was found that the hexanucleot ide  r e p e a t  
would be translated as five copies of al ternat ing amino acids ly s in e
4 0
and glutamic acid and the GAG repeat is translated as glutamic acid. 
The additional trinucleotide separating these repeats was also f o u n d  
to encode glutamic acid. Therefore  the polypurine tract t r a n s l a t i o n  
in whole was (EKXsEv in this reading frame. The full n u c l e o t id e  
sequence is described in Figure 4.8.
The sequence from this clone was then used to search b o t h  
nucleic acid (Genbank and FMBL) and amino acid da tabases  (Sw iss -  
Prot and PIR). A search using the BLASTX algorithm i d e n t i f i e d  
similarit ies between the sequence from clone 43 and four sequences 
in the non-redundant sequence database which was searched. Three 
of  these sequences were related, one of which was described as t h e  
mouse Rad21 protein, which is involved in the repair of d o u b l e ­
strand DNA break lesions. This sequence was described recent ly b y  
McKay al (1996). This paper also describes the identification of  
the human homologue of this gene. This represents  a n o t h e r  
sequence identified from this search. The second s e q u e n c e  
identified, PW29, has been described by Yu et al (1995) as h a v in g  
calcium binding ability (as tested by a calcium blot experiment).
The search of nucleic acid databases  with the sequence of  
clone mCTG 43 using the FASTA algorithm (Lipman and P e a r so n ,  
1985), in addition to identifying the sequences  reported  a b o v e ,  
found another  independent ly  identified protein coding g e n e  
sequence,  a mouse b e t a - 1,4 -ga lac tosy l t rans fe rase .  This e n z y m e  
synthesises  b e ta -4 -N -ace ty l - la c to sam in e  structure in
glycoconjugates .  The protein is required for male m a m m a l i a n  
ferti l ity in that it binds to specific 0- l inked  ol igosaccharide  l ig an d s  
on the egg coat glycoprotein ZP3. In mammals  this protein has an  
additional metabolic function in the product ion of lactose in 
s timulated m am m ary  glands.
1 4 1
From Figure 4.8 which represents  a PILFUP m u l t i p l e  
sequence alignment analysis,  it can be seen that there is identity a t  
the nucleic acid level over the whole sequence of clone mCTG 4 3 
insert  to the three gene groups described with known function.
4.4.5 Clone niCTG 410.
Clone mCTG 410 was isolated from the 8.5 dpc cDNA l ib ra ry .  
When sequence derived from this clone was used to search t h e  
da tabase  using the BLASTX algorithm (which searches the n o n -  
redundant  sequences of Genbank and FM BL nucleotide databases, in 
addition to the protein databases,  PIR and Swiss-Prot,  with a six 
frame transla tion of the input nucleotide sequence)  it was f o u n d  
that the sequence showed significant similarity (97% at the a m i n o  
acid level) to the N terminal portion of a rat nucleoporin, p54 (Hu e t  
al, 1996; AC: U63840). There is a similar degree of identity at t h e  
nucleic acid level with 95.1% of the bases being identical b e t w e e n  
the rat and mouse sequences presented here (see Figure 4 .9 .A). Th is  
protein is involved in the transport  of RNA from the nucleus to t h e  
cytoplasm and has been shown to bind RNA.
The CAG repeat is conserved between the rat and t h e  
p resum ed  mouse sequences  presented here, both at the n u c l e o t id e  
level and at the amino acid level as a polyglu tamine tract, 8 
res idues long, starting at residue 93 in the rat n u c l e o p o r in  
sequence.  This protein also has an unusual di peptide r e p e a t  
jux taposed  N-terminal  to this polyglu tamine tract which consists o f  
a l ternate  glycine residues  with larger hydrophilic side c h a in  
residues, threonine (T), leucine (L) or phenyla lan ine  (F). There is no  
conserved repeti t ive element at the nucleic acid level and th i s
4 2
Legend to Figure 4.8. S eq u en ce  an a lys is  of  clone niCTG 
4 3 .
Nucleotide sequences of M. m u s c u l u s  Rad21 cDNA (M m Rad21 , AC: 
X98293,  McKay et al, 1996); Human Rad21 cDNA (HsRad21, AC: 
X98294, McKay et al, 1996); Human calcium binding p r o t e in  
(PW29, Yu et al, 1995) and M. m u s c u l u s  |3-1 ,4- 
ga lac tosy l t rans fe rase  (Mmnb) aligned to sequences  der ived f r o m  
clone mCTG 43. The red coloured sequence indicates the p o s i t io n  
of the CAG tr inucleotide repeat in Clone mCTG 43 and the p u r p l e  
coloured triplets indicate corruptions of the CAG/CTG t r in u c l e o t i d e  
repeat.  The green coloured sequence indicates the p o l y p u r i n e  
stretch. Clone 43 sequences are indicated in blue text.
Figure 4.8
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T C A G T T T G C T  T G A G T C W M C T  A T G T C G A A A T  A C G A A C A G A A  A A C A A G C T G C
4 3
M m R a d 2 1
H s R a d 2 1
P W 2 9
M m n b
1 2 0 1  1 2 5 0
A G C A A A G . . .  T T C T A C A G C T  T T T T G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
A G C A A A G C S C  T T C T A C A G C T  T T T T G G T T C T  T A A G A A G C A G  CAAGCCATCG 
C G C A A A G T T C  T A C A G C T T C C  S C T T G G T T C T  T A A A A A G C A G  C A A G C T A T T G
4 3
i y & n R a d 2 1
H s R a d 2 1
P W 2 9
Mmnb
1 2 5 1 1 3 0 0
A G C T C A C A C A  CSMCGGAAGA G C C G T A C A G T  G A C A T C A T T G  C A A C C C C T G G  
A G C T G A C A C A  G G A A G A A C C G  T A C S M C C A G T  G A C A T C A T C G  CAACACCTGG
4 3
M m R a d 2 1  
H s R a d 2 1  
P W 2 9  
M m n b
1 3 0 1 1 3 2 1
A C C A C G G T T C  C A T A C C T T A T  C  
A C C A A G G T T C  C A T A T T A T A .  .
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Legend to Figure 4 .9 .  A) N u c leo t ide  se q u e n c e  and B )  
amino acid c o m p a r iso n  of  mCTG 410 s e q u e n c e  and R a t  
n u c l e o p o r i n  p54.
The red sequence indicates the CAG repeat identified in clone 4 1 0  
(Figure 4.8.A) and translated as a polyglutamine tract (indicated in 
red text in Figure 4.8.B). The purple coloured sequence r e p r e s e n t s  
the al ternat ing glycine repeat. The initial ATG and m e t h i o n i n e  
amino acid is indicated, in green type, on Figures 4.8.B.
F i g u r e  4.9
A )
4 1 0 G G G C C A T C T A A A T G G C T T T C A A T T T T G G G G C T C C T T C G G G C A C T T  8 2  
I l  I I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
p 5 4
M I I I  I I  1 I I  1 I I  1 I I  1 1 1 I I  1 1 1 I I  1 1 1 I I  I I  1 I I  1 1 I I  1
G G A C C A C T T A A A T G G C A T T C A A T T T T G G G G C T C C T T C G G G C A C T T  1 0 0
4 1 0 8 3 C G G G C A C C T C T A C A G C C A C C G C G G C A C C G G C G G G T G G G T T T G G A G G A T T T  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 3 2
p 5 4 1 0 1
M M 1 M 1 1 M 1 1 M M 1 1 M M M 1 M M M M 1 M M 1 M M I N I
C G G G C A C C T C T A C A G C C A C C G C G G C A C C G G C G G G C G G G T T T G G C G G A T T T 1 5 0
4 1 0 1 3 3 G G A A C A A C A A C T A C A A C T G C A G G C T C T G C C T T C A G C T T T T C A G C C C C A A C  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 8 2
p 5 4 1 5 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
G G A A C A A C A A C T A C A A C T G C A G G C T C T G C A T T C A G C T T T T C T G C C C C A A C 2 0 0
4 1 0 1 8 3 A A A C A C A G G C A G T A C A G G C C T T C T C G G T G G C A C T C A G A A C A A A G G T T T T G  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
2 3 2
p 5 4 2 0 1
M M M M M M M M M M M M M 1 1 1 1 M M 1 1 1 M M 1 M M 1 M
A A A C A C A G G C A G T A C A G G C C T T C T C G G C G G C A C T C A G A A C A A A G G T T T T G 2 5 0
4 1 0 2 3 3 G C T T T G G T A C T G G T T T T G G C A C A A C G A C G G G A A C T G G C A C T G G T T T A G G C  
1 1 1 1 1 1 1 I I  1 1 1 1 1 I I  1 1 I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
2 8 2
p 5 4 2 5 1
1 M M M 1 1 M 1 1 M M M 1 M 1 M M M 1 M M M M M M M 1 M
G C T T T G G C A C T G G T T T T G G C A C A T C G A C G G G T A C T G G C A C T G G T T T A G G C 3 0 0
4 1 0 2 8 3 A C T G G C T T G G G A A C C G G A C T T G G A T T T G G A G G A T T T A W T A C C C A G C A G C A  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 •  1 1 1 1 1 1 1 1 1 1 1
3 3 2
p 5 4 3 0 1
M 1 M 1 M M M M M 1 M M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 - 1 1 M I I  M 1 M
A C T G G C T T G G G A A C C G G A C T T G G A T T C G G A G G A T T T A A C A C C C A G C A G C A 3 5 0
4 1 0 3 3 3 G C A G C A G C A G C A G C A G A C T T C T T T A G G T G G T C T C T T C A G T C A G C C G A C C C  
M  1 1 1 1 1 1 1 1 1 M  1 1 1 1 1 1 1 1 1 1 1 1 1 1 M  1 1 1 1 M  1 1 1 1 1 1 1 1 1 1 1
3 8 2
p 5 4 3 5 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
G C A G C A G C A G C A G C A G A C T T C T T T A G G C G G T C T C T T C A G T C A G C C T G C A C 4 0 0
4 1 0 3 8 3 A G G C T C C T G C A C A G T C T A C C C A G C T C A T C A A C A C T G C C A G C G C A C T T T C T  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
4 3 2
p 5 4 4 0 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
A G G C C C C T G C G C A G T C C A A C C A A C T C A T C A A C A C T G C C A G C G C T C T T T C T 4 5 0
4 1 0 4 3 3 G C T C C A A C G C T A C T G G G G G A T G A G A G A G A C G C C A T C T T G G C A A A G T G G A A  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
4 8 2
p 5 4 4 5 1
1 1 1 1 1 1 1 1 1 1 1 1 1 M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
G C T C C A A C G C T A T T G G G G G A T G A G A G A G A T G C C A T C T T G G C A A A G T G G A A 5 0 0
4 1 0 4 8 3 C C A G T T G C A G G C C T T C T G G G G A A C A G G A A A A G G A T A T T T C A A T A A T A A C A  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
5 3 2
p 5 4 5 0 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
C C A G T T G C A G G C C T T C T G G G G A A C A G G A A A A G G A T A T T T C A A T A A T A A C A 5 5 0
B)
4 1 0 M A F N F G A P S G T S G T S T A T A A P A G G F G G F G T T T T T  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
5 0
p 5 4
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
M A F N F G A P S G T S G T S T A T A A P A G G F G G F G T T T T T 3 4
4 1 0 5 1 A G S A F S F S A P T N T G S T G L L G G T Q N K G F G F G T G F G T T T G T G T G L G T G L G T G  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M 1 1 1 M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M 1 1 1
1 0 0
p 5 4 3 5
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ■ 1 1 1 1 1 M 1 1 M 1 1 1 
A G S A F S F S A P T N T G S T G L L G G T Q N K G F G F G T G F G T S T G T G T G L G T G L G T G 8 4
4 1 0 L G F G G F X T Q Q Q Q Q Q Q Q T S L G G L F S Q P T Q A P A Q S T Q L I N T A S A L S A P T L L G  
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 5 0
p 5 4
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ‘ 1 1 M 1 1 ' 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
L G F G G F N T Q Q Q Q Q Q Q Q T S L G G L F S Q P A Q A P A Q S N Q L I N T A S A L S A P T L L G 1 3 4
4 1 0 1 5 1 D E R D A I L A K W N Q L Q A F W G T G K G Y F N N N I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 8 0
p 5 4 1 3 5
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
D E R D A I L A K W N Q L Q A F W G T G K G Y F N N N I P P V E F T Q E N P F C R F K A V G Y S C M 1 8 4
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primary  st ructure feature probably has some function in t h e
protein. In addition to the above features,  this protein also has a
threonine repeat  5 residues long, starting at res idue 30 in the r a t  
nucleoporin sequence. This is encoded by ( AC A)2 ACT AC AACT 
whichis conserved in both the rat and mouse sequence (clone mCTG 
410) presented here (see Figure 4 .9 .A).
4.4.6 Clone mCTG 411.
This sequence (see Figure 4.10) has a strong similarity to a 
nucleocytoplasmic protein from the rat, N o p p l4 0  (Meier and Blobel,  
1992). This protein interacts with nuclear localisation signals ( M e ie r  
and Blobel, 1990) and is hypothesised to be a chaperone for e x p o r t  
and import to and from the nucleus. Interestingly, this protein has a 
repeat  which contains serine tracts. At the nucleic acid level, it is
revealed that these serines are encoded by the codon AGC, a
member  of the family (determined by frame and c o m p l e m e n t a r i t y )  
of codons which includes the CTG codon which consti tuted  t h e  
p ro b e .
4.4.7 Clone niCTG 56.
Sequence analysis revealed that this clone had one of t h e  
smallest CAG repeats identified in this project. The repeat co n s is t s  
of six CAG trinucleot ides.  This is conserved between s e q u e n c e s  
which show similarity to this sequence. This clone has identity to a 
group of  related genes; CW17 (Wrehlke et al, unpublished),  a human 
transcr ip t ion factor, Zfml (Toda et al, 1994), which has b e e n  
proposed as a candidate for the gene in which mutat ions c a u s e
147
multip le  endocr ine neoplasia type 1 (however,  this gene has n o w  
been excluded as a candidate for this disease; see Lloyd et al, 1 9 9 7 )  
and a human RNA splicing factor, SF-1 (Arning et al, 1996). T h e s e  
prote ins  all share common N-terminal  sequences but h a v e  
a l te rna t ive ly  spliced C-terminal segments  as indicated in t h e  
mult ip le  sequence al ignment of the putat ive protein s e q u e n c e s  
der ived from the cDNA sequences (Figure 4.11). The region o f  
identi ty  presented  in Figure 4.11 overlaps a glu tamine and p r o l in e  
rich region common to all these proteins. The CAG repeat  found in 
clone mCTG 56 is conserved between mouse and man and is 
common to all of the sequences described here except the h u m a n  
Zfml isoform L49344. This mRNA is a l ternat ive ly  spliced at a 
position in the nucleic acid sequence corresponding  to amino ac id  
448 (Figure 4.12, No 1). At a position corresponding  to amino acid  
528 (Figure 4.12, No 2) there is likely to be another  mRNA 
al ternat ive  splicing event when the remaining sequences  w h ic h  
were hitherto  homologous, are split into two sub-groups w h ic h  
show identity to each other. The first group consists of Z fm l ,  
(isoform Z fm l- l ,  Figure 4.12) and the two SF-1 isoforms, BO and hi 1 
(Arning et al, 1996). The second group consists of CW17, mCTG 5 6 
and a Zfml isoform. This second group of sequences terminate  a t  
position 548. There is another  mRNA al ternative splicing e v e n t  
which leads to a further divergence in amino acid sequences a t  
position 597 in the SF-1 isoform BO.
4.4.8 C lone  m C T G  57.
Clone 57, derived from the 8.5 dpc whole mouse e m b r y o  
library, (Hogan et al, 1984) shows identity to a u b i q u i t o u s l y
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expressed human transcript ional  adaptor,  P300. This protein is 
believed to have a role in the repression of the cell cycle a n d
promotion of differentiat ion. It has been reported to be a part of a 
TATA binding complex ( A b r a h a m  ct al, 1993.) The human cDNA 
contains a b romodomain  (Eckner  et al, 1994) which is a p u t a t i v e  
pro te in -p ro te in  interaction domain (H ay n es  et al, 1992). It a lso  
contains 3 cys te ine-h is t id ine  rich domains. The most c a r b o x y l  
terminal of  these is found to overlap the interaction domain for t h e  
adenovirus  oncogene El A (Eckner  et al, 1994). The sequence of  
clone mCTG 57 shows similarity to a region corresponding  to a 
region encompassing amino acid residues 2232 to 2351 inclusive of  
human P300. This corresponds to positions 250 to 369 in t h e  
multiple sequence alignment in Figure 4.13.
More recently, P300 has been suggested to be a m em ber  of a 
growing family of proteins which appear  to interact with t h e  
phosphorylated form of CREB (Lundblad et al, 1995), a t r a n s c r i p t i o n  
factor (Chr ivia,  et al, 1993), as well as interacting with the E l  A
product (Arany et al, 1995). The sequence of clone mCTG 57 s h o w s
most s imilarity  to human P300, including the gaps between P 3 0 0
and the sequences  which represent  the CREB binding proteins o f  
mouse and human (Figure 4.13, Mm-CBP and Hs-CBP r e s p e c t iv e ly ,  
Chrivia et al, 1993). It is therefore  likely that clone 57 represents  a 
mouse cognate of human P300. The CAG/CTG repeat in the s e q u e n c e  
is likely to represent  a polyglutamine repeat, six res idues long, as  
indicated in Figure 4.13. This is in contrast to 2 glu tamines  at t h e  
same position found in the human P300 and three glutamines in t h e  
sequences of mouse and human CREB binding proteins.
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Figure 4 .1 0 .A
2 5 1  3 0 0
4 1 1  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
R n N o p p l 4 0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C
H s N o p p l 4 0  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H s N o p p l B O  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 0 1  3 5 0
4 1 1   G C A G G  A A T T C C A T G T  C T T A C G G T C A  A G G G C C C A G G
R n N o p p l 4 0  A T C C A G T G A C  A G C A G T G A G G  A C A G C A G T G A  GGAAGAGGAC A A A G C C C A . .
H s N o p p l 4 0   G T  G A C A G T G A G G  A C A G C A G C G A  G G A G G A G G A G  G A A G T T C A A G
H s N o p p l 3 0  C T C A T C C A G T  G A C A G T G A G G  A C A G C A G C G A  G G A G G A G G A G  G A A G T T C A A G
3 5 1 4 0 0
4 1 1  G A C T T C C C A C  A C A G A A G G C T  G C C G C A C A G G  C C A A G C G A G C  CAGTGTGCCT
R n N o p p l 4 0  . A G T T C C C A C  ACAGAAGGCT G C C G C C C C T G  C C A A G C G A G C  C A G T T T G C C T
H s N o p p l 4 0  G G C C T C C A G C  A A A G A A G G C T  G C T G T A C C T G  C C A A G C G A G T  C G G T C T G C C T
H s N o p p l 3 0  G G C C T C C A G C  A A A G A A G G C T  G C T G T A C C T G  CCAAGCGAGT C G G T C T G C C T
4 0 1  4 5 0
4 1 1  C A G C A T G C T G  G G A A A G G C A G  C A G C A A A G C T  T C A G A G A G C A  G C A G T A G T G A
R n N o p p l 4 0  C A G C A T G C T G  G G A A A G C A G C  A G C C A A A G C T  T C A G A G A G C A  G C A G T A G T G A
H s N o p p l 4 0  C  C T G  GGAAGGCTGC A G C C A A A G C A  T C A G A G A G T A  GCAGCAGTGA
H s N o p p l 3 0  C  C T G  GGAAGGCTGC A G C C A A A G C A  T C A G A G A G T A  G C A G C A G T G A
4 5 1  5 0 0
4 1 1  A G A A T C C A G T  G A T G A G G A A G  A G G A A G A G G A  C A A A A A G A A A  A A G C C T G T C .
R n N o p p l 4 0  A G A G T C C A G T  G A G G A A G A G G  A G G A G A A G G A  C A A A A A G A A A  A A G C C T G T C .
H s N o p p l 4 0  A G A G T C C A G T  G A T G A T G A T G  A T G A G G A G G A  C C A A A A G A A A  C A G C C T G T C .
H s N o p p l 3 0  A G A G T C C A G A  G A T G A T G A T G  ATGAGGAGGA CCAAAAGAAA CAGCCTGTC.
5 0 1 5 5 0
4 1 1  . . C A G A A G G C  A G C T A A G C C C  C A A G C C A A G G  C A G T C A G A C C  T C C T G C G A A G
R n N o p p l 4 0  . . CAGAAAGC A G T T A A G C C C  C A A G C C A A G G  CAGTCAGACC TCCTCCGAAG
H s N o p p l 4 0  . . CAGAAGGG A G T T A A G C C C  C A A G C C A A G G  C A G C C A A A G C  T C C T C C T A A G
H s N o p p l 3  0  . . CAGAAGGG A G T T A A G C C C  C A A G C C A A G G  C A G C C A A A G C  T C C T C C T A A G
5 5 1  6 0 0
4 1 1  A A A G C A G A G A  G C T C T G A G T C  G G A C T C G A C A  T C G G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
R n N o p p l 4 0  A A G G C A G A G A  G C T C T G A G T C  C G A G T C T G A C  T C A A G C T C A G  AGGATGAAGC
H s N o p p l 4 0  A A G G C C A A G A  G C T C T G A T T C  T G A T T C T G A C  T C A A G C T C C G  A G G A T G A G C C
H s N o p p l 3 0  A A G G C C A A G A  G C T C T G A T T C  T G A T T C T G A C  T C A A G C T C C G  AGGATGAGCC
6 0 1  6 1 8
4 1 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
R n N o p p 1 4 0  A C C A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H s N o p p l 4 0  A C C A A A G A A C  C A G A A G C C  
H s N o p p l 3 0  A C C A A A G A A C  . . . . . . . . . . . . . . . . . . . .
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Figure 4.10.B
1 0 1  1 5 0
4 1 1  P T Q K A A A Q A K  R A S V P Q H A G K  G S S K A S E S S S  S E E S S D E E E E  E D K K K K P V . Q
R n N o p p l 4 0  P T Q K A A A P A K  R A S L P Q H A G K  A A A K A S E S S S  S E E S S E E E E E  K D K K K K P V Q Q
H s N o p p l 4 0  P A K K A A V P A K  R V G L P . . P G K  A A A K A S E S S S  S E E S S D D D D E  E D Q K K Q P V . Q
H s N o p p l 3 0  P A K K A A V P A K  R V G L P . . P G K  A A A K A S E S S S  S E E S R D D D D E  E D Q K K Q P V . Q
1 5 1  2 0 0
4 1 1  K A A K P Q A K A V  R P P A K K A E S S  E S D S T S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Figure 4 .10 A l ig n m e n t  of  A) n u c le o t id e  and B) p r o t e i n  
sequences  which show s imilar ity  to clone niCTG 411.
The sequences represented are: those derived from clone 411 (411) ;  
Rciîîiis norver^icLis  140 kDa nuc leophosphopro te in  (R n N o p p  140, 
Meier and Blobel, 1992), Homo sa p ie n s  140 kDa 
n uc leophosphopro te in  (HsN oppl40 ,  Nomura et al, 1994) and H o m o  
s a p ie n s  130 kDa nuc leophosphopro te in  (HsNopp 130, Pai et al, 
1995). mCTG 411 sequences are indicated in blue coloured text a n d  
the serine repeat which is encoded by a CAG/CTG repeat in t h e  
comparison sequences (but is not shown for clone 411 because o f  
unconfirmed sequence data) is indicated in green coloured text.
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Figure 4.11 (continued)
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Figure  4.11 A l ign m en t  o f  putat ive  translat ion  of  s e q u e n c e s  
from clone m CTG  56 and proteins  which show similarity .
The numbers  in bold represent  where protein sequences d iv e rg e .  
The CAG repeat is represen ted  by a purple Q run. R e p r e s e n t e d  
sequences  are Mus m u sc u l i i s  CW17R (Whrekle et al, u n p u b l i s h e d  
AC: S52735); Homo sapiens  Z fm l-I  isoform (Toda et al, 1994), H o m o  
s a p ie n s  Z fml-I I  isoform (Breviario et al, unpublished,  AC: L 4 9 3 8 0 ) ;  
Homo sapiens  Z fm l- I I I  (Breviario et al, unpublished,  AC: L 4 9 3 4 5 )  
and Homo sa p ie n s  splicing factor 1 isoforms SF-1 hll  and SF-1 BO 
(Arning et al, 1996). Colourise text corresponded to the co lo u rs  
given to diverged and related sequences in Figure 4.12.
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Figure 4.12
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CWI7K 
Zfml-Il 
Zfml-I 
SKI-hll 
SKI-110 
ZI m l-111
Figure 4 . 1 2  D ia g r a m m a t ic  r e p r e s e n t a t io n  of  r e l a t e d n e s s  
and p u ta t iv e  sp l ic ing  events  (1, 2 and 3) b e t w e e n
sequences  related to Clone mCTG 56.
Blue filling colour represents  homologous sequences shared b y  
Clone mCTG 56, mouse CW17R, splicing factor 1 and human Zfm l  
isoforms. Red represents sequences which are common to a group of  
sequences  which includes a putative transla tion of Clone mCTG 5 6 
sequences.  Green filling colour represents  sequences common to 
sequences Z fm l-I I  (Breviario et al, unpublished) ,  SF-1 hll  and SF-1 
BO isoforms (Arning et al, 1996) which starts at splice position 2. 
Yellow filling colour represents  sequences unique to the SF-1 
isoform BO which start at position 3. Black filling colour in d ic a te s  
the unique sequence present in the Z fm l- I I I  isoform (Breviario e t  
al, unpublished) ,  after the divergence of this sequence at spl ice  
position 1.
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Figure 4.13 S eq u e n c e  a l ig n m e n t  of  t ra n s la t io n  of  c lone 5 7 
and prote in  seq u e n c es  which  show  s im ilar i ty .
A translation of sequences derived from clone mCTG 57 (57) a l i g n e d  
with Homo sapiens  P300 transcriptional adaptor (HsP300; Eckner e t  
al, 1994), Mus m u s c u l i i s  CREB binding protein (Mm-CBP; Chrivia ,  e t  
al,  1993) and Homo sapiens  CREB binding protein (Hs-CBP; Chrivia et  
r//, 1993).
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4.5 Clones with s im i lar i ty  to e x p re s sed  s eq u e n c e  t a g s  
(E S T s ) .
As described in Section 2 of this Chapter, three clones (mCTG 
12, 46 and 59) show similarity to EST sequences derived from mass 
sequencing projects.  In most cases, little is known about  t h e  
sequence, except the details of the library from which the clone w a s  
isolated. It is likely that they represent novel genes.
4.5.1 Clone mCTG 12.
Clone mCTG 12 was isolated from the 8.5 dpc library (Hogan  
et al, unpublished).  A search using the BLASTN algorithm (A l ts c h u l  
et al, 1990) with sequence obtained by priming with the e x t e n d e d  
T3 primer  (T3/T7a, see Table 2.3, Chapter 2) revealed that th i s  
clone had similarity to a group of human and mouse ESTs. I n  
addition to this, a search of databases  with the BLASTN s e a r c h  
algorithm using sequence obtained by priming with the e x t e n d e d  
pr imer  bT7 (see Table 2.3, Chapter 2) which generates  s e q u e n c e  
from the other end of the insert found similarity to a mouse EST, 
W715089,  (Figure 4.14.B).
The EST identified as having the highest similarity to c lone  
mCTG 12 (Z78337, see Figure 4.14.A) was derived from a specif ic  
human oriented project which isolated CAG repeat containing c lo n es  
from cDNA libraries (Neri et al, 1996). The clone descr ibed by Neri  
et al  (1996), ICRFp507H02194, has 6 CAG trinucleotides.  This is in  
agreement  with the CAG repeat found in Clone mCTG 12, a l t h o u g h  
the repeat is interrupted by 2 TAG triplets. This repeat may also b e  
larger as it is adjacent to vector sequences in the clone obtained.
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4.5.2 Clone mCTG 46.
A BLASTN search found that this clone had similarity to a 
mouse clone which corresponds to an EST, W91417. This s e q u e n c e  
was derived from a 13.5/14.5 dpc whole mouse embryo ( i n b r e d  
strain, C57BL/6J) cDNA library. At the nucleic acid level t h e  
s imilar ity was found to be 95.6%. Both sequences were found to  
contain a large perfect CAG/CTG repeat,  25 tr inucleotides  in leng th .  
There are also two CTG tr inucleotides  immediate ly  upstream of t h e  
large repeat.  This repeat may be transla ted as a polyalanine o r  
polyserine homopeptide.  Translation as polyglutamine is unlikely as  
there is a consistent, in frame stop codon upstream of the repeat in 
both sequences, adjacent to the CAG repeat. This is rep resen ted  in 
Figure 4.15 as the underlined trinucleotide CTA (the opposite s t r a n d  
sequence is TAG). Fur thermore ,  the EST, W91417,  represents  the 5 ' 
end sequences of a clone from a library which had been r a n d o m  
primed with oligo-dT. The opposite end contains a poly A tail w h ic h  
restricts the possible reading frames that this trinucleotide r e p e a t  
can be translated  {i.e. GCT, CTG or TGC). Alternatively  the r e p e a t  
may lie in an untranslated region.
4.5.3 Clone mCTG 59.
This sequence showed similarity to a single human EST, 
W91417,  derived from a human foetal spleen cDNA library. T h e  
homology only extended to a 122 nucleotide overlap (Figure 4.16).
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Figure 4 .1 4 .A A l ig n m e n t  of  n u c le o t id e  s e q u e n c e s  d e r i v e d  
from clone 12 and ESTs which show s imilarity .
Alignment of clone mCTG 12 sequences (blue text) and: Z 78337 ,  
clone IC R F p 5 0 7 H 0 2 194 derived from a human foetal brain cDNA 
library (Neri et al, 1996), Z42809 and R 17799 (human 5' ESTs).
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Figure 4 .14.B.  Com parison  of  sequences  der ived  from c l o n e  
12 and mouse EST W71508.
The clone mCTG 12 sequence described here was derived from a T7 
primed sequencing reaction and represent ing  sequence from t h e  
opposite end of clone mCTG 12 to that descr ibed in Figure 4 .1 4 .A. 
The mouse EST described here, W71508,  was derived from a 13.5 
dpc whole mouse embryo cDNA library. Clone mCTG 12 s e q u e n c e s  
are indicated in blue text. Bars indicate positions of identity,  : 
indicates similar nucleotides  and spaces non-identical nucleic ac id s  
at those particular positions.
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Figure  4.15 Sequence  a l ignm ent  of  sequences  der ived  f r o m  
clone mCTG 46 and mouse 5* EST W91417.
Red sequence represents  the CAG/CTG tr inucleotide identified in 
clone mCTG 46 (sequences  indicated in blue coloured text) and t h e  
mouse EST W91417. The underl ined CTA tr inucleot ide represents  a 
stop codon (in the opposite strand) which is immediate ly  u p s t r e a m  
and in frame to prevent t ranslat ion of the trinucleotide as  
polyglu tamine.  For further details refer to the main text. Bars  
indicate positions of identity,  : indicates similar nucleotides a n d  
spaces non-identica l nucleic acids at those par t icular  pos i t ions .
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Figure 4.16 Al ignm ent  of  s e q u e n c e s  d er ived  from clone 5 9 
and human EST W86172.
This human EST was derived from a foetal liver spleen cDNA 
library. The sequence represen ted  here represents  the 3' end o f  
clone 416399.  Clone mCTG 59 sequences are indicated in b l u e  
coloured text. Bars indicate positions of identity,  : indicates s im i l a r  
nucleotides and spaces non-identica l  nucleic acids at t h o s e  
par t icular  positions.
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4.6 Clones with no similarity  to any sequence.
These clones, as of the 6th of November  1996, having b e e n  
used to search databases  with the algorithms, BLASTX, BLASTN 
(Altschul et al, 1990) and FASTA (Lipman and Pearson, 1985) d o  
not show any identity,  similarity or homology at either in t h e  
nucleic acid or amino acid level to any sequence found in t h e
databases.  These are clones mCTG 26, 27, 28, 210, 45, 414, 61, 81 ,
82, 86 and 92. The sequence of these clones can be found in  
appendix A of this thesis.
4.7 D is c u ss io n .
The results presented in this Chapter prove conclusively  t h a t  
the library screening method adopted in this study was a success .
An initial guide was the output numbers  from the primary cDNA
library screens, described in Chapter 3, and that they hybridised to  
the repeat oligonucleot ide probe consistently through f u r t h e r  
rounds of purification.
4.7.1 S ize,  s tructure  and numbers  o f  tr inucleot ide  repeats .
Partial sequencing of the first 23 lambda probe p o s i t i v e  
inserts sub-cloned into the phagemid  vector, pBluescript  KS-, 
identified CAG/CTG triplet repeats in 21 of the inserts s e q u e n c e d .  
These CAG/CTG repeats exist in a wide range of sizes ranging from 6 
to 26 trinucleotide repeats (see Table 4.1). This spectrum of sizes is 
also evident  in the human study (Li et al, 1993) which used t h e  
identical screening conditions. The smallest repeat in their study is
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5 CAG/CTG triplets in length. The largest un in te r rup ted  repeat w a s  
15 triplets in length.
In this respect the mouse data presented here exceeds this .  
Eight clones have perfect repeats with length greater than or e q u a l  
to 15 triplets (clones mCTG 28, 210, 46, 61, 63, 81, 82 and 92) .  
Other  large repeat sequences contain imperfections in the r e p e a t i n g  
unit. These are relatively common. Cryptic or imperfect  repeats  a r e  
described in both the Riggins ct al (1992) and Li et al (1993) h u m a n  
studies, as well as in the data presented in this work. In a d d i t i o n  
they are observed in mouse in the work of Abbott and C h a m b e r s  
(Abbott  and Chambers,  1994; Chambers  and Abbott,  1996). T h e s e  
cryptic repeats  may have accumulated subst i tut ive nucleotide b a s e  
muta t ions  (transi tions and t ransversions)  in an ancestral r e p e a t  
during evolution. Alternat ively  the repeat s tructure is a product  o f  
convergent  evolution, where there was an advantage for t h e  
accumulat ion of a cyclical repetit ion. Insert ions and deletions o f  
bases tend to be absent as they would disrupt the open r e a d i n g  
frame, if the repeat existed in a t ranslated region. Fur thermore ,  a 
large number  of these mutations tend to be in the 3rd position of  
codons in a p resum pt ive  open reading frame. Due to the nature of  
the genetic code, this leads to no change in the amino acid e n c o d e d  
by that codon, in many cases. The 3rd position of codons are k n o w n  
to be the most var iable position, where different bases can b e  
tolerated in accepting the same amino acid. This effect is due to t h e  
anticodon wobble. Accumulat ion of this type of mutat ion in 
t ranslated  tr inucleotide  repeats without disturbing the amino ac id  
hom opept ide  argues for some functional significance of t h a t  
homopeptide and thus of the repeat.
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Recent work done by Karlin and Burge (1996) noted a
p rep o n d e ran c e  of multiple repeats  in certain proteins of h i g h e r  
eukaryotes .  These can consist  of repeats of the same or d i f f e r e n t  
trinucleotide,  encoding different amino acids. Their w o r k  
concentra ted  on Drosophila  and human proteins. They m e n t i o n  
mouse data, but do not discuss it. The partial sequence d a t a  
described in this Chapter show some evidence for this in m o u s e  
genes. Most of these apparent ly  encode OCN type repeats  and a r e  
likely to encode polyproline stretches (where N equals A, C, G or T). 
They were first identified in Drosophila  proteins,  were named PEN 
repeats (Digan et al, 1986) and are bel ieved to be fu n c t io n a l ly  
significant. G e rb e r  et al (1994) have shown that p o l y p r o l i n e  
hom opep t ides  have a stimulatory effect on basal t r a n s c r ip t io n .
Polyprol ine and polyglutamine have also been found in close  
proximity to each other in certain proteins. One example is t h e  
human hunt ingtin protein, which possesses two proline s t r e t c h e s ,  
one of which is adjacent to the glutamine stretch, al terat ions in t h e  
length of which have been associated with changes in the s e v e r i t y  
of the disease (Pecheux et al, 1995).
There are examples of other repeats.  For example, there is a 
GAG repeat  in clone mCTG 43 that encodes a glutamic acid r e p e a t .  
This is in addition to the CAG tr inucleotide which encodes a
po lyg lu tam ine  tract (see Figure 4.8). This is part of a l a r g e r
polypurine  stretch of which the remainder  forms a h e x a n u c l e o t i d e  
repeat, which encodes an alternate di-amino acid repeat,  g l u t a m a t e -  
lysine (EK).
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4.7 .2  C om par ison  with other CAG/CTG co n ta in in g  cD N A  
s c r e e n i n g  s tu d ie s .
In a recent study, Abbott and Chambers (1996) screened a 
mouse adult  brain cDNA library for CAG/CTG tr inucleotide r e p e a t s  
and found a similar number  of CAG/CTG tr inucleotide r e p e a t  
positive clones (60 positives per 20000 pfu screened)  compared to  
that observed by myself  in the adult mouse brain cDNA library (5 3 
clones per 20000 pfu screened).  However,  when sequence a n a ly s i s  
was performed the largest repeat size was 10 copies of CAG (C. 
Abbott,  personal comm.).  This maximum is smaller than the r e p e a t  
lengths which I observed in clones derived from the 8.5 dpc a n d
12.5 dpc mouse whole embryo cDNA libraries.  It may be p o s s ib le  
that CAG/CTG tr inucleotide repeats that are expressed are s m a l l e r  
in the adult brain compared to those in development .  H o w e v e r ,  
from the reverse dot-blot exper iments  with some of the c lones  
derived from the 8.5 dpc and 12.5 dpc embryonic  cDNA l i b r a r i e s  
described in Chapter  3 of this work, clones which contain l a rg e  
t r inucleotide repeats  are expressed not only t h r o u g h o u t  
deve lopm ent  but also in adult tissues including mouse b ra in .  
Therefore  the smaller repeat size derived by Abbott  and C h a m b e r s  
(1996), must be caused by some other influencing factor. A b b o t t  
and Chambers  themselves suggest that this effect may be caused b y  
the fact that the library which they used was derived from o l igo-dT 
pr imed first strand cDNA synthesis and the resulting library is 
biased towards  3' t ranscr ipt clones. An al ternat ive explanation is 
that the hybrid isa t ion conditions under which the libraries w e r e  
screened were different.  Abbott and Chambers (1996) used a 
wholly aqueous based hybr idisat ion solution combined with a h ig h
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t em pera tu re  of hybrid isat ion (59°C). The hybrid isat ion c o n d i t io n s  
which I used to screen the cDNA libraries screened here differ in 
that the hybrid isation solution was 50% formamide with a 
hybrid isa t ion  tem pera tu re  of 42°C. Formamide is known to be a b l e  
to de-stabi l ise  secondary structure. It also known to increase t h e  
effect ive tem pera tu re  of hybridisation.  Therefore  the e f f e c t iv e  
t em p era tu re  of my conditions is 72°C. The secondary s tructure d e ­
stabilising effect may have contr ibuted to a larger size of r e p e a t  
being available for hybridisat ion to the probe (CTG)io, used in t h e  
exper im ents  described in this work. An additional factor in 
detect ing larger repeat sequences  in this work would be the l a r g e r  
size of the oligonucleotide probe used. It is known that nucleic ac id  
hybrid stability is dependent  on the length over w h ic h  
c om plem en ta r i ty  can be achieved. This phenom enon is m o r e  
pronounced for smaller probes than for larger ones. Therefore  a 
probe which has 10 copies of the t rinucleot ide CTG, as used in t h e  
exper iments  described in this thesis will form more stable h y b r i d s  
than the one with only five copies of CTG which was used by A b b o t t  
and Chambers  (1996).
4.7 .3  C ross  spec ie s  re la t ionsh ips .
As an assessment of hum an-m ouse  tr inucleotide r e p e a t  
conservat ion,  a comparison of tr inucleot ide repeat sequences  w a s  
performed. It was found that in all cases that the size of the r e p e a t  
sequence of the mouse was greater than or equal to the r e p e a t  
sequence found in the human homologue (see Figure 4.4).
In a larger repeat (mCTG 23, a homologue of RepA 70 kDa 
subunit) where a m ouse-hum an  comparison could be made t h e r e
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seems to be more of a divergence between species. In this case, t h e  
mouse gene appears to have an expanded CAG repeat compared to  
both the human and X e n o p u s  homologues  which do not (See F ig u re  
4.5). This observat ion also supports the idea of asce r ta inm ent  b ia s  
where the selection of large microsatell i te repeats from o n e  
organism are smaller than in others rather than the other t h e o r y  
proposed by Rubinzstein et al (1995) which proposes  that d i f f e r e n t  
organisms have different rates of microsatell i te dynamics.  H o w e v e r  
from the work presented here, it appears that the mouse r e p e a t s  
are larger than the human counterpar t .  Only in 1 out of 5 c a se s  
where a m ouse-hum an  comparison could be made (i.e. clone mCTG 
56, Figure 4.4, Figure 4.7), is there no change in the number  o f  
repeats.  Furthermore,  there are no examples in the work p r e s e n t e d  
here, where the CAG/CTG tr inucleotide  repeat identified in m o u s e  
sequence is smaller than in the comparable human sequence. This is 
a small sample number  and any general conclusion will have to b e  
tested with more comparisons.  The isolation of human h o m o lo g u e s  
for more of the mouse genes containing CAG/CTG t r i n u c l e o t i d e  
repeats  presented here in this work would help in extending th i s  
o b s e rv a t io n .
This data is also consis tent with the work of Beckmann and W e b e r  
(1992) whose survey of rat and human microsatel li tes  i n d i c a t e d  
that in general, rodent microsatel li tes  were longer than h u m a n  
microsatel l i tes .  However,  it was not indicated whether  r o d e n t  
microsatel l i te  sequences that were conserved at o r th o lo g o u s  
posit ions  between distantly related mammalian species were la rge r .  
A separate trinucleotide microsatelli te study (Stallings, 1994) f o u n d  
that there was some evidence of conservat ion of t r i n u c l e o t i d e
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repeats  at the same position, but in evolut ionari ly  distant m a m m a l  
species and those examples  studied were a small fraction of t h e  
overall  number  t rinucleotide  repeat  microsatel li tes  analysed a n d  
these tended to be in protein coding sequences. Of those e x a m p l e s  
indicated,  one had larger repeats  in the rodent gene, one larger in 
the human gene (these, were both in the same gene, the a n d r o g e n  
receptor) and two did not have the repeat conserved in the h u m a n  
gene sequence. The final example had an identical number  of a m i n o  
acids in the human and rodent gene sequence. This n o n  
conservat ion is not a general observat ion about microsatell i tes.  I n  
separa te  studies, looking at (GT)n/(CA)n and (CT)n /(GA)n  
dinucleotides ,  Stallings (1991 and 1995, respect ively)  showed t h a t  
there is some degree of conservation at orthologous positions f o r  
these microsatel li tes  and in the work dealing with the (GT)n/(CA)n  
dinucleotides  (Stallings, 1991), it is indicated that there is m o r e  
conservation between more closely related mammalian species t h a n  
more distant ly related ones.
4.7.4 Clones  that are s imilar to other sequences.
At first sight there appears to be no similarity in g e n e r a l  
function between any of the clones that have similarity to k n o w n  
proteins.  However  seven of the nine genes which have k n o w n  
functions, are nucleic acid binding proteins.  Three bind DNA ( tw o  
d o u b le - s t ran d ed  DNA, 24, 57; one s ingle-s t randed DNA, 23) a n d  
three bind RNA (clones 29, 410, 411). A final clone, mCTG 56, s h o w s  
identity to both a DNA binding transcription factor (Zfml;  Toda et al, 
1994) and an RNA binding protein (SFl ,  a splicing factor; Arning e t  
al,  1996)
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In addition, all the nine proteins are known to f o r m
complexes  with other proteins. This should be no surprise,  since as
ment ioned  in the Introduct ion (Section 1.9.1), g l u t a m i n e  
hom opep t ides  have been shown to adopt a specific t e r t i a r y
structure which will enable them to behave as p r o t e i n - p r o t e i n  
interaction domains. This however would only apply to repeats  t h a t  
were proved to be translated into glutamine tracts. Most of t h e
repeats that occur in genes whose proteins have a defined func t ion ,  
appear  to encode glutamine homopeptides.  Five encode g l u t a m i n e s  
(clones 23, 24, 410, 56 and 57), three are undef ined (clones 29, 4 6 
and 59) and one encodes a serine repeat (clone 411).  The final c lone  
63 occurs in presumed 3' UTR sequences. This clone will b e
discussed further in Chapter  6.
4.7.5 M ult ip le  hits with genes  of  known function.
In database searches, it is often the case that there is no
similarity with a known sequence and if there is, the s e q u e n c e  
found may not have any assigned function. Just as perplexing m a y  
be the case when multiple genes of known function are i d e n t i f i e d  
by a single sequence. This is the case with clones 43 and 56 in th is  
study. They appear  to have remarkable  similarity to either two (in
the case of clone 56) or three (in the case of clone 43) genes.
For clone mCTG 43, these genes are a mouse b e t a - 1,4-  
ga lac tosy lt ransferase ,  a mouse calcium binding prote in PW29 a n d  
the Rad21 protein which is involved in doub le - s t rand  break r e p a i r  
in eukaryotes.  All have been character ised by different g roups .  
Clone 56 shows identity to the splicing factor, SFl (Arning ct al, 
1996): the transcription factor Zfml (Toda et al, 1994) and a m o u s e
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cDNA, C W 17. The sequences all appear to share identical N - t e r m i n a l  
domains (Figure 4.12).
This can have occurred because of a few reasons. Firstly t h a t  
the sequence presented here represents  a common domain s h a r e d  
by separa te  genes. Alternatively  this sequence may r e p r e s e n t  
shared exons between these genes. Another  a l ternat ive e x p l a n a t i o n  
is that they are the same gene and separate groups working in  
separate specific fields of interest have only partially identified t h e  
functions of a single gene product.  The identification of such c ross  
references  is likely to be a by-product  of random screens such as  
this work. There are reports of EST and STS sequences g e n e r a t e d  
from separa te  mass DNA sequencing exper iments  being c l u s t e r e d  
into groups of related sequence (grouped together  by p r o g r a m m e s  
such as Beauty; Worley ct al, 1995). This is exempli fied  by t h e  
multiple ESTs that have been found to have similarity to Clone 
mCTG 29 (Section 4.4.3 and Figure 4.7) and Clone mCTG 12 (Sect ion
4.5.1 and Figure 4.14.A). However, as far as it is known, t h e  
examples  presented here are the first grouping of sequences w h ic h  
encode proteins of known functions.
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Chapter 5
Further  Character isa t ion  O f  Selected  Clones.
7 1
5.1 In troduct ion
Because this research is focused on develop inen ta l ly  r e g u l a t e d  
genes which contain CAG/CTG tr inucleotide  repeats,  the criteria f o r  
selecting clones for further  study were: the size of the repeat (as  
described in Chapter 3), initial expression data (as descr ibed by t h e  
reverse  northern data in Chapter 3) and presumed novelty. In th i s  
last  respect,  after initial database searches using sequences f r o m  
these clones, four clones from the 8.5 and 12.5 dpc whole m o u s e  
embryo  cDNA libraries were selected for further  c h a r a c t e r i s a t i o n .  
These were mCTG 26 and 210 (from the 8.5 dpc whole m o u s e  
embryo cDNA library) and clones mCTG 61 and 63, both from t h e
12.5 dpc whole embryo cDNA library (Logan et al, 1992) .  
Subsequent  database searches identified sequences  in the d a t a b a s e  
which show similarity to some of these cloned genes.
For the character isa t ion of a gene it is important  to k n o w  
whether  it is a single copy gene or belongs to a family of r e l a t e d  
genes, where and when it is expressed in the embryo and the a d u l t  
organism, if there are single or multiple transcripts  and the size o f  
messenger  RNA(s). Reverse dot blotting experiments (Chapter 3, this 
work),  gives valuable information about the expression levels o f  
these genes, but does not give either the size or numbers  of mRNA 
species. Elec trophoretic separat ion and subsequent  hybrid isa t ion o f  
RNA species (northern blot) with probes derived from specif ic  
clones will allow the de termina tion  of the size of the m e s s e n g e r  
RNA species and whether multiple mRNA species exist.
The previous Chapters detailed two routes to character ise  c lones  
identified from the 8.5 and 12.5 dpc whole mouse embryo l ib ra r ie s .  
Firstly, reverse  dot-blot exper iments  were used to identify c lones
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which showed expression in embryonic or adult mouse t i ssues .  
Secondly, DNA sequencing was employed to character ise  the r e p e a t .  
This Chapter  presents the further molecular character isa t ion  of f o u r  
selected clones, mCTG 26, 210, 61 and 63. This will cover the fu ll  
sequencing of the clones isolated, initial character isa t ion  of t h e  
genomic organisation of the sequences and genes from which t h e  
cDNA clones were derived from and finally character ise  the mRNA 
species expressed  at time points through deve lopm ent  and in  
selected adult t issues (brain and liver).
5.2 Further analysis  o f  Clone mCTG 26.
This clone was originally derived from the 8.5 dpc w h o le  
mouse embryo library (Hogan et al, unpublished) .  It was found to  
be present  in lower amounts  in adult tissues, than in e m b r y o s .  
Within adult tissues it appeared to be more abundant  in m o u s e  
brain compared to liver. Initial sequence analysis indicated that th i s  
clone had a perfect trinucleotide  repeat of 12 repet it ive units. W i th  
this pre l iminary information, further  character isa t ion  w a s  
u n d e r t a k e n .
5.2.1 Sequence  analysis  of  Clone mCTG 26.
In order to obtain a complete sequence of this clone, a s e r i e s  
of end deletions was generated using the Erase-a  base k i t  
(Promega)  and sequenced. A summary of the deletions o b t a i n e d  
and clone information is given in Figure 5.1. The ABl a u t o m a t e d  
sequencing apparatus with adapted, extended sequence p r i m e r s ,  
T 3 / T 7 a  and bT7 was used. The sequence was assembled using the
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Figure  5.1
A )
B g l  II E c o  RI
‘ ■■
(CTG) 4,7
KH3.2
KH2.1
KH2r3
T7 13
B)
1 0  3 0  5 0
G A A T T C A T G T C T T A C G G T C A A G G G A C A A C G G C C C C T G G C A G C C G C T C G G C C C C C T C A G A G
C T T A A G T A C A G A A T G C C A G T T C C C T G T T G C C G G G G A C C G T C G G C G A G C C G G G G G A G T C T C  
7 0  9 0  1 1 0
C C C T T T C T G T T T A A C A G A G A C C G C T C G T T G C C G A T G G G T C C T G G T C T G T G C T C C T r G C T C
G G G A A A G A C A A A T T G T C T C T G G C G A G C A A C G G C T A C C C A G G A C C A G A C A C G A G G A A C G A G  
1 3 0  1 5 0  1 7 0
T G T G C A G A G C C T T G T T C T G A G T C C T T G T G C T C C G C C T G C T T C T G A G C T T G G T C C T T G T G G
A C A C G T C T C G G A A C A A G A C T C A G G A A C A C G A G G C G G A C G A A G A C T C G A A C C A G G A A C A C C  
1 9 0  2 1 0  2 3 0
C T G T C G G C C T T A G T A T C C C G C C A G G C C A G G C C C G C T A A T T T C C T C A G G G T T G A G A G T G C C
G A C A G C C G G A A T C A T A G G G C G G T C C G G T C C G G G C G A T T A A A G G A G T C C C A A C T C T C A C G G  
2 5 0  2 7 0  2 9 0
A T A T G G G G A A C C T G C G C T G A G G A G G G C A G A C T A C T C C C G A G A C T C A G C A C T C A A T C A A C G
T A T A C C C C T T G G A C G C G A C T C C T C C C G T C T G A T G A G G G C T C T G A G T C G T G A G T T A G T T G C  
3 1 0  3 3 0  3 5 0
C C A C T A T C T C C C T G G C T G C T C T T A A A C C C C T C T G A G G T G C C A G G C T C A G T A C T G C T G A A G
G G T G A T A G A G G G A C C G A C G A G A A T T T G G G G A G A C T C C A C G G T C C G A G T C A T G A C G A C T T C  
3 7 0  3 9 0  4 1 0
G C A G T G A C A G C T G T C C T C C A T G A G T C A C T G G C G G C G C C C T G C A C A G G G A G G G C T T G G C T G
C G T C A C T G T C G A C A G G A G G T A C T C A G T G A C C G C C G C G G G A C G T G T C C C T C C C G A A C C G A C  
4 3 0  4 5 0  4 7 0
C T G T T C T C C C A A G A T C T C A G T G C C C A G C T G C T G C C A G G C A C A A T C A C A T C T T C T C A G A C A
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G A C A A G A G G G T T C T A G A G T C A C G G G T C G A C G A C G G T C C G T G T T A G T G T A G A A G A G T C T G T  
4 9 0  5 1 0  5 3 0
C A G G C C G T T C T G C T T T T T A G C A A A C C G A G G A G G A A T C C G G G A T G A A A G G C C C C G A C C T T T
G T C C G G C A A G A C G A A A A A T C G T T T G G C T C C T C C T T A G G C C C T A C T T T C C G G G G C T G G A A A  
5 5 0  5 7 0  5 9 0
G A C A G G C A C C T G A G C A G C C T G T T C T T T T T T T C T T C T C T C C T C C T C C A G C A G G C G A C G C T G
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C T G T C C G T G G A C T C G T C G G A C A A G A A A A A A A G A A G A G A G G A G G A G G T C G T C C G C T G C G A C  
6 1 0  6 3 0  6 5 0
C T T C T T G G T C A G G A C T T C A A T G A A G C C T T C A C C C A C C A C A G A G C T T G C T T C A T T C T C T T C
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G A A G A A C C A G T C C T G A A G T T A C T T C G G A A G T G G G T G G T G T C T C G A A C G A A G T A A G A G A A G
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F igure  5 .1 .B  ( cont inued)
6 7 0  6 9 0  7 1 0
C C C A G G G C T G G A G G C G C A G T T G T C A A T G A G A G C A T T T C C A T A G C C C A G G T C A A A C T G C T T
G G G T C C C G A C C T C C G C G T C A A C A G T T A C T C T C G T A A A G G T A T C G G G T C C A G T T T G A C G A A  
7 3 0  7 5 0  7 7 0
C C G G G C C T C T T C C T G C T C A C T A G C C C T C T G G G T A G G C A A A G A A A C C T C T C T C T C T G A T T T
G G CCCG G A G A A G G A C G A G T G A TC G G G A G A C C C A TC C G TT TC TT TG G A G A G A G A G A C T A A A  
7 9 0  8 1 0  8 3 0
C T T A C T G G G G G T T T C A G G A C C G T C A G A G C T G G C G T G A G T G G T T C T C T C C A A G G C A T A G G G
G A A TG A C C C C C A A A G T C C T G G C A G T C T C G A C C G C A C T C A C C A A G A G A G G T T C C G T A T C C C  
8 5 0  8 7 0  8 9 0
T G A A T G G C TG C C A A G G C C TC C A G G C A A G G C C TC A TC TG G A G A C C TG A A G G A TG C A G G G C T
A C T T A C C G A C G G T T C C G G A G G T C C G T T C C G G A G T A G A C C T C T G G A C T T C C T A C G T C C C G A  
9 1 0  9 3 0  9 5 0
G A G G G G TA G A A G TC C A C G G G C G T C C G T G T C G G G G T G A TG C G TG G G TC C A TG TA G G A A G G C
C T C C C C A T C T T C A G G T G C C C G C A G G C A C A G C C C C A C T A C G C A C C C A G G T A C A T C C T T C C G  
9 7 0  9 9 0  1 0 1 0
A TC A TC A TC C A C C G T G G G T C A A A G C C C A G C A T C T G G G G G T G G T G T G G G T A G A A G G T G C G C
T A G T A G T A G G T G G C A C C C A G T T T C G G G T C G T A G A C C C C C A C C A C A C C C A T C T T C C A C G C G  
1 0 3 0  1 0 5 0  1 0 7 0
T G G G G G TG A G A A G G TG G G G G G TA G A C C G G C TG C C A G TG C TG C A TG C G TT G T A C A G C G T G C
A C C C C C A C T C T T C C A C C C C C C A T C T G G C C G A C G G T C A C G A C G T A C G C A A C A T G T C G C A C G  
1 0 9 0  1 1 1 0  1 1 3 0
T C C T G C T G C T G C T G C T G C T G C T G T T G C T G C T G T T G C T G C IT IC C G T G G C G C T G G A A A C G G G
A G G A C G A C G A C G A C G A C G A C G A C A A C G A C G A C A A C G A C G A C G G C A C C G C G A C C TT TG C C C  
1 1 5 0  1 1 7 0  1 1 9 0
G A G G A A G G A C T T C T G G T A C T T G C T G A A C T C C T G T G C A G G G G G A T C A C G G A C T C G C C G G A C
C TC C T T C C T G A A G A C C A T G A A C G A C T T G A G G A C A C G T C C C C C T A G T G C C T G A G C G G C C T G  
1 2 1 0  1 2 3 0  1 2 5 0
T T C C T C C T C G A T G C T G C T A C T G C T G C T A C T G C T G C T G C T G C T A T T G C T C T G A G C G A C T G T
A A G G A G G A G C TA C G A C G A TG A C G A C G A TG A C G A C G A C G A C G A TA A C G A G A C TC G C TG A C A
1 2 7 0
T G G G G A T G T T G C A G G T G T C T C
1 2 6 1   +  + -  1 2 8 1
A C C C C TA C A A C G TC C A C A G A G
Figure 5.1 Full nucleotide sequence of  Clone mCTG 26.
A) Diagrammatic  represen ta t ion  of Clone mCTG 26. Yellow b a r  
represents  the whole clone, the CAG/CTG tr inucleotide r e p e a t  
r ep resen ted  in black and the numbers of repeats in red text. Blue
bars represent  the exo 111 deletion clones used for sequencing t h e
rem ainder  of Clone mCTG 26. The thin black bar represents  t h e
500bp BglU- BaniHl  fragment of Clone A26KH32 which was used as
a probe for subsequent  Southern and northern analysis.  B) DNA
sequence of this clone, derived by the end sequencing of c lones
derived from an exonuclease III deletion library of Clone mCTG 2 6 
(indicated on Figure 5.1.A) The CAG/CTG tr inucleotide repeats  a r e  
indicated by red coloured sequence. Corruptions of the repeats  a r e
in blue (TTG) and green (CTA).
1 7 5
MacAlign package (IBI). The full nucleotide sequence is r e p r o d u c e d  
in Figure 5.I.B. Sequence derived from clone 26 was in i t ia l ly
analysed, firstly for open reading frames using Pickett 's m e t h o d
(Fickett , 1982) as part of the Mac Vector sequence package (IBI).  
Addit ional  analysis was performed on the UWGCG Gene A n a ly s i s  
Package (Devereux et al, 1984) version 8.1. No open reading f r a m e  
was detected by the application of Pickett's a lgor ithm (Fickett ,  
1982) .
5.2 .2  Southern  blot ana lys is  with s e q u e n c e  in Clone mCTG
2 6 .
A 500 bp Bam U \-  BglU  central f ragment of a deletion l i b r a r y  
derived clone, A26KH32 (Figure 5.1) was used to probe m o u s e  
genomic DNA digested with the restriction enzymes EcoRl, H i n ô l l l  
and B a m U l .  This yielded single fragments  of sizes 14.5, 7.3 and 4.1 
kbp respectively.  This probe does not contain the t r i n u c l e o t i d e
which precludes  cross reaction of repeti t ive sequences abundant  in 
the genome. The results are displayed in Figure 5.2.
5.2.3 Further  expression analysis of  Clone mCTG 26.
In order to character ise the messenger  RNA species that a r e  
der ived from the mCTG 26 cDNA clone, nor thern blot analysis w a s  
performed on electrophoret ica l ly  separated total RNA. Total RNA 
was derived from the previous time points used as templates  f o r  
the first  strand probes for the reverse dot-blot experiments
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Figure 5.2 Southern analysis of Clone mCTG 26.
lOpg of genomic DNA was digested with the restriction enzymes E 
(Ecy^ RI), H (/// /7dIII) and B They were probed with a 5 0 0
bp 5^^/II-^c//77Hi fragment of clone A26KH3.2 which does not co n ta in  
a t rinucleotide  repeat.
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(Chapter 3). The 500 bp BamYW-BglW  internal fragment was used as  
a template  to derive a random primed, radio-act ively  l a b e l l e d  
probe. This yielded results which were, in the most part, c o n s i s t e n t  
with those of the reverse dot-blot experiment .  However t h e r e  
appears to be an absence of expression in the adult  liver. The l e n g th  
of the mRNA(s) corresponding to the broad band detected by t h e  
500 bp B a i n \ \ \ - B g l \ \  derived probe was measured  to be between 9 
to 12 kb (Figure 5.3).
5.3 Further analysis  o f  Clone inCTG 210.
This was a clone derived from the 8.5 dpc whole m o u s e  
embryo cDNA library (Hogan et al, unpublished) .  Sequence a n a ly s i s  
had revealed that it contained a cryptic CAG/CTG trinucleotide.  I t  
had no detectable expression in the reverse dot-blot experiments.
5.3.1 Sequence  analysis  of  Clone niCTG 210.
Fragments  of sequence data from both automated s e q u e n c e  
(Perkin Flmer) and manual sequence (derived from using T7 
po lym erase  kit, Pharmacia)  were assembled together  using t h e  
MacAlign programme (IBl). A contiguous sequence was derived a n d  
exported  to the sequence analysis package MacVector  (IBl) fo r  
further  analysis.  The sequence of clone mCTG 210 is descr ibed in 
Figure 5.4. The clone was found to be 906 nt in length b y  
sequencing. No open reading frame was identified from a p p l ic a t io n  
of Pickett's Testcode Algorithm (Fickett, 1982). No sequences w e r e  
identified when the sequence of  clone mCTG 210 was used to s e a r c h  
nucleic acid databases with the FASTA algorithm.
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Figure 5.3 Northern h lot of Clone inCTG 26.
Approximate ly  10 pg of total RNA from 8)  8.5 dpc whole e m b r y o s ,  
12 )  12.5 dpc whole embryos 17)  17.5 whole embryos,  B) m o u s e  
brain, adult and L) adult mouse liver were probed with a 500 b p
B g l \ \ -B (u n U \  radioactively labelled fragment of clone A26KH3.2
which does not contain a repeat. M easurements  are in k i l o b a s e s
(kb). A fragment of a mouse GAPdh cDNA was used as a lo ad ing  
control.  18S and 288 indicate the major ribosomal RNA bands.
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5.3.2 Southern analysis of Clone niCTG 210.
A 400 bp S m a l -E c o R l  fragment of the original clone 210 w a s  
used to probe mouse embryonic  stem cell genomic DNA u n d e r  
s tr ingent  hybrid isat ion and wash conditions (detailed in Chapter  2, 
Section 2.22). This yielded a single band for &Y)R1 (7.3Kb) a n d  
B a m H l  (3.4Kb) respectively (See Figure 5.5.B).
This exper im ent  was repeated, but the sequence w h ic h  
represent the remainder  of clone 210 was used as a probe (a S m a l -  
EcoRl  f ragm ent  550 bp in size). This f ragment  gave a m u l t i p l e  
banding pattern (Figure 5.5.A). This probe contains the r e g io n  
known to contain the trinucleotide repeat (as described in s e q u e n c e  
analysis. Chapter 4, this work).
5.4 Further analysis  o f  Clone mCTG 61.
This is a clone derived from the 12.5 dpc whole m o u s e  
embryo cDNA library. From initial sequencing data, it was found to  
contain a large un in te r rup ted  tr inucleot ide repeat,  25 repeat  u n i t s  
in size (Chapter 4, this work). It had no detectable  expression lev e l s  
in the reverse dot-blot experiments .  A nor thern blot e x p e r i m e n t  
was conducted but showed no detectable expression either (data not 
shown). Southern analysis was also performed to de termine  t h e  
genomic organisation of sequences represented  in clone 61. F u r t h e r  
sequencing was conducted to fully sequence the clone, in order to  
discover any patterns that may help in further  charac ter isa t ion  of  
this gene.
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Figure 5.4 S eq u en ce  of Clone mCTG 210: A) T3 p r i m e d
s e q u e n c e ,  B) T7 primed se q u e n c e  and C) d i a g r a m m a t i c  
r e p r e s e n t a t i o n .
Sequence was derived from priming DNA sequencing r e a c t io n s  
using derivat ives  of the T3 and T7 primers which prime s e q u e n c e  
from the multiple cloning site of pBluescript  KS-. The CAG/CTG 
trinucleotide repeats found in this clone are indicated in r e d  
sequence.  No over lapping sequence was detected. Black b a r s  
indicate the 400 and 500 bp S m a \ -E c o R \  f ragments  of Clone mCTG 
210 which were used as probes in the Southern experiments.
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Figure 5.5 Southern analysis ol Clone mCTG 210
Ten microgranis of mouse genomic DNA was digested with t h e  
restriction enzymes: EcoRl  (E), BamHl  (B) and HincWU (H) a n d  
probed with a 550 bp S ma \ -Ec oR \  fragment (+CAG) and a 400 b p  
S m a \ - Ec oR \  fragment (-CAG).
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5.4.1 Sequence analysis of Clone niCTG 61.
Manual sequencing did not reveal the whole sequence of th i s  
clone. Automated sequencing was performed using the ABI s y s t e m
(Perkin Elmer) to extend and complete the sequence from this clone.
The cumulat ive  data for clone 61 was first conver ted  i n to
MacVector  (IBI) format sequence files for import and assembly i n to  
continuous sequence by the MacAlign sequence assembly s o f t w a r e  
package (IBI). The contiguous sequence was re -expor ted  to
MacVector  for further  analysis. No open reading frame was f o u n d  
using Pickett 's  algorithm (1982). The sequence is rep resen ted  in  
Figure 5.6.
5.4.2 G enomic  organisat ion of  Clone inCTG 61.
Southern blot analysis was conducted using a random p r i m e d  
probe, generated from a 650 bp H in dW- Hi néW  f ragment  of t h e  
original sub-clone of mCTG 61 (Figure 5.6.A). Sequence analysis h a d  
de te rm ined  that the large tr inucleotide  repeat was not c o n t a i n e d  
within this fragment.  Radio- labelled probe from this H i n é W  
f ragm ent  identified single bands under  st r ingent  h y b r i d i s a t i o n  
condi tions to restriction enzyme digested mouse genomic DNA, 
which was s ize-separa ted by agarose gel e lectrophoresis .  T h e  
individual fragment lengths identified were; 4.2 kb for Ecy;RI, 9.7 k b  
for B a m H l  and 3.8 kb for the HindWl  digested genomic DNA (F igu re  
5.7).
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Figure 5.6 Full nucleotide sequence of  Clone niCTG 61.
A) The full DNA sequence of Clone inCTG61.  This was derived f ro m  
an assembly (using the MacAlign programme, IBI) of Clone mCTG 61 
derived sequences generated by both manual T7 p o l y m e r a s e  
sequencing (Pharmacia)  and f luorescent- label l ing  DNA cycle  
sequencing (Applied Biosystems). The trinucleotide  repeat is 
indicated as red coloured sequence. B) Diagrammatic  r e p r e s e n t a t i o n  
of Clone mCTG 61 ; the black bar represents  sequences used as a 
probe for the northern and Southern blot exper iments  (a 650 b p  
H i n d \ \ - H i n d U ) .  T3 and T7 indicate the orientation of the s e q u e n c e s  
rep resen ted  relative to the multiple cloning site of pBluescr ipt KS-. 
The trinucleotide in this clone is indicated as a black bar within t h e  
yellow section, with the repeat number  indicated in red.
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5.5 Further analysis of Clone inCTG 63.
Clone mCTG 63 also derives from the 12.5 dpc whole m o u s e  
embryo  cDNA library. This clone is of primary interest because i t  
contains  the longest uninterrupted CAG/CTG repeat identified in this 
study, extending to 26 trinucleot ides.  This sequence was also f o u n d  
to have high expression during deve lopm ent  and in the a d u l t  
t issues tested. Reverse slot blot experiments (see Chapter  3) s h o w e d  
that, although expression levels were high they were also v a r i a b le ,  
compared to other highly expressed sequences.
5.5.1 Sequence  analysis  of  Clone niCTG 63.
Manual sequencing yielded reliable sequence from only o n e  
end of this clone. This sequence was found to have similarity to a 
group of human 3' ESTs derived from independent  mass s e q u e n c i n g  
projects based on cDNA libraries from different  t issues (see F ig u re  
5.8.A and B). This is in agreement  with the wide spread e x p r e s s i o n  
of the mouse clone during deve lopm ent  and in adult tissues a s  
observed from the reverse dot-blot exper iments  described in 
Chapter 3. The regions of overlap were found to be similar in all t h e  
matches and therefore these probably represent sequence from t h e  
same gene. The result  are shown as a pileup p rogram m e output in  
Figure 5.8.B. The clone itself had a large po ly-adenosine  s t r e t c h  
(46nt) with a strong po ly-adenyla t ion  signal upstream of it ( s e e  
Figure 5.8.A). Further  sequencing showed that it contained t h e  
largest repeat found so far in this work (26 repeats) and that this
1 8 7
Figure 5.7
k b p
23.0
9.4
6.6 -  
4.3
E H B
y
9,7
4.2
3.8
2.3
Figure 5.7 Southern analysis of Clone mCTG 61.
Mouse genomic DNA was restricted with three enzymes: EcoRl  (E), 
B am Ul  (B) and HindWl  (H). The digested DNAs were probed w i t h  
sequence derived from a 650 bp /7/7k1II-7//7?dII of clone mCTG 61. 
This fragment does not contain CAG/CTG repeat sequences.
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was CTG in the coding strand in the putative 3' end of the transcript.
This perhaps could be taken as an analogy for the repeat in t h e
myotonic  dys trophy protein kinase (Brook et al,  1992), where a 
large CTG repeat exists in the 3' untranslated region.
Automated  sequencing provided sequence data from t h e
opposite end of the clone. Sequence from this end was found to  
have identity to a human clone JC310, isolated by J. Colicelli and M. 
Wigler (Colicelli et al, 1991) who identified JC310 as a f u n c t io n a l  
inhibitor of the RAS protein. Alignments  show that the sequence o f  
clone mCTG 63 shows a high degree of conservat ion with JC310 a t  
the nucleotide level (Figure 5.8.C). This is also true at the p r o t e i n  
level (see Figure 5.8.D). Respectively, the percentages  of s im i l a r i t y  
are 87.5% and 92%.
5.5.2  G enomic  organisat ion of  Clone inCTG 63.
A 1.5kb H i n d U l - E c o R l  fragment of the original mCTG 63 c lo n e  
was used to probe mouse genomic DNA derived from an ES cell l ine. 
This sequence represents  the probable 3' end of the gene, as i t  
contains a poly-A tail as well as a high quality poly-A s ignal  
consensus sequence upstream of the poly-A tail. This yielded t h r e e
single bands, one for each restricted DNA (with single e n z y m e s  
E c oR l ,  B a m H l  and Hindl l l ) .  The detected restriction f ragments  w e r e  
of sizes 5.2 kb, 3 kb and 2.4 kb respect ively (as shown in F ig u re  
5.9). This 1.5 kb H i n d l l l - E c o R l  f ragment contains the t r i n u c l e o t i d e  
repeat and a poly-A tail. A combinat ion of the tr inucleotide r e p e a t  
and a mononucleotide stretch results in a repetit ive banding pattern 
seen in exposures longer than one day.
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Figure 5 .8 .A
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Figure 5 .8 .A D ia g r a m m a t ic  r e p r e s e n ta t io n  of  Clone inCTG 
6 3 .
Clone mCTG 63 sequences are represen ted  by a yellow bar. T h e  
regions of  homology to the human RAS protein inhibitor is i n d i c a t e d  
by the blue bar and the sequence that shows similarity to v a r i o u s  
human and mouse ESTs is rep resen ted  by a thick green bar. T h e
black bars show the f ragments  which were used to d e r i v e
radioact ively  labelled probes for Southern and nor thern  a n a ly s i s  
{i.e. 1.0 and 1.5 kbp £'coRl-/// /7dlII fragments) .  The position of t h e  
CAG/CTG trinucleotide  is indicated by the black bar inset into t h e  
yellow bar and the length of the repeat is indicated in red text. T3
and T7 indicate the orientation of the insert relative to the m u l t i p l e
cloning site of pBluescript KS-.
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6 1 6 5 6 4 ---- ------------------------------------------------------------------------------------------------------------ --------
a a l9 9 8 1 5  -----------------------------------------------------------------------------------------------------
W93359
n 9 8 9 3 1
W81207
h 2 5 9 2 7  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
h 2 7 6 6 8
n 6 5 9 7 5
h 2 8 3 1 8
h 0 5 6 3 3  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
1 4 4 1 3 5  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
h 2 4 2 9 1
n 6 2 3 1 2  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
4 0 1  4 5 0
6 3  T T T C G G G A C C  A C A T T T G C T T  . . . C A C A A C A  C A C C A C A G T C  C A A C G A C C C A
a a l 0 6 2 1 0  T C T C C G T A G A  C C A C A T C T G T  C T C C A C A C C A  C A C C A C A G T C  C C A C G A C C C A
a a l 4 5 4 5 6  T C T C C G T A G A  C G A C A T C T G T  C T C C A C A C C A  C A C C A C A G T C  C C A C G A C C C .
n 7 9 0 6 7  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
1 4 0 9 7 6  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
6 1 6 5 6 4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Z41184---------------------------------------------------------------------------------------------------------
a a l 9 9 8 1 5  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
W93359
n 9 8 9 3 1
W81207
h 2 5 9 2 7  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
h 2 7 6 6 8
n65975
h 2 8 3 1 8
h 0 5 6 3 3  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
1 4 4 1 3 5  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
h 2 4 2 9 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
n 6 2 3 1 2  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Figure 5.8.B (continued)
63
a a l0 6 2 1 0
a a l4 5 4 5 6
n79067
140976
616564
Z41184
aa l9 9 8 1 5
W93359
n98931
W 81207
h 2 5 9 2 7
h27668
n 6 5 9 7 5
h28318
h05633
144135
h24291
n62312
451 500
AC..GGAACGC G ..... GC T.CCGAACG AGAG.AGA GGACTA.GT.
TGATGGAACGG AAAAGACGG GTCCCGAACG AGAGGAAGAG GGACTAAGTC 
..ATGGAACGG AAAAGACGG GTCCCGAACG AGAGGAAGAG GGACTAAGTC
5 0 1  5 5 0
6 3  A T . T C G T C G  T C G T C G T C G T C  G T C G T C G T C G  T C G T C G T C G T  C G T C G T C G T C
a a l 0 6 2 1 0  A T A T C G T C G  T C G T C G T C G T C  G T C G T C G T C G  T C G T C G T C G T  C G T C G T C G T C
a a l 4 5 4 5 6  A T A T C G T C G  T C G T C G T C G T C  G T C G T C G T C G  T C G T C G T C G T  C G T C G T C G T C
n79067---------------------------------------------------------------------------------------------------------
140976---------------------------------------------------------------------------------------------------------
6 1 6 5 6 4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Z 4 1 1 8 4 -----------------------------------------------------------------------------------------------------------------------------------------------------------
aa l9 9 8 1 5 ---------------------------------------------------------------------------------------------------------
W93359 --------------------------------------------------------
n 9 8 9 3 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
W81207 -----------------------------------------------------------------------------------------------------
h25927---------------------------------------------------------------------------------------------------------
h 2 7 6 6 8  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
n 6 5 9 7 5 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
h28318---------------------------------------------------------------------------------------------------------
h05633---------------------------------------------------------------------------------------------------------
144135---------------------------------------------------------------------------------------------------------
H 2 4 2 9 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
n62312---------------------------------------------------------------------------------------------------------
5 5 1  6 0 0
6 3  G T C G T C G T C G  T C G T C G T C G T  C G T C G T C G T C  G T C G . AGACG A G G C G C G G C A
a a l 0 6 2 1 0  G T C G T C G T C G  T C G T C G T C G T  C G T C G T C G T C  . . . G C A G A C C  G A G G T G T C G T
a a l 4 5 4 5 6  G T C G T C G T C G  T C G T C G T C G T  C G T C G T C G T C  . . . G C A G A C C  G A G G T G T C G T
n 7 9 0 6 7  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
140976---------------------------------------------------------------------------------------------------------
6 1 6 5 6 4 -----------------------------------------------------------------------------------------------------------------------------------------------------------
Z41184---------------------------------------------------------------------------------------------------------
a a l 9 9 8 1 5 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
W93359 -----------------------------------------------------------------------------------------------------
n 9 8 9 3 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
W81207 -----------------------------------------------------------------------------------------------------
h25927---------------------------------------------------------------------------------------------------------
h 2 7 6 6 8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
n65975 ~~~~~—-- —-  -------------     — ----------  — --------
h28318---------------------------------------------------------------------------------------------------------
h05633---------------------------------------------------------------------------------------------------------
144135---------------------------------------------------------------------------------------------------------
h24291---------------------------------------------------------------------------------------------------------
n62312 -----------------------------------------------------------------------------------------------------
9 4
Figure 5.8.B (continued)
6 0 1
6 3  T T C T A C T T A C  A G T T 'C G C G l’G  AAG
a a l 0 6 2 1 0  C C G T G G C C A T  T C T C C T A A C C  T C T A T C C A G T  C T C T C C G T C
a a l 4 5 4 5 6  C C G T G G C C A T  T C T C C T A A C C  T C T A T C C A G T  C T C T C G
n 7 9 0 6 7  ----------------------
1 4 0 9 7 6 ------------------------------
6 1 6 5 6 4 ----- ----------------------
Z41184--------------------
a a l 9 9 8 1 5  ----------------------
W 9 3 3 5 9  ------------------------
n 9 8 9 3 1  ----------------------
W81207 ----------------
h 2 5 9 2 7  ----------------------
h 2 7 6 6 8  ----------------------
n 6 5 9 7 5  ----------------------
h 2 8 3 1 8  ----------------------
h 0 5 6 3 3  ----------------------
144135 ----------------
M 2 4 2 9 1  ------------------------
n 6 2 3 1 2  ----------------------
Figure 5.8.B A l ig n m e n t  of  EST s e q u e n c e s  which s h o w  
similarity to Clone mCTG 63.
Two sequences  (aa 106210 and aa 145456) are derived from m o u s e  
cDNA clones. The rest of  the sequences represented here are h u m a n  
in origin and are derived from cDNAs. The tr inucleotide repeat is 
indicated in red text sequence. Note that both mouse ESTs contain a 
CAG/CTG tr inucleotide repeat.  The human EST sequences a r e  
indicated in two colours to show the sequence which s h o w s  
similarity to clone mCTG 63 sequences {i.e. green coloured text) a n d  
those which do not (yellow sequence).  Mouse EST sequence w h ic h  
shows similarity to mCTG 63 sequence is indicated in blue text.
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Figure 5.8.C and D Alignment of  the RAS inhibiting p r o t e i n ,  
JC310 and sequences  derived from Clone mCTG 63.
The sequences represented  here aie derived from T3-pr imed DNA 
sequences  reactions performed on Clone mCTG63 (63) a n d  
sequences derived from the RAS protein inhibitor, JC310 (Colicelli e t  
cil, 1991). C) represents  the nucleotide secpience al ignment and D) 
represents translations of these sequences.
1 9 7
Figure 5.9
kbp E B H
23.0 —
9.4__
6.6 —
4.3 —
—  3.0
2.3 —  -  —  2.4
F ig u re  5.9 S o u th e r n  ana lys is  of‘ c lone m C T G  63.
T h e  1.5 k b p  H i n d \ \ \ - E c o R \  f r a g in e i i t  w a s  u s e d  as a p r o b e  to d e t e c t  
m C T G  63 s p e c i f i c  b a n d s  in E c o R l  (E) ,  B a n i U \  ( B )  and H i n d U l  (H)
d i g e s t e d  m o u s e  g e n o m i c  D N A .
I 9S
Figure 5.10
kb 8 12 17 B L
—  _  28S
4.4
   3.5 kb
—  18S
1.35 —
0.24 —
t f - f f
GAPdh
F ig u r e  5.10 A n a ly s i s  of the  e x p r e s s i o n  of  Clone  inCTG 6 3 
w i th  1.5 kb f r a g m e n t .
10 pg of total RNA from 8.5 (8), 12.5 (12) and 17.5 (17) dpc w h o le  
embryos and from adult brain (B) and liver (L) was probed w i th  
rad ioac t ive ly - labe l led  sequences derived from the 1.5 kb HindVW-  
&Y;R1 fragment of Clone mCTG 63. This blot was re-probed w i th  
mouse GAPdh sequences as a loading control.
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Figure 5.11 E xpress ion  analys is  of  s eq u e n c e s  c o n t a i n e d  
within the 1000 bp /// /z d 111-E co  Rl fragm ent  of  Clone mCTG 
6 3 .
10 pg of total RNA from: embryonic stem cell (ES), 8.5 (8), 12.5 (12 )  
and 17.5 (17) dpc whole mouse embryos were probed w i th
sequences from the 1 kb fragment of Clone mCTG 63.
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5.5.3 Further expression analysis of Clone mCTG 63.
Radioac ti  vely- label led  DNA fragments  derived by r a n d o m  
priming from a 1.5 kbp E c oK l -H i nd l U  f ragment  of clone mCTG 6 3 
were used as a probe for hybridisat ion against total RNA s a m p le s .  
The RNA samples were derived from different embryonic stages (ES 
cells, equ iva len t  to 3.5 dpc p re - im plan ta t ion  embryo; 8.5 dpc; 12.5  
dpc and 17.5 dpc embryos)  and adult mouse tissues (brain a n d  
liver, derived from inbred strain C57BL/6J).  An mRNA calculated to  
be 3 to 4kb in size was detected in total RNA derived from 12.5 d p c  
embryos and adult  brain and liver. In a separate exper iment ,  u s in g  
the remainder  of clone 63 as a template  for a probe, two mRNAs in  
ES cell total RNA were detected but no expression was observed in 
RNA samples derived  from other sources (8.5, 12.5 and 17.5 d p c  
whole m ouse  embryos) .
5.6  D is c u ss io n .
The further  character isa t ion  of a few of the t r i n u c l e o t i d e  
repeat-containing clones described in this Chapter has lead to s o m e  
general observat ions .  These are: 1) the genes selected are s ing le
copy per haploid genome; 2) expression is more complex than f i r s t  
observed for the reverse dot blot exper iments  described in C h a p te r  
3. Character isa t ion  is incomplete and further  work will have to b e  
conducted to resolve the questions raised by the work presented.
All the genes which have been character ised appear  from t h e  
available genomic Southern blot hybrid isat ion analysis, to be s ing le  
copy genes.
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Messenger  RNA expression is more complex. Clone mCTG 2 1 0  
appears to produce a single transcript. Clone 26 also yielded a s ing le  
mRNA. However  the lack of detectable  expression in mouse l i v e r  
total RNA in the nor thern  blot exper im ent  using a partial f r a g m e n t  
of Clone mCTG 26 is contradictory  to the result of the reverse d o t -  
blot experiment (Chapter 3) in which a high level of expression w a s  
detected  with a he terogeneous  first strand cDNA probe d e r i v e d
from adult  liver. This may be explained by al ternative sp l ic ing  
events ,  where sequences  from a single gene are d i f f e r e n t i a l l y  
expressed in different  tissues and at different stages d u r i n g  
development .  This is possible because not all the sequences t h a t  
were used as a target for the reverse dot-blot were used as a p r o b e  
in the northern experiment  described in this Chapter. Therefore  t h e  
sequences omitted from the northern blot exper im en t  of th i s  
Chapter  may be expressed  in the liver. The c o m p l e m e n t a r y
experiment ,  using the other section of the clone, was not done. This  
was because of the presence of the tr inucleotide repeat  in th is  
fragment.  Repeats can affect the result of an experiment .  In th is  
Chapter (Figure 5.5) I have already shown the effect of t h e  
existence of a triplet repeat in a probe sequence; a multiple b a n d i n g  
pattern is observed in genomic sequence with a probe co n ta in in g  
the trinucleotide repeat of Clone mCTG 210. Furthermore Du boule e t  
al  (1987) observed a multiple banding pattern on poly A e n r i c h e d  
mouse RNA with a CAG/CTG rich Drosophila m e l a n o g a s t e r  OPA 
repeat probe. Attempts  to probe with sequences that c o n t a i n e d  
CAG/CTG repeats would yield similar results.
Clone 63 was a single copy gene as shown in genomic Southern
results (Figure 5.9) but expression of the sequences  in this clone is
likely to be complex. This is evident from the northern r e s u l t s
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presen ted  in this Chapter. A fragment containing the t r i n u c l e o t id e  
yielded a single broad band expressed through RNA extracted f r o m  
deve lopm ent ,  and adult  liver and brain. This replicates  the r e s u l t s  
of the reverse dot blot data for this clone described in Chapter 3 
(Section 3.3). However  in a separate  northern  experiment,  a p r o b e  
derived from the whole sequence of Clone mCTG 63 gave two b a n d s  
in embryonic  stem cell total RNA with no detectable  express ion in 
total RNA derived from embryo of several deve lopm en t  t ime p o in t s  
tested (Figure 5.11). These two transcripts are similar to t h o s e  
described for the human RAS protein inhibitor, JC310 (Colicelli et al, 
1991). J. Colicelli observed two transcripts  of 3 and 4 k b  
respect ive ly  (J. Colicelli, pers. comm.). This is contradic tory  to t h e  
nor thern  result .
This contradic tory  evidence from the two n o r t h e r n  
experiments  will require further analysis.  For example probing w i th  
the rem ainder  of the sequences of Clone mCTG 63 would allow t h e  
identification of sequences which contribute to a single band. It may 
also be possible that this clone is a chimaera. Although this is a r a r e  
occurrence, caution must be applied in any in terpre ta t ion  of t h e  
results.  This can be resolved with the isolation of the r e m a i n i n g  
sequence from this clone. This would allow for an analysis of o p e n  
reading frames contained within this clone, any d iscrepancies  in t h e  
reading frames may indicate putative a l ternat ive splicing e v e n t s  
giving rise to different  mRNA species and hence different i so fo rm s  
of the protein.
The effect of repeat  sequences (as part of probing s e q u e n c e s )  
on Northern and Southern analysis is clear from the e x p e r i m e n t s  
presen ted  in this Chapter (see Figure 5.5). This is not u n e x p e c t e d  
because trinucleotides  are known to be o v e r - r ep re se n ted  in
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mammalian genomes and it is not surprising that a probe c o n ta in in g  
repet i t ive  sequences  would tend to pick up many of the s e q u e n c e s  
sharing the sequence. Indeed this is the basis of the initial i so la t ion  
o f  t rinucleotide  repeat-contain ing sequences in this work, where a n  
o l igonucleotide containing 10 copies of the tr inucleotide CTG w a s  
used to screen mouse cDNA libraries. In addition triplet r e p e a t s  
were found to be repet it ive in eukaryotes  by cross h y b r id i s a t i o n .  
The original work on the Drosophi la No t ch  gene, described b y 
W harton  et al  (1985), where a single fragment from a Notch  cDNA 
clone gave a multiple banding pattern on genomic DNA. Duboule e t  
al  (1987) has showed a similar multiple banding pattern by using a 
OP A  repeat rich sequence to probe mouse mRNA.
In summary,  from the work described in this Chapter, it c a n  
be concluded that these genes selected here are single copy w i t h  
respect to the haploid genome. Their expression however,  m a y  
prove to be more complex than that observed from the reverse d o t -  
blot data. For example a sub-f ragm ent  of clone 26 used as a p r o b e  
for total RNA in the northern exper iment  is not expressed in m o u s e  
adult liver, whereas the reverse dot-blot exper iments  of Chapter 3, 
using the sequences of whole clone indicated that there w a s  
expression in mouse adult liver.
More work is required on these clones to take them to a s t a g e  
where a clearer molecular character isa t ion is achieved. This wi l l  
provide a strong base for the further study of these genes and t h e i r  
products  at the protein and cellular level. In addition we can u s e  
the information to drive towards picking tr inucleotide loci w h ic h  
are located in single copy sequence in the genome. This will help in 
mapping the sequences and the genes from which they are d e r i v e d  
f rom.
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C hapter 6 
C o n c lu d in g  Remarks.
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6.1 In troduct ion .
The overall aim of this work was to identify previously  u n ­
charac te r ised  genes that are expressed  during development .  T w o  
d iffe rent  approaches were used. The first approach involved t h e
analysis of enhancer  trap integration sites (see Appendix B), w h ic h  
had been pre-selected for deve lopm enta l  expression in head o r
neuronal structure by analysis of reporter  gene expression p a t t e r n s  
in chimaeric  embryos.
The second approach was based on part icular  features  of
d eve lopm en ta l ly  regulated genes. It involved the identificat ion of
expressed sequences from mouse embryonic  cDNA libraries w h ic h
contain CAG/CTG trinucleotide  repeats.  As discussed in the g e n e r a l  
in troduction there are several reasons to think that CAG/CTG 
repeats  may be found in deve lopm enta l ly  regulated genes. For  
example, it is known that many deve lopm enta l ly  regulated g e n e s  
from Drosophila m e l a n o ^ a s t e r  contain OPA repeats  which c o n ta in  
CAG triplet repeats (Wharton ct al, 1985). Many of these g e n e s  
encode transcript ion factors or other types of regulatory  p ro te in s .  
More recent ly  this type of t rinucleot ide repeat has been shown to 
be associated with a novel class of human diseases, the d y n a m i c  
muta t ions  (Ross, 1995). These diseases are character ised  by t h e  
instabili ty  of the tr inucleotide  repeat,  in which an u p w a r d
expansion of the trinucleotide copy number  is associated with an
increasing severity of disease. Although these diseases have as y e t
only been observed to occur naturally in H. sap iens ,  the best a n im a l  
model in which to study the diseases is the mouse. T h e  
character isa t ion  of repeats in mouse will provide a resource  f o r  
which to study repeat biology.
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The major merit of the enhancer  trap approach is the e a r l y  
identification of expression patterns that can be used as the basis of  
an informed choice of which enhancer  trap integra tion s i t e  
containing ES cell lines to study further  (see Appendix B). With t h e  
t r inucleot ide  repeat cDNA library screening approach th i s  
information  comes at the end of the expected process.  Screening of  
em bryon ic  cDNA libraries can be quicker  compared to t h e  
ident ification of flanking sequences from the enhancer  trap site. I n  
some cases the gene can be distant from the actual ETS a n d  
addi tional  cloning steps would be required for c o m p l e t e  
characterisat ion of the gene.
Another  advantage that the t rinucleotide  cDNA library s c r e e n  
has over ETS analysis is the high capacity for screening l a rg e  
numbers  of clones. This approach allows the identification of m a n y  
genes which can be analysed for sequence to find a n o n y m o u s  
sequences. The ETS analysis requires a lot of work initially to i so la te  
the appropria te  gene sequences  and then to compare with o t h e r  
sequences to establish whether it is a previously character ised  g e n e  
or not.
6.2 W hat  have we learnt?
6.2.1 L ib ra ry  screen ing .
The screening of mouse embryonic  cDNA libraries with a 
(CTG) 10 oligonucleotide has yielded many positive clones. These a r e  
similar in numbers to those isolated from human brain cDNA 
libraries (Riggins et al, 1992 and Li et al, 1993) and mouse a d u l t
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brain cDNA library (Abbott and Chambers,  1996) which had b e e n  
previously screened for CAG/CTG trinucleotide repeats.
The size of CAG/CTG tr inucleotide  repeats found in the m o u s e  
em bryonic  cDNA libraries screened here are most similar to t h o s e  
identified by the Li et al, (1993) study which used id en t ic a l  
conditions. The range of repeats identified in both these studies w a s  
large, although many were larger than 10 tr inucleotides in leng th ,  
the CAG/CTG repeats  identified by the other human study (Riggins 
et al, 1992) and the mouse adult brain cDNA library (Abbott a n d  
Chambers,  1996) are smaller.  The repeats  in these studies are all 
less than or equal to 10 trinucleotides  in length. This reflects e i t h e r  
less stringent hybridisation conditions, the absence of formamide,  a 
known nucleic acid secondary s tructure de-stab il iser ,  in t h e  
hybrid isat ion solution, or a smaller ol igonucleotide probe used fo r  
screening cDNA libraries. In the case of the adult mouse brain cDNA 
library screened by Abbott and Chambers (1996), a 15 m e r  
oligonucleotide was used to probe the library compared to a 3 0 m e r  
oligonucleotide used in this work and in the Li et al  (1993) study.
However  all studies described above identified s im i la r  
numbers  of t rinucleotide repeat containing clones i r respect ive of  
the screening conditions used. This may be because of the quality of  
cDNA library screened (C. Abbott, pers. comm.) or the way in w h ic h  
the library was constructed.  Alternat ive ly  it could be that t h e  
differing screening conditions have a predisposit ion towards t h e  
isolation of trinucleotide repeats of a certain size with an u p p e r  
l imiting value, dependent on the screening conditions used {e.g. t h e  
use of formamide and oligonucleotide probe length).
Partial sequence analysis of clones from the 8.5 dpc (Hogan e t  
al, unpubl ished)  and 12.5 dpc (Logan et al, 1992) mouse w h o le
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embryo  cDNA libraries identified CAG tr inucleotide  repeats in 21 of  
the 23 clones analysed in this work. This indicates that the l i b r a r y  
screening conditions were a success. Many of the repeats  w e r e  
corrupted  with base pair substitutions.
6 .2 .2  C o m p a r a t iv e  ana lys is .
The sequence data for the clones were used to search b o t h  
nucleic acid and protein databases  using FASTA (Lipman a n d  
Pearson, 1985) and BLAST (Altschul et al, 1990). This a n a ly s i s  
identified  that 10 were entirely anonymous  in that there was no  
s imilar ity to any nucleic acid or protein sequence in the d a t a b a s e s  
that were searched. A further  3 clones had identity to a n o n y m o u s  
sequences,  ESTs. The remaining 10 clones had some degree of  
s imilar ity or identity to genes, most of which (9), have a s s ig n e d  
functions. Three have identity to previously descr ibed mouse g e n e s  
(mCTG 43, Rad21; mCTG 56, C W 17; mCTG 24, nuclear receptor  c o ­
r e p r e s s o r ) .
Comparison of the repeats between species, where poss ib le ,  
shows that in most cases, the mouse repeat is longer than or e q u a l  
in length to the repeat found in the homologous human gene ( se e  
Figure 4.4). This can be taken as evidence for an asce r ta inm en t  b ia s  
where the screened species t rinucleotides are larger because of a 
positive selection for larger repeats over smaller repeats.  This is 
contrary to the idea proposed by Rubinzstein et cz/, (1995), p r o p o s e  
that there is a species specific difference in rates of m ic ro s a te l l i t e  
expansion in primate species, with humans possessing a m a r g in a l l y  
higher microsatel li te  mutat ion rate. Forty two i n d e p e n d e n t  
microsatell i te  loci were examined in a variety of primate  spec ies
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and it was found that the human loci were significantly larger t h a n  
those cognate repeats from other primate species.
An ascertainment bias between the two sets of data is a m o r e  
likely explanat ion.  This hypothesis  states that microsatel li tes  f r o m  
different species selected on a size basis will show larger repeats  in  
the screened species compared to the comparison species. T h e  
larger t r inucleotide repeats from this work in mouse tend to h a v e  
smaller  counterpar ts  in human genes. For example Clone mCTG 2 3 
which has a trinucleotide repeat 12 units in length; this repeat  u n i t  
is absent  from the human gene (the 70kDa subunit of r e p l ic a t io n  
protein A). This repeat encodes a polyglutamine tract in th i s  
p r o te in .
This leads to another observation. Most of the t r a n s l a t e d  
CAG/CTG tr inucleotides  encode polyglutamine tracts. In 5 out 6 
sequences for which a definite position can be de termined for t h e  
t r inucleotide within the coding region of a gene, by virtue of  
identity to other genes, the CAG repeat is translated into a 
po lyg lu tam ine  homopeptide.  This is not entirely u n e x p e c t e d  
because there is a tendency for this class of repeat to e n c o d e  
glutamines in Drosophi la  (Karlin and Burge, 1996). These are k n o w n  
as OPA repeats  (Wharton et al, 1985). Most of the genes in w h ic h  
these OPA repeats  occur are expressed  in deve lopm ent  and in t h e  
nervous system (Karlin and Burge, 1996). It has also been o b s e r v e d  
that g lu tamine homopept ides  are the most abundant  in e u k a r y o t i c  
proteins (Green and Wang, 1994). There has been no data p u b l i s h e d  
for mouse, but there are examples of proteins which c o n ta in  
po lyglu tamine  tracts, e.g. Brain 2 (a POU domain t r a n s c r i p t i o n  
factor, Hara et al, 1992).
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Another  feature that is striking is that a high proportion of the 
sequences  which have identity to previously character ised g e n e s  
are nucleic acid binding proteins.  Seven of the nine known g e n e s  
identified encode proteins that bind nucleic acids (either DNA o r  
RNA).
As mentioned  above, recent research has shown that a l a rg e  
num ber  of DNA binding t ranscript ion factors contain CAG 
trinucleotide repeats,  and that these repeats often encode g l u t a m i n e  
(Gerber  et a!, 1994; Karlin and Burge, 1996). Within these g e n e s  
that bind nucleic acids, there are examples  of transcript ion f a c to r s  
(clone mCTG 24 which shows similarity to the nuclear receptor  c o ­
repressor  and clone mCTG 57 which shows homology to t h e  
transcriptional adaptor  protein P300). This is however  a low o v e ra l l  
proport ion of the CAG/CTG repea t-con ta in ing  cDNAs and t h e r e f o r e  
the suggestion that there is a tendency for CAG repeats  that a r e  
translated as polyglutamine to occur in transcription factors,  may be 
false or at least have to be modified. It is presumed that t h e  
polyglutamine tract has an interactive property with other p ro te in s .  
With all the prote ins identified, it is known that they do i n t e r a c t  
with other proteins. This may indicate that proteins that i n t e r a c t  
with nucleic acids do so in conjunction with other proteins as part o f  
complexes  in many cases.
6.2.3 Larger  C A G /C T G  trinucleot ide repeats  are more l i k e l y  
to exist  in novel genes.
The t r inucleotide repeats in clones with similarity to g e n e s  
with known function are generally in the small to m edium  size 
spectrum (six to twelve repeats).  Larger repeats  isolated by th i s
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screen tend to be in clones which are likely to be in previously u n ­
characterised genes. This is an interesting observation.  This j u s t i f i e s  
the screen as an a ttempt to identify novel mouse genes. H o w e v e r ,  
this may be an artifact, as no com prehens ive  screen of mouse cDNA 
libraries for CAG/CTG tr inucleotide  repeats has been p r e v i o u s l y  
conducted and therefore the potential set of CAG/CTG t r i n u c l e o t i d e  
repeat-containing clones is large.
This also indicates that many of the larger CAG/CTG r e p e a t s  
reside in novel mouse genes. One aspect of their usefulness lies in  
the fact that they could be used more successfully as microsatellites.  
It has been observed that larger repeats are more likely to b e  
variable than smaller repeats (Weber,  1990). This could also p o i n t  
to par t icular ly  unstable repeats in the mouse, which may act a s  
models for uns table  human tr inucleotide repeats which have b e e n  
associated with diseases (Ross, 1995).
6.3 A n a ly s is  of  express ion .
A major goal of the work presented here was to i d e n t i f y  
developmental ly  regulated genes. This has been partially success fu l .  
This section will consider the results of this work.
From the work presented here it is interesting to point o u t  
that al though 1 have no information on the majori ty of the g e n e s  
examined in this work, of those which 1 do have information on  
their expression, some are highly expressed but do not c o r r e s p o n d  
to known genes. This indicates that there are many unknown g e n e s  
in the mouse which are still waiting to be discovered which are a s  
yet not character ised  in organisms which are far more advanced in 
the analysis of developmental processes.
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6.3.1 Reverse dot blots.
In an a t tempt to identify genes which are expressed d u r i n g  
development,  a technique was used which had a high capacity. This  
was necessary to analyse multiple clones at one time. The t e c h n i q u e  
which was used reversed  the normal northern procedure  by f ix ing  
the defined quant it ies  (i.e. the clones) to a nylon m em brane  a n d  
probing them with a probe derived from heterologous o l igo-dT 
pr imed first strand cDNA products.  This is known as r e v e r s e  
nor the rn  procedure .
Unfor tunate ly  the detection threshold of this exper im en t  w a s  
high. Although a few clones were detected as having h ig h  
expression, and some show differences  in expression (in the a d u l t  
tissues), most do not show any signal. Fur therm ore  the p o s i t iv e  
controls selected did not show any detectable  expression.  It w a s  
concluded that the sensitivity level of this experiment was low.
Nevertheless  a high sensitivity test of expression will need to  
be used in the future if the remaining clones from this work are to  
be charac ter ised  by their expression patterns during d e v e l o p m e n t  
and in adult tissues. One way to achieve this is by enrichment of t h e  
RNA sample (from which the first strand cDNA probe is p r e p a r e d )  
for poly A+ mRNA. This will effectively concentra te  mRNA 
molecules  which are derived from the genes corresponding  to t h e  
clones identified here.
RT-PCR would be another route to pursue. This r e q u i r e s  
sequence from the clones to be known so that pr imers  can b e  
designed which would amplify specific regions of a particular  c lone
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from first strand c D N A  products by PCR. This tech n iq u e  h a s
suff ic ient  sensit ivity.
In addition if the pr imers were to include the r e g io n
conta ining the CAG/CTG repeat,  the pr imers could be re-used f o r  
m apping  the gene by using congenic strains of mouse which a r e  
hybrids  of M. m u sc u l i i s  and M. s p r e tu s  species of mouse to a s s ign  
the genes to chromosomes and EUCIB backcross panel DNAs to  
locate them to 2-5 cM regions {e.g. McCallion et al, 1996)
6 .3 .2  N orthern  blot  analysis .
In an attempt  to broaden the expression informat ion d e r i v e d  
from the reverse northern experiments,  northern blots were used to 
character ise the expression of four selected clones. This uncovered a
level of  complexity in the expression of the genes from which t h e s e
sequences  are derived, that was not evident from the r e v e r s e  
nor thern  experiments.  For example sequences from d i f f e r e n t  
f ragments  of clone mCTG 26 appear  to be expressed in d i f f e r in g  
tissues. It was found from the northern blot using total RNA f r o m  
various embryos and adult t issues (brain and liver) that the 5 0 0 b p  
B a m H l - B g l U  f ragment (which was used to prepare  the r a d io -  
actively labelled probe) did not detect expression in liver total RNA. 
This is contrary to the reverse dot-blot experiment where there was 
a signal detected from the adult mouse liver (Figure 3.1).
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6.4 Future work.
6.4.1 Extended molecular  characteri sat ion.
A major component  of any future work on these clones will b e  
the continued characterisation of these genes at the molecular  level .  
This has been started for a few of the clones. Not all of these c lones  
will fit the criteria set for further  analysis,  namely the existence o f  
a large repeat which is t ranslated and occurs in a d e v e l o p m e n t a l l y  
regulated protein. The clones which do not meet these r e q u i r e m e n t s  
need not be discarded as there are al ternat ive criteria which cou ld  
make use of these clones. For example, the repeats could be u s e fu l  
in the mapping of genes onto the mouse genome, or genes could b e  
of importance in adult physiology.
In the latter stages of this research I concentra ted on f o u r  
clones. Three of these have turned out be novel, with the f o u r t h  
showing similarity to a human RAS inhibitor (Clone mCTG 63, JC310; 
Colicelli  et al, 1991). Two of these were widely expressed (clones 2 6 
and 63). This is an interest ing parallel to the genes which a r e  
affected in human unstable trinucleotide repeat diseases which a lso  
show widespread  expression, beyond the groups of tissues w h ic h  
are affected by that par ticular disease. It would therefore b e  
interest ing to pursue the isolation of the human coun te rpar ts  of  
these mouse genes to ascertain if they also contain t r i n u c l e o t i d e  
repeats.  This may allow the identification of the genes in p a r t i c u l a r  
human diseases.  The tr inucleotides  may also allow the mapping o f  
these genes to regions of the genome which may contain p r e v i o u s l y  
identified genetic disease loci. Fur therm ore  m o l e c u l a r
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character isation of these mouse genes may lead to the i d e n t i f i c a t io n  
of novel regulatory genes.
Cloning and analysis of the remaining clones from the 8.5 d p c  
(Hogan et al, unpubl ished)  and 12.5 dpc (Logan et al, 1992) m o u s e  
embryo cDNA libraries as well as those from the other two l ib ra r ie s ,  
the 13.0 dpc mouse embryo cDNA library and the mouse adult brain 
cDNA library was not carried out in part due to the large num ber  o f  
clones to be purified. This should be pursued to identify m o r e  
repeats to improve the statistical significance of the o b s e r v a t i o n s  
concerning 1) the size and structure of repeats in mouse; 2) t h e  
observat ion of an ascer ta inment  bias; 3) that most t r a n s l a t e d  
repeats encode glutamine tracts.
An ongoing DNA sequencing project will generate a resource of 
proteins that are likely to interact with other proteins,  and a h i g h e r  
incidence of regulatory genes. This could be tested by taking t h e s e  
anonymous genes and use them to test for s timulation of  
t ranscr ip t ion in whole cell protein fractions as described by G e r b e r  
et al (1992). This involves the fusion of the sequences  c o n ta in in g  
the CAG/CTG repeat with a GAL4 DNA binding domain w h ic h  
interacts with binding domains  in a reporter  construct  to s t i m u l a t e  
transcriptional activity of a reporter gene.
6.4 .2  S u b stra tes  for tr inu c leo t id e  b ind ing  prote ins .
These tr inucleotide repeats  may have a role in t h e  
character isa t ion  of the CAG/CTG nucleic acid tr inucleotide r e p e a t  
binding proteins that have been previously described in both H o m o  
s a p ie n s  (Richards et al, 1993; Timchenko et al, 1996) and  M u s  
m u sc u lu s  (Yano-Yanagisawa et al, 1995). The identificat ion and u s e
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of these isolated CAG/CTG trinucleotide repeats as substrates for t h e  
action of these proteins in the mouse could help in the d e v e l o p m e n t  
of  in v i v o  models for the role of these proteins in t r i n u c l e o t i d e  
repeat  biology and pathology.
6 .4 .3  H u m a n  unstab le  tr inu c leo t id e  repeat  d isease  m odels?
Recently a new class of mutation that causes disease in h u m a n  
has been identified. These are known as dynamic mutations and a r e  
caused by the hyper -expans ion  of t r inucleotide repeats.  The m o s t  
common triplet repeat which causes this type of disease a r e  
members of the CAG/CTG repeat class. Of these most of the d i s e a s e s  
are caused by the expansion of CAG triplets which e n c o d e
polyg lu tam ine  repeats.  Some of the repeats identified in m o u s e  
during this work are large and may represent  models in which a n  
expansion may cause a disease. It has been shown that h u m a n
transgenes  of ataxin, the gene mutated by a C A G /p o ly  g lu ta m in e
expansion in the disease SCA l,  in mouse confer a mutant  p h e n o t y p e  
in the mouse. This suggests that the necessary cellular m e c h a n i s m s  
which are recruited for the cell death that occurs in the h u m a n  
disease are present in the mouse. On this basis it is a v a l id
exper im en t  to expand an endogenous mouse CAG t r i n u c l e o t i d e  
repeat  that encodes a polyglutamine tract to look for a d i s e a s e  
phenotype as a result of neuronal cell death. All of the diseases t h a t  
have been found to be caused by a polyglutamine expansion d i s p l a y  
a disease specific death of certain populat ions of neurons ( s e e  
Figure 1.5 of  the Introduction).
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6.4.4 Large mouse trinucleotide repeats: models for r e p e a t
v a r ia b i l i ty  and d isease .
The existence of hypervar iab le  mouse tr inucleotide r e p e a t s  
would help in the study of the human dynamic diseases in that i t  
would help to establish a credible in v ivo  animal model for t h e s e  
diseases.  This however,  is a controversial proposit ion as there h a s  
been a lack of observed variabili ty in human transgenes which have 
been in troduced into mice, although it can be coun te r -a rgued  t h a t  
the reason for this observation is that this approach is p r o b le m a t i c  
because of the hemizygous nature of any introduced transgene. This  
may preclude the par tic ipation of repeats (which exist as part  of a 
t ransgene which is single copy per diploid genome) in cell d iv i s io n  
(i.e. unable to pair in mitosis and/or  meiosis) or even e x p a n s io n  
events  (e.g. if sister chromatids  are required for the m echanism  of  
repeat  expans ion) .
Another  argument  against using the mouse is that the m o u s e  
homologues  of those human genes which have u n s t a b l e  
t rinucleotide repeats show little or no repeat s tructures  (see F igu re  
1.6 in the Introduction). From this people have suggested that m ic e  
do not have the part icular cellular env ironm ent  under  w h ic h  
t r inucleotide repeats can expand in an uncontrollable  fash ion .  
Candidate genes for this explanat ion would be those which e n c o d e  
prote ins that are involved in recombination. This a rgument  is 
weakened  by the observat ion that mouse repeats (and r o d e n t  
microsatel l i tes  in general) are longer and as variable as h u m a n  
repeats.  For example, a CAG/CTG trinucleotide  repeat (w h ich  
encodes a polyglutamine homopept ide)  in Sry  (the Mus m u s c u l u s  
domest icus  sex determining gene) is variable in the wild t y p e
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mouse population. Repeats of 17 and 14 CAG triplets were found in  
the Sry  genes of trapped wild mice (from Denmark and F r a n c e  
respectively;  Nagamine et al, 1992) compared to 12 CAG triplets in 
the inbred strain C57BL/6J(B6). This suggests that CAG/CTG 
tr inucleot ide  repeats  are var iable in the general population.  T h e
problem with inbred laboratory mouse strains is that they are not a 
natural  population and are quite unlike the human p o p u la t io n .  
These mice strains are in effect a snap-shot  of a single n a t u r a l  
mouse at the time of capture. They therefore may contain important 
co-factors  that preclude repeat variabili ty.  Alternat ive ly  they m a y  
rep resen t  the fit individuals in the population. This r e a s o n i n g  
suggests  that mice which are born in to the wild populat ion w i t h
CA G /CTG trinucleotide repeats are inherently at a d isadvan tage  a n d  
are e l iminated within a few generat ions due to ant icipation, w h e r e  
successive generat ions  succumb to a particular  disease ear lier  in  
their life and more severely. This does not occur in the h u m a n
species,  where C AG/poly glutamine repeat diseases are c o n c e r n e d ,  
because  of the unique care we provide for other individuals  of t h e  
same species {e.g. hospitals, medical care, families).  It is w o r t h
noting that this is not true for all dynamic diseases. In the case o f  
FRAXA males and congenital DM infants, the ability to reproduce  is 
severe ly d iminished and therefore the genotypes  of t h e s e  
individuals  are eliminated from the gene pool.
In teres t ingly ,  the Sry  CAG repeat has been associated with a 
sex reversal phenotype in crosses of the C57BL/6J(B6) inbred s t r a i n  
and other Mus musculus d o m e s t i c u s  strains (Coward et al, 1994) .  
The critical feature of this phenomenon appears to be the n u m b e r  
of  glutamines (and hence the CAG triplets) at this position in the S r y  
protein. Strains which cause a sex reversal phenotype  when c r o s s e d
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with C57BL/6J(B6) mice contain either 11 or 13 glutamines  (CAG
triplets) at this position, compared with C57BL/6J(B6) w h ic h  
contains  12 glutamines. Strains which do not lead to a sex r e v e r s a l  
phenotype contain 12 glutamines (CAG triplets).  From this it can b e  
concluded that in certain cases in the mouse, the number  o f
glutamines  in a hom opept ide  can be critical for the p r o p e r
functioning of proteins.  This therefore argues for a critical role f o r
mouse CAG/CTG tr inucleotides  in certain cases. Therefore  a v a l id  
route of  further exper im enta t ion  would be to test the var iabi li ty o f  
these repeats  and examine them for variabili ty and p o t e n t i a l  
associations with disease.
6.4.5 A model  for M yoton ic  Dystrophy?
CAG/CTG repeats are not exclusively associated w i t h  
pathologies  that involve the translation of the repeat i n to  
polyglutamine. In the case of myotonic dystrophy,  the t r i n u c l e o t i d e  
repeat  resides in the 3'UTR of the DMPK gene. The t r i n u c l e o t i d e  
identified in clone 63 is the largest repeat  identified so far in th i s  
study (where there are 26 perfect trinucleotide repeats).  It is l ik e ly  
that this repeats lies in the 3'UTR of a gene which is a homologue o f  
a human RAS inhibitor  (Colicelli ct al, 1991). The coding s t r a n d  
sequence is CTG, which would be transcribed as CUG in RNA. This is 
analogous to the situation in the DM region, where the t r i n u c l e o t i d e  
is similar ly found in the 3' UTR of the DMPK gene. This m o u s e  
repeat could act as a model system for the effect of the DMPK 3 ' 
UTR CTG trinucleotide. However as indicated in the introduct ion th i s  
may be complicated by the existence of other genes which are in  
the vicinity of the DMPK gene (Johnson ct al, 1996). The isolation o f
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a CUG repeat in a gene which may lie in a less gene-rich region m a y  
allow the study of a RNA CUG repeat independent ly  of the f ie ld  
effect postulated by Johnson et al (1996).
6.5 S u m m a r y .
In conclusion this study has been successful in that it h a s  
identified mouse CAG/CTG tr inucleotide repeats  in novel m o u s e  
genes which are expressed in development .  Within the group o f  
charac ter ised  repeats which were identified, larger repeats  tend to  
exist  in novel gene sequences. This indicates that there is a n  
en r ichm ent  for novel genes within this screening p r o c e d u r e .  
Fu r the rm ore  those clones which were selected for f u r t h e r  
invest igat ion have lead to the identification of genes for which a 
search for the human homologues  would be worthwhile  to  
invest igate  the existence of the trinucleotide  repeat and p o s s ib le  
associat ions  with human diseases.
2 2
A p p en d ix  A 
Sequence  From Novel Clones.
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A . l  Introductory  remarks.
As previously mentioned in Chapter 4 (Section 4.5), analysis of 
the DNA sequence from clones derived from the 8.5 and 12.5 d p c  
whole mouse embryo cDNA libraries revealed that eleven (out of  
23) showed no similarity or identity to sequences in the nucleic ac id  
or protein databases. Three of these (clones mCTG 26, 210 and 6 1 )  
were selected for further  molecular  analysis and are described in  
Chapter  5.
The remaining clones are represented  here in this a p p e n d i x  
and the CAG/CTG tr inucleotide  repeats identified within t h e s e  
sequences are indicated (if present).  Other sequence motifs a r e  
indicated where necessary. For the details of each clone refer to t h e  
legend for each Figure.
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Figure A . l  Partial nucleotide sequence of  clone inCTG 27.
The sequence presented here was derived from a T 7 - p r i m e d  
manual sequencing reaction (Pharmacia  T7 polymerase  kit). No 
trinucleotide was identified in this clone.
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Figure A .2.A
1 0  3 0  5 0
GAATTCATGTCTTACGGTCAAGGCTTGGGGCATCATGGGCTTCATCAGTCCTGAAGGATG
CTTAAGTACAGAATGCCAGTTCCGAACCCCGTAGTACCCGAAGTAGTCAGGACTTCCTAC 
7 0  9 0  1 1 0
CAGGGCTGAGGGGTAGAAGTCCACGGGCGTCCGTGTCGGGGTGATGCGTGGGTCCATGTA
GTCCCGACTCCCCATCTTCAGGTGCCCGCAGGCACAGCCCCACTACGCACCCAGGTACAT 
1 3 0  1 5 0  1 7 0
GGAAGGCATCATCATCCACCGTGGGTCAAAGCCCAGCATCTGGGGGTGGTGTGGGTAGAA
CCTTCCGTAGTAGTAGGTGGCACCCAGTTTCGGGTCGTAGACCCCCACCACACCCATCTT 
1 9 0  2 1 0  2 3 0
GTGCGCTGGGGGTGAGAAGTGGGGGGTAGACCGGCTGCCAGTGCTGCATCTTGTACAGCT
CACGCGACCCCCACTCTTCACCCCCCATCTGGCCGACGGTCACGACGTAGAACATGTCGA 
2 5 0  2 7 0  2 9 0
GCTCCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGTTGCTGCTGCTGCTGGCGCTGGAACG
CGAGGACGACGACGACGACGACGACAACGACGACAACGACGACGACGACCGCGACCTTGC 
3 1 0  3 3 0  3 5 0
GAGAAGGACTTCTGGTACTTGCTGAACTCCTGTGCAGGACCGGACTCCGGACTTCTCTCG
CTCTTCCTGAAGACCATGAACGACTTGAGGACACGTCCTGGCCTGAGGCCTGAAGAGAGC 
3 7 0  3 9 0  4 1 0
ATGCTGCTACTGCTGCTACTGCTGCTGCTGCTATGCTCTGACACTGTGGATGTGCAGTGT
TACGACGATGACGACGATGACGACGACGACGATACGAGACTGTGACACCTACACGTCACA 
4 3 0  4 5 0  4 7 0
CTCCTCCCAAAAAATGTGGTGCTTCCTIXSAAAGGAACCCTGGGAACCTTGCGAAAAAGGC
GAGGAGGGTTTTTTACACCACGAAGGAACTTTCCTTGGGACCCTTGGAACGCTTTTTCCG 
4 9 0  5 1 0  5 3 0
CATCCCTGCGGGAAACTCCCAATCCCGGATTGGGAATCCTTCCCTGGTTCGGTCCCTTGC
GTAGGGACGCCCTTTGAGGGTTAGGGCCTAACCCTTAGGAAGGGACCAAGCCAGGGAACG
Figure A .2. A S eq u en ce  from Clone m C Ï G  28 using T 3 / T  7 a  
p r i m e r .
T h i s  s e q u e n c e  w a s  d e r i v e d  f r o m  u s i n g  the  T 3 / T 7 a  o l i g o n u c l e o t i d e  
to p r i m e  D N A  s e q u e n c i n g  r e a c t i o n s  o n  the  p l a s m i d  c o n t a i n i n g  t h e  
m C T G  2 8  in s e r t  s u b - c l o n e d  f r o m  l a m b d a .  T h e  C A G / C T G  
t r i n u c l e o t i d e s  are i n d i c a t e d  b y  red c o l o u r e d  te x t .  N o t e  that  th er e  are  
c o r r u p t i o n s  in the  t r i n u c l e o t i d e  r e p e a t  ( i n d i c a t e d  b y  b l u e  c o l o u r e d  
te x t ) .  T h e  t r i n u c l e o t i d e  r e p e a t s  are C T G c t c ( C T G ) 7 t t g ( C T G ) 2 t t g ( C T G ) 4  
and a t g C T G c t a ( C T G ) 2 C t a ( C T G ) 4 Cta. T h e  b o ld  s m a l l  c a s e  n u c l e o t i d e s  
r e p r e s e n t  the  third p o s i t i o n  c o d o n  c h a n g e s .
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Figure A.2.B N u c leo t ide  seq ue nc e  of  Clone mCTG 2 8 
derived  from T7 primed DNA sequencing.
T h e  s u b - c l o n e d  n iC T G  2 8  insert  ( d e r i v e d  f r o m  the 8 .5  d p c  w h o l e  
m o u s e  e m b r y o  c D N A  l ibrary )  w a s  s e q u e n c e d  both  w i t h  the  s ta n d a rd  
T 7  p r i m e r  ( P r o m e g a )  and the  bT7  e x t e n d e d  D N A  s e q u e n c i n g  
p r i m e r s  ( S t r a t a g e n e ) .  N o  t r i n u c l e o t i d e  r e p e a t s  w e r e  o b s e r v e d  in t h i s  
s e q u e n c e  but  t r i n u c l e o t i d e s  w e r e  o b s e r v e d  in T 3  p r i m e d  D N A  
s e q u e n c i n g  ( s e e  F i g u r e  A . 2 . A) .  T h e  e x i s t e n c e  o f  m o r e  C A G /C T G  
t r i n u c l e o t i d e s  c a n n o t  be d i s c o u n t e d  as the  c l o n e  is not  f u l l y  
sequenced.
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Figure A.3
1 0  3 0  5 0
GAATTCTTGTCTTACGGTCGAGGGCCCAAGGACTTCCCACGCAGAAGGCTGCCGCACAGG
CTTAAGAACAGAATGCCAGCTCCCGGGTTCCTGAACxGGTGCGTCTTCCGACGGCGTGTCC 
7 0  9 0  1 1 0
TCAAGCGAGCCATTGTGCCTCAGCATGCTGGAGAGGCAGCAGCCACAGCTTCAGAGAGCA
AGTTCGCTCGGTAACACGGAGTCGTACGACCTCTCCGTCGTCGGTGTCGAAGTCTCTCGT 
1 3 0  1 5 0  1 7 0
GCAGTAATGAATAATCCAGTGAGGAAGAGGAGGAGGACAAAAAGATCTGCCTGTCCAGAA
CGTCATTACTTATTAGGTCACTCCTTCTCCTCCTCCTGTTTTTCTAGACGGACAGGTCTT 
1 9 0  2 1 0  2 3 0
GGCAGCTAACCCCCAAGCCGAGGCAGTCCGACCTCCTGCGAAGAAGGCAGAGAGCTCTGA
CCGTCGATTGGGGGTTCGGCTCCGTCAGGCTGGAGGACGCTTCTTCCGTCTCTCGAGACT 
2 5 0  2 7 0  2 9 0
GTCGGACTCAGACTCGGATTCGGACTCCAGCTCAGAGGAAGAAACACCACAGACCCAGAA
CAGCCTGAGTCTGAGCCTAAGCCTGAGGTCGAGTCTCCTTCTTTGTGGTGTCTGGGTCTT 
3 1 0  3 3 0  3 5 0
GCCAGAGGCAGCTGTGGCAGCAAAAGCTCAGACTAAAGCCGAAGCCAACCTGTACACCAG
CGGTCTCCGTCGACACCGTCGTTTTCGAGTCTGATTTCGGCTTCGGTTGGACATGTGGTC 
3 7 0  3 9 0  4 1 0
CGAAAGCACAGCCTATGGTAGCCAATGGCAAGCCGCAGCCGCCAGCAGCAGCAC-CAGCAG
GCTTTCGTGTCGGATACCATCGGTTACCGTTCGGCGTCGGCGGTCGTCGTCGTCGTCGTC 
4 3 0  4 5 0  4 7 0
CAGCAGCGATGACTCGAGAGAGAGAGCGCTGCTCTCCAAGAAGACTGTACCAAATAGCTT
GTCGTCGCTACTGAGCTCTCTCTCTCGCGACGAGAGGTTCTTCTGACATGGTTTATCGAA 
4 9 0  5 1 0  5 3 0
GTCGTGGCCGAGGCCAGTGATAGTCTGCGCCACAACCGAGACTCAGCAATGATGATCTCC
CAGCACCGGCTCCGGTCACTATCAGACGCGGTGTTGGCTCTGAGTCGTTACTACTAGAGG 
5 5 0  5 7 0  5 9 0
GTGAAGAGGAGAGGACGACCACCCTGAGAAGTGCCGTCCTAATTCATCACACCTCTGTCC
CACTTCTCCTCTCCTGCTGGTGGGACTCTTCACGGCAGGATTAAGTAGTGTGGAGACAGG 
6 1 0  6 3 0  6 5 0
TTACAAGATCCCGGACCCGCTCAAGAAGCTGCTGCCCAAACGCCTGCAAACATACAAGCT
AATGTTCTAGGGCCTGGGCGAGTTCTTCGACGACGGGTTTGCGGACGTTTGTATGTTCGA 
6 7 0  6 9 0  7 1 0
TGACATCTATCGTTCTGAGAAAAACACTCCRTAGAGGCTCCCAAACCCCCACTTCATAAA
ACTGTAGATAGCAAGACTCTTTTTGTGAGGYATCTCCGAGGGTTTGGGGGTGAAGTATTT
Figure A 3  N u c leo t id e  s eq u e n c e  of  Clone mCTG 45 d e r i v e d  
from T7 primed DNA sequencing.
Clone mCTG 45 insert (derived from the 8.5 dpc whole m o u s e  
embryo cDNA library) was sequenced using T7 based pr imers  (T7, 
Promega; bT7, Stratagene) .  The sequences were aligned in t h e  
MacAlign program m e (IBl). A single CAG/CTG tr inucleotide r e p e a t  
was observed. The sequence was cgc(CAG)gcga and is indicated as  
red coloured sequence. A CT/AG dinucleotide  repeat adjacent  to t h e  
trinucleotide is coloured green.
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Figure A.4
1 0  3 0  5 0
GAATTCTCATACCTTAATGTTAATGTGTTCAGGAGGTCCCTCAGGGGCTGGGAGGGCAGC
CTTAAGAGTATGGAATTACAATTACACAAGTCCTCCAGGGAGTCCCCGACCCTCCCGTCG 
7 0  9 0  1 1 0
TTCACACGTGGGAAGGTAGGATGAACGTGATACTCCTGCCTCAGTGGCCACACCTCTAAA
AAGTGTGCACCCTTCCATCCTACTTGCACTATGAGGACGGAGTCACCGGTGTGGAGATTT 
1 3 0  1 5 0  1 7 0
ATAGGAATGTGACAGTAGCCTGATCCTACTAATGAGGTGTGGAAGAAGGAGATGCTGCTG
TATCCTTACACTGTCATCGGACTAGGATGATTACTCCACACCTTCTTCCTCTACGACGAC 
1 9 0  2 1 0  2 3 0
CTGCTGCTGCTGCTGCAGCTGCAGTGGTCTGACTGCTTGTTAAGAGTAGCAGTCACAGGC
GACGACGACGACGACGTCGACGTCACCAGACTGACGAACAATTCTCATCGTCAGTGTCCG 
2 5 0  2 7 0  2 9 0
TGCTCTTCGCTCCTGCTTCTCGCTGTTGTGGCCCCAAGCTGCTATTTTCTACCAAATTAA
ACGAGAAGCGAGGACGAAGAGCGACAACACCGGGGTTCGACGATAAAAGATGGTTTAATT 
3 1 0  3 3 0  3 5 0
AATCCACTCCAGTGCTTTTCCTGTCCCCAAATAAAAACTCCTCTCCAAGCTTCTGCCCTG
TTAGGTGAGGTCACGAAAAGGACAGGGGTTTATTTTTGAGGAGAGGTTCGAAGACGGGAC 
3 7 0  3 9 0  4 1 0
TTTACAGCGAGACTTTTTAATAGACTCTGCCTCGTTAGAACCATGARACATATGTTCCAA
AAATGTCGCTCTGAAAAATTATCTGAGACGGAGCAATCTTGGTACTYTGTATACAAGGTT 
4 3 0  4 5 0  4 7 0
TTAGCAGAATAATTTTGCTTAAATATGCAGATAACTGTTGACTGACACAGTGCACGCTCT
AATCGTCTTATTAAAACGAATTTATACGTCTATTGACAACTGACTGTGTCACGTGCGAGA 
4 9 0  5 1 0  5 3 0
GAAGCTAATTTAAGGCAAGAAGCTGGGACTGTTGTACTGCTCTCCCCATCTATKTTGCAC
CTTCGATTAAATTCCGTTCTTCGACCCTGACAACATGACGAGAGGGGTAGATAMAACGTG 
5 5 0  5 7 0  5 9 0
CTCCCCCACCCATGTCAGCTTTCTCTCTCTAACTTTCTTGCCACGATTTCTCTGACACTA
GAGGGGGTGGGTACAGTCGAAAGAGAGAGATTGAAAGAACGGTGCTAAAGAGACTGTGAT 
6 1 0  6 3 0  6 5 0
ATGATCTAGGGCTCTCCTGTGCTCACTGTCAATATCAGGTGACATCCATAACCTGACACT
TACTAGATCCCGAGAGGACACGAGTGACAGTTATAGTCCACTGTAGGTATTGGACTGTGA 
6 7 0  6 9 0
ACGCCTGAATGCTCCTATCACGTGTGACCGGTATG
TGCGGACTTACGAGGATAGTGCACACTGGCCATAC
Figure A 4 partial nucleotide sequence of  Clone m CTG 414
This clone was isolated from the 8.5 dpc whole mouse embryo cDNA 
library, the DNA sequence represen ted  here was der ived from a 
sequencing reaction using a PCR cycle sequencing optimised, TV- 
based primer. This sequence contains the tr inucleotide repeat ( r e d  
coloured text) found in this clone. It reads: atg(CTG)7cagCTG. T h e  
reading frame remains to be de termined with further  s e q u e n c i n g  
in fo rm a t io n .
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Figure A .5
1 0  3 0  5 0
GAATTCGAGGATCCGGGTACCATGGTTGATTTGGTTTTCACCCTGTCTTACCCCATCAAA
CTTAAGCTCCTAGGCCCATGGTACCAACTAAACCAAAAGTGGGACAGAATGGGGTAGTTT 
7 0  9 0  1 1 0
TATAGCATATAGGGAAGTTATTCTTGAAGTTTGAAATTCAAACTCATGCTTGTAATCCAA
ATATCGTATATCCCTTCAATAAGAACTTCAAACTTTAAGTTTGAGTACGAACATTAGGTT 
1 3 0  1 5 0  1 7 0
GCATTTAGTTCAAACTTTAAAAATACTTTAAGAATATTACAAAGAGCTTGTATATACTTT
CGTAAATCAAGTTTGAAATTTTTATGAAATTCTTATAATGTTTCTCGAACATATATGAAA 
1 9 0  2 1 0  2 3 0
TCCTCCTGTACCCCAGGATAACCTGAAACTTGGTATGTGTTACTAGAATGACTCTCAAGT
AGGAGGACATGGGGTCCTATTGGACTTTGAACCATACACAATGATCTTACTGAGAGTTCA 
2 5 0  2 7 0  2 9 0
CCTAATCCTCCTGCTTTTGTTCACTCCCCAGGCTGGGAATACAGGTGCCTACCCCCACAC
GGATTAGGAGGACGAAAACAAGTGAGGGGTCCGACCCTTATGTCCACGGATGGGGGTGTG 
3 1 0  3 3 0  3 5 0
GGGCCTAGCAAGGTGTTTATTTGTTATTTGATGGTTGGGGCTGGGGCTGCTGCTGCTGCT
CCCGGATCGTTCCACAAATAAACAATAAACTACCAACCCCGACCCCGACGACGACGACGA 
3 7 0  3 9 0  4 1 0
GCTGCTGCTGCTGCTGCTGCTGCTiGCTGCTGGTCTGTCTTGTTGTTGAACTTGATGTCAC
CGACGACGACGACGACGACGACGACGACGACCAGACAGAACAACAACTTGAACTACAGTG 
4 3 0  4 5 0  4 7 0
TCTTGGCTTCCACTGAGCGAATTCAGATGCTCTAGTAATGATGGATGCTGCACATGTCTT
AGAACCGAAGGTGACTCGCTTAAGTCTACGAGATCATTACTACCTACGACGTGTACAGAA 
4 9 0  5 1 0  5 3 0
AGAGACATATCTCATTAATGCTACTTGTGTATAATACAGTAGCCTAGTCCAGAATGAAAT
TCTCTGTATAGAGTAATTACGATGAACACATATTATGTCATCGGATCAGGTCTTACTTTA 
5 5 0  5 7 0
CGTGTCTAGATCCTGGTGTACATGTGAATACTCTAACATTAAAGG
GCACAGATCTAGGACCACATGTACACTTATGAGATTGTAATTTCC
Figure A .5 Nucleot ide sequence of  Clone m CTG  81.
Clone mCTG 81 was initially isolated from the 12.5 dpc whole m o u s e  
embryo cDNA library. The sequence presented here was t h a t  
obtained from using a PCR cycle-sequenc ing  T3 based primer. T h e  
CAG/CTG tr inucleotide  repeat is represented  in red coloured text.  
The repeat is ggg(CTG )i5tct.
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Figure A.6
1 0  3 0  5 0
CTTAAGCTCCTAGGCCCATGGTACCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
GAATTCGAGGATCCGGGTACCATGGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT 
7 0  9 0  1 1 0
AAAAAAAAAAAAAAAAAAAAAACCCTGGGAACGAAATAAATGTGTCATTTTCCTTGTTGG
TTTTTTTTTTTTTTTTTTTTTTGGGACCCTTGCTTTATTTACACAGTAAAAGGAACAACC 
1 3 0  1 5 0  1 7 0
TTTAAGGACTCTGATCTCACCGACATCACGTTCTGTCAGTGCCGGACAGTCCCCCCCTCC
AAATTCCTGAGACTAGAGTGGCTGTAGTGCAAGACAGTCACGGCCTGTCAGGGGGGGAGG 
1 9 0  2 1 0  2 3 0
GTCCGCTACCACGCACCACGATTGCTCGTCTGGGTCGTACCCGTCGGATGTCCGACGTCG
CAGGCGATGGTGCGTGGTGCTAACGAGCAGACCCAGCATGGGCAGCCTACAGGCTGCAGC 
2 5 0  2 7 0  2 9 0
GGACTACCCAAGACCGAGTGGTGCGGTAAGTGGTGTGACGGAGTTTGTCATGGCGACGAC
CCTGATGGGTTCTGGCTCACCACGCCATTCACCACACTGCCTCAAACAGTACCGCTGCTG 
3 1 0  3 3 0  3 5 0
GACGACGACGACGACGACGACGGACCGACCCTGCCGTGTGCACCGGGATCGTCCATGGGC
CTGCTGCTGCTGCTGCTGCTGCCTGGCTGGGACGGCACACGTGGCCCTAGCAGGTACCCG 
3 7 0  3 9 0  4 1 0
CTAGGAGRTTAAGTTATAGTTCGAATAGCTATGGGAGTTGGAGCTCCCCCCCGGGCCATG
GATCCTCCAATTCAATATCAAGCTTATCGATACCCTCAACCTCGAGGGGGGGCCCGGTAC 
4 3 0  4 5 0  4 7 0
GGTGAAAACAAGGGAAATTACTTCCAATTAACGGGGGAACCGCATTAGTACAGTATGACA
CCACTTTTGTTCCCTTTAATGAAGGTTAATTGCCCCCTTGGCGTAATCATGTCATACTGT 
4 9 0  5 1 0
AGGGCAAAAATTTAACAATGGCGAGTGTAGGG
TCCCGTTTTTAAATTGTTACCGCTCACATCCC
Figure A .6 Partial nucleotide sequence of  Clone m CTG  82.
Clone 82 was derived from the 12.5 dpc whole mouse embryo cDNA 
library. DNA represen ted  here describes  the 3' region of an mRNA, 
due to the presence of a large poly-adenosine  stretch (n=52; g r e e n  
coloured sequence. Note also the existance of a P o l y a d e n y l a t i o n  
signal immedia te ly  5 ’ to the poly A/T stretch). The t r i n u c l e o t i d e  
repeat found in the clone is represented in red text. The sequence of  
the repeat is agg(CAG)gcgg in the presumed coding strand {i.e. t h a t  
strand in which the polyA/T stretch is read as poly A).
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Figure A .7
A )
1 0  3 0  5 0
GAATTCGAGGATCCGGGTACCATGGAGCCTTTGCCTTCTTCAAGGGTGACCTTCTGTCTG
CTTAAGCTCCTAGGCCCATGGTACCTCGGAAACGGAAGAAGTTCCCACTGGAAGACAGAC 
7 0  9 0  1 1 0
TCTGGAACCTTCTCTTTGCTGGGAGTCTGCTCATATCTCTCTGGTCTTCCTCTGTTTTGA
AGACCTTGGAAGAGAAACGACCCTCAGACGAGTATAGAGAGACCAGAAGGAGACAAAACT 
1 3 0  1 5 0  1 7 0
GGGGCAGGTCTCTCGTAGCTGCTGCTGCTGCTGCTC;CTGCTACTGCTGCTG
CCCCGTCCAGAGAGCATCGACGACGACGACGACGACGACGATGACGACGAC
B)
1 0  3 0
GAATTCGAGGATCCGGGTACCATGGTGCTACTGCTGCTGCT
CTTAAGCTCCTAGGCCCATGGTACCACGATGACGACGACGA
Figure A .7 Partial DNA sequence of  Clone niCTG 86.
Clone mCTG 86 was initially isolated from the 12.5 dpc whole m o u s e  
embryo cDNA library. DNA sequence from this clone was derived b y 
DNA sequencing reactions primed by T3 and T7 primers,  o p t i m i s e d  
for PCR cycle-sequencing.  Note that the available DNA sequence is 
very short due to secondary structure within the cloned insert. Th is  
may involve the CAG/CTG trinucleotide repeats (indicated in red) a s  
the sequence te rminates  in both reactions in the middle of t h e s e  
repeats.  The repeats are also con t ra -s t randed  and therefore it is 
possible that these tr inucleotides can dissociate and form p a i r e d  
in t ra -m olecu la r  pseudo-helical  hairpins. The tr inucleotide r e p e a t s  
are: A) (CTG)7Cta(CTG)3 and B) (CTG)3.
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Figure  A .8
1 0  3 0  5 0
CTTAACCTCCTACCCCCATCCTACCCCCACAACAACAACAACCACAACAACCACCACCAC
CAATTCCACCATCCCCCTACCATCCCCCTCTTCTTCTTCTTCCTCTTCTTCCTCCTCCTC 
7 0  9 0  1 1 0
AACCACAACCACCACCACCACCACCACCACCACCACCACCACCCCACACTCATCCCCCAC
TTCCTCTTCCTCCTCCTCCTCCTCCTCCTCCTCCTCCTCCTCCCCTCTCACTACCCCCTC 
1 3 0  1 5 0  1 7 0
ACCCTATTCCCACCCTCCCACCACACCCTCCACTCCCCTCCACTCCTCCCACCTCACTCA
TCCCATAACCCTCCCACCCTCCTCTCCCACCTCACCCCACCTCACCACCCTCCACTCACT 
1 9 0  2 1 0  2 3 0
CTATTCCTCCACACACACTCCCCCCACTCCTCCCTCTCCACCTCTCACCACCACAACCAC
CATAACCACCTCTCTCTCACCCCCCTCACCACCCACACCTCCACACTCCTCCTCTTCCTC 
2 5 0  2 7 0  2 9 0
CACCACCACCACCTCCTCACCCTCCACCCCTCCCTCTTCCTCCCCCACCCTACCCACCCT
CTCCTCCTCCTCCACCACTCCCACCTCCCCACCCACAACCACCCCCTCCCATCCCTCCCA 
3 1 0  3 3 0  3 5 0
CACCACCCCCCTCTTCACCACCTCCTCCTCCCCCACCACTCAACCACCCTCCCTCTTCCC
CTCCTCCCCCCACAACTCCTCCACCACCACCCCCTCCTCACTTCCTCCCACCCACAACCC 
3 7 0  3 9 0  4 1 0
CCACTCCCAATCCTCCCTCTCCCACCAACACACCCCCTCCAACAACAACAACCTAACCCT
CCTCACCCTTACCACCCACACCCTCCTTCTCTCCCCCACCTTCTTCTTCTTCCATTCCCA 
4 3 0  4 5 0  4 7 0
CCACCCCATTCTCCACAACCACAACAACAACCAC'AACAACAACAACCACCACCACCACAT
CCTCCCCTAACACCTCTTCCTCTTCTTCTTCCTCTTCTTCTTCTTCCTCCTCCTCCTCTA 
4 9 0  5 1 0  5 3 0
CAAACACTCCCTCCACCTAACCAACCACCACCTCCACATCAACCCAAACCACATTTTCCC
CTTTCTCACCCACCTCCATTCCTTCCTCCTCCACCTCTACTTCCCTTTCCTCTAAAACCC 
5 5 0  5 7 0  5 9 0
ACCTCACTCCACCTTCCCAACCCTCTCCTTCTAACCCCCCCTTCTTCCACCCTCCCCCCC
TCCACTCACCTCCAACCCTTCCCACACCAACATTCCCCCCCAACAACCTCCCACCCCCCC 
6 1 0  6 3 0  6 5 0
CTCACTTCCTACCTCCCTCTCCTCTTACCACCACAACCACCACAACCCCCTTCCATCATA
CACTCAACCATCCACCCACACCACAATCCTCCTCTTCCTCCTCTTCCCCCAACCTACTAT 
6 7 0  6 9 0  7 1 0
ACTCCTTACCTCCTCCTCTCACACCTCCATCATCCTATCCCCCACCTCCCTCCTACCATC
TCACCAATCCACCACCACACTCTCCACCTACTACCATACCCCCTCCACCCACCATCCTAC
Figure A .8 Partial nucleotide sequence of  Clone niCTG 92.
DNA sequence was derived from using the cycle sequence o p t i m i s e d  
primers.  The CAG/CTG tr inucleotide  repeats are indicated in 
italicised text. The four repeats  are highly degenera te  and c o n ta in  
equal numbers  of CTG (red text) and TTG (blue) t rinucleotides .  T h e  
reverse of TTG is CAA. This is the second triplet which encodes a 
glutamine codon. Therefore it is highly likely that these r e p e a t s  
encode polyglutamine homopeptides,  if they are translated. There is 
a continuous open reading frame found throughout this sequence.
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A ppendix  B
Isolation And Characterisat ion Of G enomic  DNA From  
Enhancer  Trap Cell l ines.
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B . l  Introduct ion.
As described in the general int roduct ion,  there are m a n y  
ways to identify new genes within parameters  of interest  and e a c h  
of them have their advantages and disadvantages. Some of them are 
more suited to developmenta l  gene identificat ion than o th e rs .  
Enhancer  trap constructs involve the introduction of transgenes  in to  
the genome of various organisms and have been developed to a s s a y  
for spatial and temporal gene expression in embryos (e.g. Goss 1er e t  
al, 1989 and Korn et al, 1992). The aim of the exper iments  is to  
detect  the expression of a reporter  gene with a minimal p r o m o t e r  
random ly  inserted in the genome. Expression will occur if t h e  
reporter gene is in the vicinity of endogenous regulatory  s e q u e n c e s .  
These sequences are responsible for normal transcription from t h e i r  
endogenous target gene (or genes) and therefore this technique can  
indirectly identify sets of genes which are activated under specif ic  
condit ions, for example during the deve lopm ent  of the n e r v o u s  
s y s te m .
The creation of a series of embryonic  stem cell lines w i t h  
independen t  transgene integrations takes time. In a c o l l a b o ra t io n  
with A. Gossler from Germany, our laboratory gained access to a 
group of embryonic  cell lines which contain integra ted PLSN 
enhancer  trap transgenes (Figure B.l;  Gossler et al, 1989). T h e s e  
positive embryonic  cell lines had a head and/or  a spinal cord lacz  
transgene expression during development ,  when the cell lines w e r e  
injected into donor blastocysts and allowed to contr ibute  to  
chimaeric embryos.  The analysis of the unique flanking s e q u e n c e s  
from the transgene integration sites in the t ransgene positive cell
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lines will help identify genes which are expressed d u r i n g  
development  in the mouse.
This Chapter  will focus on the initial character isa t ion  of t h e  
enhancer  trap positive cell lines D3-240 and D3-052. A S o u t h e r n  
blot analysis was carried out to detect the transgene integra tion s i te  
and also to locate unique restriction enzyme sites in the s e q u e n c e s  
ad jacent  to the enhancer  trap. It is also necessary to check the cell 
lines for tandem insertions of the transgene and that the e n h a n c e r  
trap site had not undergone pos t- in tegra t ional  r e a r r a n g e m e n t ( s ) .  
F lanking sequence was amplified from circularised genomic DNA 
using inverse PCR (IPCR) with pairs of nested primers; neol  a n d  
neo2; n e o l 0 and n e o l l  (Chapter 2 and Figure B.l).  To c h a r a c t e r i s e  
these amplified sequences, the products of inverse PCR were s u b ­
cloned into a deoxythymidine-overhang vector and DNA s e q u e n c e d .  
Further  Southern analysis was carried out using cell lysate g en o m ic  
DNA, sent from Germany. This showed that DNA derived f r o m  
different  cell lysates gave the same restriction f ragments  u p o n  
digestion with different  endonucleases,  when hybrid ised w i th  
radioact ively  labelled probes derived from the reporter  genes, lacz  
and neo.  This indicates that they actually contained the s a m e  
enhancer  trap integration site.
B.2 L a c z  and n eo m y c in  p h o s p h o t r a n s f e r a s e  gene s p e c i f i c  
p r o b e s .
Figure B.l  shows a map of the enhancer  trap vector pLSN. I t  
contains the genes lacz and neomycin p h o sp h o t ran s fe ra se  (neo),  
which are derived from the E. coli strain K12 genome lac o p e r o n
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(Maniatis  et al, 1989) and from the E. coli  t ransposon T n 5  
r e s p e c t i v e l y .
Restriction sites at both ends of the vector can be used to  
charac te r ise  the integration event and the co-linear ity of lacz a n d  
n e o  genes and to distinguish between unique insert ional  events  in  
different  enhancer trap positive cell lines. Probes derived from b o t h  
these genes were used.
The neo  gene specific sequences (1 kbp) were isolated f r o m  
the plasmid pGTl (Gossler et al, 1989), using X h a l  r e s t r i c t i o n  
endonuclease .  A lacz gene fragment ,  (1.8 Kb H in cU -H in cU ,  2349 n t  
to 4177 nt of the whole lac operon of the E. coli K12  g e n o m e ,  
Maniatis et al, 1989) was isolated from the lacz fusion c a s s e t t e  
vector  p M C l 871 (Shapira et al, 1983). This vector does not c o n ta in  
the n e o  gene, which reduces the probabili ty  of probe c ro ss  
contaminat ion ,  which could confuse the end flanking s e q u e n c e  
results.  Both fragments  were recovered according to t h e  
methodology described in Materials and Methods (Chapter  2.15).
B.3 G en om ic  o r g a n isa t io n  of  en h a n cer  trap ce l l - l in e  D 3 -  
2 4 0 .
Genomic DNA from this part icular  enhancer  trap positive ES 
cell-l ine was extracted by the method described in Chapter  2.8.3 of  
this thesis,  using the Nucleon genomic DNA extraction kit (Sco tlab)  
and restricted with the endonucleases which were known to cut t h e  
enhancer  trap vector.
10 pg aliquots of D3-240 genomic DNA were rest r icted  w i t h  
each of the enzymes Ecr;Rl, BamWl,  Kpn\ ,  N c o \  and Sail.  The cut DNA 
was t ransferred  and fixed to nylon m em brane  after gel
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elec t rophores is  and probed with Uicz. and neo  specific probes, to  
ident ify  rest rict ion sites in the sequences flanking the i n t e g r a t i o n
site.
The neo  specific probe detected single unique f r a g m e n t s
conta ining neo sequences for the restriction enzymes, Ecy^RI, K p n \  
and BamY{\.  The calculated sizes were 2 kbp, 3.2 kbp and 7.5 k b p  
respectively (Figure B.2.A). The restriction enzyme Nco\,  in a d d i t i o n
to the enhancer  trap N c o \  internal f ragment  (5.5 kbp), detected a
flanking restr iction f ragment of 3.5 kbp (Figure B.2.A). There w a s
no S a i l  fragment detected with the n e o  probe.
Using the lacz. specific probe, unique flanking restr ict ion s i tes  
in the endogenous  mouse genome were detected for the e n z y m e s ,  
EcdRI,  K p n l  and Sail.  The detected fragment sizes were 10 kbp, 9.5 
kbp and 9.0 kbp respectively (Figure B.2.B). BainUl  and Neol
detected internal restriction fragments,  3.5 and 5.5 kbp respectively
(Figure B.2.B). A summary of these results is shown in diagraimnatic 
form in Figure B.3.
B.4 I so la t ion  of  EcoR I f lanking  s eq u e n c e s  adjacen t  to t h e
n e o  gene of  the vector pLSN insert ion  in ES ce l l - l in e  D 3 -
2 4 0 .
On the basis of the initial genomic charac ter isa t ion  of t h e
insertion site of enhancer  trap ES cell-line D3-240, the n e a r e s t
flanking restr iction site in the mouse genomic DNA at the neo  g e n e  
end of the enhancer  trap construct  was de termined to be Ecy^RI. I t  
was calculated to be 0.5 kbp from the 3' end of the enhancer  t r a p  
inser tion site. This was selected for cloning flanking sequences  b y
the IPCR method (Ochman et al, 1990; Chapter 2, Section 2.19).
237
Figure B. l
pLSN
(enhancer trap vector)
Ikb TK22 3N20
n e o l ntM>2
n e o  1 0  n e o l l
□
a
□
□
hsp promoter
S u p  F
thymidine kinase promoter 
l a c z
neomycin phoshotransferase
SV40 poly adénylation signals
PCR primers used to amplify flanking sequences 
{neo )  and prime DNA seipiencing (TK22 and 3N20).
Figure B. l  D ia g ra m m a t ic  r e p r e s e n ta t io n  of  the e n h a n c e r  
trap vector pLSN.
This enhancer  trap vector was constructed by Gossler et o/, (1 9 8 9 ) .  
It contains the E. coli lacz. gene (as the reporter gene), with a m o u s e  
minimal hsp68 promoter; an E. coli SupE  amber suppressor  tRNA 
gene, for use in plasmid rescue experiments;  the Tii5 n e o m y c in  
p h o sp h o tran s fe ra se  gene {neo)  as positive selectable m a r k e r  
immedia te ly  dow ns tream  of a thymidine kinase c o n s t i t u t i v e  
promoter.  Both genes {lacz and neo)  have SV40 derived p o ly -  
adenylat ion mRNA terminat ion sequences.
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Figure B.2
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Figure B.2 S outhern  biot analys is  of  the en h a n cer  t r a p  
in tegrat ion  site o f  ES cel l - l ine  1)3-240.
10 p g of genomic DNA extracted from cell-line D3-240 was d i g e s t e d  
with restriction endonucleases,  EcoR\ (E); Bam H l  (B); Neol  (N); K pnl  
(K) and Sail  (S). The blots were probed with A) lacz. specific p r o b e  
and B) neo  specific probes.
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Figure B.3 Enhancer  trap pLSN insert ion  site of c e l l - l i n e  
D 3-240  deduced  hy Southern  hlot analysis .
Flanking restriction sites were obtained from the combined data o f  
the Southern blot analysis shown in Figure B.2. placz. and p n e o  
indicate the positions of the lacz and neo  sequence specific p ro b es ,  
relative to the enhancer  trap. The enzymes indicated are: (E);
BainHl  (B); Cla\  (C): Nco\  (N); Kpnl  (K) and Sail (S).
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B.4.1 A m p l i f i c a t io n  of  f lanking  s eq u e n c e s  of  D 3 -2 4 0  b y 
inverse  PCR.
Inverse PCR was used to amplify endogenous m o u s e  
sequences which are adjacent to the neo  gene at the D 3 - 2 4 0  
insertion site. Outwardly directed nested primer  pairs (shown in
Figure B.l),  neol  and 2 and neo 10 and 11 were used in t w o  
sequentia l rounds of PCR reactions. The primers  neoiO and n e o l l  
were used in the first PCR reaction and the second PCR r e a c t i o n  
used neo l  and neo2 primers on a 1/1000th  dilution of the f i r s t  
round PCR reaction.
A single 1050 bp fragment was detected after the s e c o n d
round of PCR (Figure B.4). A combination of size of the PCR f r a g m e n t  
and the non-amplified sequences (0.85 kbp) gives an es timated size 
of the template  as 1.9 kbp. The circularised PCR template  s h o u ld  
correspond to the size of the Err;Rl fragment detected by S o u t h e r n  
blot; this was calculated as 2.0 kbp. This is consistant  with the i d e a  
that the amplified sequences  were derived from this EcoRl  
f r a g m e n t .
B.4 .2 C loning o f  the D3-240 specif ic IPCR product .
For cloning purposes,  three separate second round PCR 
reactions were pooled and treated with Promega Wizard DNA c l e a n ­
up system and the recovered DNA was re -suspended  to
approximate ly  50 ng per 3 pi. Recovered amplified DNA was m i x e d  
in separa te  reactions with two types of T-overhang v ec to rs .
pBluescrip t  KS-T and pGem-T, were used in the ligations at m o l a r  
end ratio of 3:1 insert to vector.
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Figure B.4
1050
Figure B.4 A m p l i f i c a t io n  of  s e q u e n c e s  f lanking  the n e o  
gene o f  the enhancer  trap posit ive cel l - l ine  D3-240.
9 pi of 25 pi of second round PCR leactions using combinations  of  
primers  were loaded on a I % agarose gel. Template  DNA for PCR 
was I pi of a l/IOOO fold dilution of the first round PCR leaction 1) 
primers  neol and neo2 (using primers neo 10 and n e o l l ) .  2) no 
primers  control; 3) neol primer only; 4) neo2 primer only; 5 )  
control without DNA.
2 4 2
D H 5 a  E. coli  cells were t ransformed by electroporat ion w i t h  
the ligated plasmid and plated on the LB plate containing am pic i l l in ,  
X-gal and IPTG.
Five positive white colonies were observed from t h e  
pBluescr ip t  KS- based T-vector  and five from the pGem b a s e d  
vector, GEM-T. These were picked and grown in liquid LB in t h e  
presence of the appropria te  antibiotic markers and grown for 1 6 
hours.  DNA was recovered from these bacterial cultures by u s in g  
the Wizard plasmid DNA mi ni prep system (Promega).  Test d ig e s t io n  
of these plasmids  with restriction enzymes that would release t h e
captured insert, revealed that all 5 inserts of the pBluescr ipt KS- T - 
vector had identical 1050 bp inserts. This is the same size as t h e  
second round PCR product (Figure B.5).
B.4.3 Sequencing of  KS-T and GEM- T 240 IPCR inserts.
To establish if sequences contained within the insert d e r i v e d  
from the IPCR reaction were similar to any other sequence in t h e  
databases,  partial DNA sequencing was under taken  to r e t r i e v e
insert  specific sequences  to use for nucleic acid database sea rc h e s .  
The sequencing was conducted using the materials as described in  
Chapter 2 (Section 2.23.1), according to the m a n u f a c t u r e r s  
reco m m en d a t io n s  (Pharmacia) .  The primers TK22 and 3 N 2 0  
(Chapter  2, Table 2.3 and Figure B.l this Chapter) were used to 
pr ime the reactions. These primers were designed to minimise  t h e  
vector specific flanking sequence which were required to be r e a d  
through before coming across unique flanking sequence. Both  
primers  were designed from sequences which were expected to  
occur in the cloned IPCR product.
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Sequences  from both 3N20 and TK22 pr imed DNA 
sequencing react ions were recovered and were used to search t h e
Genbank and EMBL database using the FASTA search a l g o r i t h m
(Lipman and Pearson, 1985). From this it was found that s e q u e n c e  
der ived from 3N20 primed reactions on the KS-T240 p l a s m i d  
containing the PCR insert  (clone 3; see Figure B.5, lane 4) w a s
identical to the 3' UTR of the rabbit P-globin gene (with respect  to  
rabbi t  P-globin sequences (AC J00660) nucleotides 5 5 1 - 6 0 4  
inclusive; see Figure B.5.A). Similar data was recovered from t h e
other clones sequences (data not shown).
DNA sequencing, using the TK22 pr imer  which is 
complementary  to the thymidine kinase promoter  sequences (TK22, 
Figure B.l and Table 2.3), which drives neo  gene expression in t h e  
enhancer  trap vector, pLSN (Gossler et al, 1989), identified a sm a l l  
f ragment  of sequence identical to 5' of the thymidine k i n a s e  
p rom oter  sequences. These are present in the pLSN t r a n s g e n e  
(Gossler et al, 1989) and should also be present in the IPCR p ro d u c t .  
The remaining sequence identified showed similarity to the r a b b i t  
p-globin sequences. Data upstream of the thymidine k i n a s e  
homologous fragment was found to be identical to the rabbit  p-
globin gene (Figure B.6.B). This sequence corresponded to s e q u e n c e s  
3' in relation to the rabbit p-globin homologous sequences  id e n t i f i e d
by the 3N20 primed DNA sequencing reactions (TK22 p r i m e d  
reaction; nucleot ides 970-1 150 inclusive of the rabbit  p -g lo b in  
sequence, AC: J00660 and 3N20 primed DNA sequencing r ea c t io n ,  
nucleotides  inclusive of the rabbit  sequence AC: J00660). T h e  
re la t ionship  between identified sequences is represented  in F ig u re  
B.6.C.
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Figure B.5 Analys i s  of  s ub - c l o ne s  der ived from l igat ion o f  
second round PCR product  l igated into T - v e c t o r s  
pBluescr ipt  KS-T and pGem-T.
4 pi of plasmid DNA recovered by Promega Wizard m i n i p r e p  
protocol from 3 ml of overnight bacterial cidtiires was digested w i th  
the restriction enzymes, Kpn\  and ,S’/n^/l (KS-T DNA only) and Nco\  
and Sa!\  (pGem-T DNA only). 10 pi of the digests were t h e n  
e lectrophoresed.  Lane I) pBluescript KS- cut with K pn\  and S m a \ \  
lanes 2) to 5), KS-T clones 2, 3, 5 and 6 digested with enzymes K p n \  
and Sm a\ \  lane 6) pGem-T digested with the restriction e n z y m e s  
N c o \  and Sal\ \  lanes 7) to II) ,  pGem-T 240 clones, 8,9,10,11 and 13 
digested with the restriction enzymes Nco\  and Sa!\\ Lanes 12) 3 0 0  
ng of 100 bp double stranded DNA marker ladder (BRL); 13). 300 ng 
of I kbp double stranded DNA m aiker ladder (BRL); lane 14). 3 pi of  
the second round PCR reaction using primers neol and neo 2.
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Legend to Figure B.6 Seq uen ce  a l i g n m e n t  with s e q u e n c e s  
der ived  from K S- T- 24 0  clone 3, using pr imers  A) 3 N 2 0  
and B) TK22.
A) Alignment of sequences from KS-T-240, clone 3, using p r i m e r  
3N20 and rabbit p-globin sequences  and Tn5 neo  sequences  (AC: 
J01834; Beck et al, 1982). B) Alignment of sequences  from KS-T- 
240 clone 3, using primer TK22, and rabbit  p-globin s e q u e n c e s  
(AC: J00660). C) Diagrammatic  represen ta t ion  of the r e l a t i o n s h i p  
of sequences  der ived from TK22 and 3N20 primed DNA s e q u e n c e  
reactions performed on clone 3, relative to the s tructure  of KS- 
T240 clone 3 insert. Arrows indicate the primers; p -g lob in  
represents  sequences  identical to rabbit p-globin s e q u e n c e s  
(indicated in purple coloured text); tk represent  thymid ine  k i n a s e  
promoter  sequences (blue coloured text) and n eo  (green t e x t )  
indicates neomycin p hospho trans fe rase  specific sequences.  T h e  
dashed lines indicates unidentified sequence in formation from t h e  
insert  of clone 3. Colours are coordinated in the sequence (A a n d
B) and in the diagrammatic representation (C).
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Figure B.7 Southern  analys i s  on two s eparate  g e n o m i c  
DNAs  derived from two separate  cell lysates.
10 Mg of genomic DNA was extracted from the cell lysates D 3 - 0 5 2  
and D3-240 in the manner described in Chapter 2 and digested w i th  
the restrict ion endonucleases,  E (Fcr^Rl) and B (^c//7îH1) and p r o b e d  
with A) lacz. and B) nco  gene specific probes.
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B.5 So uth er n  analys i s  of  gen omi c  DNA d er i ved  from c e l l  
l ysates  o f  enhancer  trap l ines,  D3-052  and D3-240.
Genomic DNA derived from line specific ES cell l y s a t e s  
obtained from Achim Gossler was extracted by the m e t h o d  
described in Chapter 2, section 2.8.3. Erom Figure 8.7 it can b e  
observed that in genomic DNA from independent  ES cell lines D3-  
052 and D3-240, fragments  of the same size for the r e s t r i c t i o n  
enzymes  EcoRI and Bam Wl  are observed. This is true for w h e n  
probed with a neo  specific random primed probe ( Ik b p  X h a \ - X h a \  
f ragm ent  of plasmid incorporat ing the gene- t rap vector PGTl,  
Gossler et al, unpublished data) or lacz. specific random p r i m e d  
probe (1.8 kbp H in c U -H in c U  f ragment of plasmid p M C 1871 ,  
Shapira et al, 1983). An &Y;R1 fragment of 2.0 kbp and 7.5 k b p  
BainH l  were detected in the genomic DNA digests using the n e o  
specific probe (Figure B.7.A). Likewise 9.5 kbp Ecy^RI and 3.5 k b p  
B a m H l  fragments were detected in genomic DNA derived from b o t h  
the cell lysates,  when probed with lacz specific sequences (F igu re  
B.7.B).
B.6 Di scuss ion .
The identification of novel genes by the analysis of e n h a n c e r  
trap integrations , has been used successfully by Korn et al ( 1 9 9 2 ) .  
The main feature of this approach is the identification of specific  
express ion patterns of a reporte r  gene driven by e n d o g e n o u s  
regulatory sequences. The native gene(s) which is (are) the target of  
these regulatory  elements  is presumed to be in the vicinity of t h e  
insertion site. As a pre l iminary step to identif ication of the gene .
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cloning of the unique sequences  from around the integration site is 
required to start  a search of the surrounding genomic region. This  
can be achieved by a number  of ways such as lambda l i b r a r y
construction from the genomic DNA of that part icular  enhancer  t r a p  
cell-line and identification of clones which contain insertion s i te  
sequences  (which are known and character ised) .  L i b r a r y
construction is time consuming. There are PCR based methods w h ic h  
can and have been used to isolate flanking regions.
B.6.1 Inverse  PCR.
Korn et al (1992) have already used the inverse PCR (IPCR) 
procedure  to clone and identify mouse endogenous f la n k in g  
sequences, using outwardly directed PCR primers.  IPCR is
dependent on the availabili ty of suitable restriction enzyme sites in 
the endogenous  mouse DNA which do not cut between the PCR 
pr imer  pairs and are not so distant from the insertion site as to
reduce the efficiency of the PCR reaction directed from t h e
circularised product of  ligation.
IPCR from line D3-240 was carried out and a specific PCR
product  was detected. However,  sequence analysis revealed that t h e  
insert  of this cloned product had 97.75% identity to the 3' UTR 
region of the rabbit  p-globin gene, in addition to the e x p e c t e d  
residual neo  and thymidine kinase promoter  sequences d e r i v e d  
from the vector. This can have came about in several ways. A n
obvious point to consider is that a DNA contaminat ion had o ccu r red .  
This event  may have been possible at multiple stages. First to
consider is that there has been a contamination of the cell-line w i t h  
the vector containing the pLSN enhancer  trap itself. This is u n l ik e ly
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because: 1) The vector construct in which pLSN is mainta ined d o e s  
not contain a eukaryot ic  origin of replication (but does contain t h e  
plasmid origin of replication; Gossler et al, 1989). 2) P e r s o n a l
communicat ions with A. Gossler revealed that the pLSN vector d o e s  
not contain p-globin poly-adenyla t ion  signal sequences, but i n s t e a d  
contains SV40 derived poly-adenylat ion signal sequences.
A lternat ive ly  we may be dealing with an enhancer  t r a p  
in tegra tion which has retained the flanking Ecr^Rl restr iction s i te  
which is present  in the parent  plasmid polylinker.  However this is 
also unlikely because p-globin derived po ly-adeny la t ion  s ignal  
sequences are not present in the pLSN enhancer  trap vector (A. 
Gossler,  pers. comm.).
Another  explanation to consider is that an air-borne DNA 
containing both neo  sequences and the rabbit  p-globin s e q u e n c e s  
may have contaminated  the PCR reaction (or genomic DNA d e r i v e d  
from the cell-lysates).  This is a possibility because of the e x i s t e n c e  
of vectors which have utilised both neo  gene sequences  as a 
reporter gene and the 3' UTR sequences of the rabbit  p-globin g e n e  
as poly-adenylation signal sequences. These have been in use, all b e  
it many years ago, in the depar tm en t  in which this work w a s  
conducted.  The P-globin sequences are used in connect ion with t h e  
po ly -adeny la t ion  signal sequences which are used to t e r m i n a t e  
t ranscr ip t ion from expression vectors. An example of this type of  
vector would be p S V 2 tk n e o p g  (Okayama and Berg, 1983). This  
vector contains a neo  gene which has at its 3' extremity, s e q u e n c e s  
from intervening sequence 2 (IVS or intron 2) of the rabbit  p -g lob in  
gene. These sequences  are represented  in the sequence d e r i v e d  
from the sequencing experiments  described in this Chapter  ( s e e  
Figure B.6). Fur thermore ,  a hypothet ical restriction of this v e c t o r
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and its parent plasmid vector backbone with reveals that t h e
restriction product containing the neo  gene and rabbit p-globin g e n e  
sequences  is 1.9kb in size. This is similar in size to the EcoRl  
genomic f ragment  detected in cell-line D3-240 by a neo  s e q u e n c e  
specific probe, (as described in this Chapter; see Section B.2.3 a n d  
Figure B.2). This vector (or a closely related der ivat ive)  m a y  
rep resen t  the contamination in this experiment .  However  th i s  
vector  does not contain the lacZ g en e  and the remaining g e n o m ic  
DNA Southern blot restriction fragment data is consis tent  with a 
pLSN enhancer  trap integration. For example the e x p e c t e d  
f ragm ents  internal to the pLSN vector, are detected (see Sect ion 
B.3).
A contamination may have been introduced at other points in 
the exper imenta l  process. For example the plasmid m e n t i o n e d  
above, p S V 2 tk n e o p g  (Nicolas and Berg, 1983), contains an S V 40  
replicat ion origin and this may have been introduced into the cel l-  
line (at sometime in the past) and would have been c o n t in u a l ly  
propaga ted  as a replicon by the constant presence of neomycin o r  
an analogue {e.g. G418) as a selection agent. Therefore in a g e n o m ic  
DNA isolation from a cell-line, a plasmid contaminat ion  w o u ld  
already be present.  There is no way to derive the origin of th i s  
con tam inat ion  and it is an unfortunate  aberration. This c o n t r i b u t e d  
to the abandonment of this particular line of research.
B . 6 . 2 One cel l - l ine?
Another  point to consider was the discovery from g e n o m ic  
Southern blot experiments  that the same restriction fragments  w e r e  
observed for genomic DNA isolated from lysates from two d i f f e r e n t
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enhancer  trap cell lines using the neo  specific probe. The g e n o m ic
DNA from lysates from cell lines D3-240 and 52 were observed to  
have f ragments  sized at 2 kbp and 7.5 kbp for Ec-oRI and B a m H l  
respect ive ly  (Figure B.7). A similar result was observed using t h e  
lacz  specific probe. A 9.5 kbp Ecr^Rl fragment  and a 3.5 kbp B a m H l  
f ragm ent  were detected both for D3-052 and D3-240 (Figure B.7).
From  this it was concluded that these cell-lysates contained genomic 
DNA with the same insertion site. This may have occurred due to  
contamination by a cell-line which over-grew the original cell l ines.  
A l terna t ive ly  an operator  error may have occurred and c e r t a i n  
lysates  were mis labelled.
The final piece of evidence which also persuaded  me to  
discontinue this par ticular  line of research was that a student  in A. 
Gossler 's laboratory who was working on an enhancer  trap c e l l - l in e  
that was supposed to give an expression pattern distinct from t h a t  
of D3-240, cloned the insertion site flanking sequences  of the ETS 
from that cell-line by IPCR and checked that the sequences w e r e  
novel. A new gene was identified in the proximity of the i n s e r t i o n  
site. Using these novel gene sequences, a in s i tu  h y b r i d i s a t i o n  
exper im en t  identified the expression pattern of this gene. It w a s  
found that this gene had a similar expression profile in d e v e l o p i n g  
mouse embryo to the original t ransgene expression p a t t e r n
described for the enhancer  trap positive cell-line D3-240. This
supports the idea that the same cell-line, in some way c o n t a m i n a t e d  
other ETS cell-line isolates.
It was possible that IPCR could have been a t tempted,  u s in g  
other restriction fragments.  For example the flanking K p n l  a n d  
BajnH l  restriction sites (Figure B.3) at the neo  "end" of the pLSN 
vector integration could have been used to provide a template  fo r
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IPCR, using the neo  primers. Alternatively , Ecy>RI, K p n l  and Sai l  
restr ic tion sites (Figure B.3) were suitably positioned in the u n i q u e  
f lanking sequences, beyond the lacz. "end" of the insertion s i te  
(Figure B.3), using lacz sequence specific primers used by Korn et al
(1992). This was deemed as unproduct ive  as it was evident  that I 
was  dealing with multiple uncerta int ies  in this exper iment ,  some of  
which could not be overcome by repeating the approach a l r e a d y  
described in this Chapter i.e. the apparent identity in the r e s t r i c t i o n  
f ragments  detected by Southern blot analysis of genomic DNA f r o m  
supposedly different  cell lines.
Another  route which could be used was that using the E. coli,
S u p F  amber  repressor  tRNA gene, to rescue DNA fragments  t h a t
conta ined the integration site. This requires the prepara t ion  of a 
lambda (or plasmid) l ibrary from the source DNA. Once again, t h e
uncer ta inty  surrounding the source of the DNA which exhibited t h e
same integration pattern, made this line of work unattractive.
B . 6 . 3 Final  remarks .
Being unable to find source material to continue this p r o j e c t
left me with an important  decision. This was whether  to c o n t i n u e
with this research or identify an al ternat ive approach to t h e  
identification of new deve lopm enta l ly  expressed  genes. The r o u t e s  
available to do this are outlined in Chapter 1 (Section 1.1 to 1.4; s ee
also Figure 1.1). I chose a homologous screening approach in
deciding to at tempt  the isolation of anonymous genes from m o u s e  
embryonic  cDNA libraries which contained CAG t r i n u c l e o t i d e  
repeats.  This was the focus of the rest of the work in this thesis.
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A b b r e v i a t i o n s
M e a s u r e m e n t s
A a m p e r e
b p base pair
a c u r i e
c m c e n t i m e t r e
cM c e n t i m o r g a n
c p m counts  per  minute
«C degrees  cent igrade
d p m disin tegrat ions  per  minute
g g r a m
k b k i lo b a s e
k b p kilobase pair
kDa kiloDalton
1 l i t r e
LB p o u n d
M m o l a r
m g m i l l i g r a m
m i n m i n u t e
m l m i l l i l i t r e
m m m i l l i m e t r e
m M mil li m o la r
ng n a n o g r a m
r p m revolu tions per minute
s se c o n d s
sq. in. square inch
pCi m ic ro c u r i e
pF m ic ro F a r a d
Mg m i c r o g r a m
Ml m ic ro l i t r e
V vol t
A b b r e v i a t i o n s  a n d  s y m b o l s .
& a n d
A amp or Alanine
AC Accession number  (databas
AR androgen receptor
a m p am pic i l l in
ATP aden o s in e  5 ' - t r iphospha te
BLAST Basic Local Alignment Se arc
cDNA complementary  DNA
CNS central nervous system
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Abbreviat ions  and symbols  (continued) .
d A T P  d e o x y a d e n o s in e  5 ' - t r ip h o sp h a te
dCTP d eo x y cy to s in e  5 ' - t r iphospha te
DDBJ DNA data bank of Japan
d d N T P  d ideoxy  nuc leos ide  ^ ' - t r ip h o sp h a te
dGTP d e o x y g u a n o s in e  ^ ' - t r ip h o sp h a te
dN TP d eo x y n u c leo s id e  5 ' - t r iphospha te
dT T P  d e o x y th y m id in e  5 ' t r i p h o s p h a t e
DM myoton ic  dys trophy
DMSO dimethyl  su lphoxide
DMF d im ethy l  fo rm a ld eh y d e
DNA deoxribonucleic  acid
DNAse d e o x y r i b o n u c l e a s e
BSA bovine serum albumin
d p c  days post coitum
DTT d i th io th r e i t o l
D yedNTP dye labelled dideoxy nucleoside 5' - tr iphosphate .
EDTA ethylenediaminete traace t ic  acid (d isodium salt)
e.g. for example
EMBL european molecular  biology laboratory
ES em bryonic  stem
EST expressed sequence tag
EtBr e th id ium  bromide
E x o I I I  exonuclease  111
f tp  file transfer protocol
UWGOG university of Winsconsin , genetics computer  group
y-ATP gamma phosphate  labelled phosphate  deoxyadenos ine
^ ' - t r i p h o s p h a t e  
GCG genetics computer  group
G A Pdh g l y c e r a l d e h y d e - 3 - p h o sp h a te  d e h y d r o g e n a s e
HSV herpes  simplex virus
HD Huntingtons  disease
IPTG i s o p r o p y l - p - D - t h i o g a l a c t o - p y r a n o s i d e
X l a m b d a
LM P low melting point
lacZ lactose operon (of the bacteria E. coli), gene Z
k b  k i lo b a s e
k b p  ki lobase  pair
mRNA messenger  ribonucleic acid
n e o  n e o m y c in
n t  n u c l e o t id e
OD. optical density
ORE open reading frame
IPCR inverse PCR.
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Abbreviat i ons  and symbols  (continued) .
pA polyadeny la t ion  site
32p phosphorous,  isotope 32
PCR polymerase  chain reaction
p.f.u. plaque forming unit
P IR protein identificat ion resource
RNase r ib o n u c le a s e
35S sulphur,  isotope 35
SDS sodium dodecyl  sulfate
SM suspens ion  m edium
S V 4 0 simian virus 40
S w is s - P r o t protein sequence databank of Switzerland
TEMED N ,N ,N 'N ' , - t e t r a m e th y le th y le n e d ia m in e
TK thym idine  kinase
U u n i t s
UTR untrans la ted  region
U.V. ul travio le t light
vol v o l u m e
V  /  V volume per volume
W  /  V weight per volume
W watt  ( jou le /second)
X-gal 5-b rom o-4-ch lo ro -3 - indo ly l P - D -g a l a c to s id e
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